Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
11272103 123856 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL363840 123856 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
11272103 123856 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.087
CHEMBL363840 123856 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.087
11272103 123856 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil at 30 nMAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil at 30 nM
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.087
CHEMBL363840 123856 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil at 30 nMAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil at 30 nM
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.087
11272103 123856 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL363840 123856 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
11272103 123856 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL363840 123856 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44455820 94998 0 None - 1 Human 11.0 pIC50 = 11.0 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 551 11 3 7 4.9 CCC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL257074 94998 0 None - 1 Human 11.0 pIC50 = 11.0 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 551 11 3 7 4.9 CCC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
10458976 94569 0 None - 1 Human 10.9 pIC50 = 10.9 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 509 9 3 7 3.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254930 94569 0 None - 1 Human 10.9 pIC50 = 10.9 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 509 9 3 7 3.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44455711 168168 0 None - 1 Human 10.9 pIC50 = 10.9 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 509 9 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL437031 168168 0 None - 1 Human 10.9 pIC50 = 10.9 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 509 9 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11340670 126712 0 None - 1 Human 10.8 pIC50 = 10.8 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 483 7 2 3 5.8 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)ccc1F 10.1021/jm049530m
CHEMBL365820 126712 0 None - 1 Human 10.8 pIC50 = 10.8 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 483 7 2 3 5.8 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)ccc1F 10.1021/jm049530m
11328714 78588 0 None - 1 Human 10.8 pIC50 = 10.8 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113074 78588 0 None - 1 Human 10.8 pIC50 = 10.8 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44455686 95048 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 523 9 3 7 4.3 CC(C)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL257293 95048 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 523 9 3 7 4.3 CC(C)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455869 97096 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 507 9 2 7 4.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270582 97096 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 507 9 2 7 4.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455509 165873 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 493 9 2 6 4.4 CCc1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL427728 165873 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 493 9 2 6 4.4 CCc1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455485 154960 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 507 9 2 6 5.0 CC(C)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL404122 154960 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 507 9 2 6 5.0 CC(C)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11329244 70772 10 None 20 7 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL195433 70772 10 None 20 7 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
11329244 70772 10 None 20 7 Human 10.5 pIC50 = 10.5 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
CHEMBL195433 70772 10 None 20 7 Human 10.5 pIC50 = 10.5 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
11227406 93909 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL250689 93909 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
11227406 93909 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at CCR3 assessed as inhibition of chemotaxis by cell based assayAntagonist activity at CCR3 assessed as inhibition of chemotaxis by cell based assay
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm300682j
CHEMBL250689 93909 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at CCR3 assessed as inhibition of chemotaxis by cell based assayAntagonist activity at CCR3 assessed as inhibition of chemotaxis by cell based assay
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm300682j
11227406 93909 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL250689 93909 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
11227406 93909 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL250689 93909 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
10050884 154115 10 None -1 3 Human 10.4 pIC50 = 10.4 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.087
CHEMBL399495 154115 10 None -1 3 Human 10.4 pIC50 = 10.4 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.087
11227406 93909 1 None 107 4 Human 10.4 pIC50 = 10.4 Functional
Inhibition of eotaxin-induced chemotaxis of Cynomolgus monkey eosinophilsInhibition of eotaxin-induced chemotaxis of Cynomolgus monkey eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL250689 93909 1 None 107 4 Human 10.4 pIC50 = 10.4 Functional
Inhibition of eotaxin-induced chemotaxis of Cynomolgus monkey eosinophilsInhibition of eotaxin-induced chemotaxis of Cynomolgus monkey eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
10050884 154115 10 None -1 3 Human 10.4 pIC50 = 10.4 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL399495 154115 10 None -1 3 Human 10.4 pIC50 = 10.4 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
11169258 140366 0 None - 1 Human 10.4 pIC50 = 10.4 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 587 8 2 10 3.8 Cn1nnnc1-c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1021/jm049530m
CHEMBL382108 140366 0 None - 1 Human 10.4 pIC50 = 10.4 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 587 8 2 10 3.8 Cn1nnnc1-c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1021/jm049530m
11488078 78591 0 None - 1 Human 10.4 pIC50 = 10.4 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113077 78591 0 None - 1 Human 10.4 pIC50 = 10.4 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44455683 154549 0 None - 1 Human 10.3 pIC50 = 10.3 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 531 9 3 7 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL401879 154549 0 None - 1 Human 10.3 pIC50 = 10.3 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 531 9 3 7 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
44455745 154762 0 None - 1 Human 10.3 pIC50 = 10.3 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 559 8 3 7 4.0 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(Br)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL402983 154762 0 None - 1 Human 10.3 pIC50 = 10.3 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 559 8 3 7 4.0 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(Br)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455793 94783 0 None - 1 Human 10.2 pIC50 = 10.2 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 483 9 3 5 4.4 CC(=O)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL256068 94783 0 None - 1 Human 10.2 pIC50 = 10.2 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 483 9 3 5 4.4 CC(=O)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
11397114 132948 0 None - 1 Human 10.2 pIC50 = 10.2 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2cn[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL3706810 132948 0 None - 1 Human 10.2 pIC50 = 10.2 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2cn[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44455766 95241 0 None - 1 Human 10.2 pIC50 = 10.2 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 479 8 2 6 4.3 C[C@H](C[C@@H](C)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL258156 95241 0 None - 1 Human 10.2 pIC50 = 10.2 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 479 8 2 6 4.3 C[C@H](C[C@@H](C)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11953409 93781 0 None 7 4 Human 10.2 pIC50 = 10.2 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249854 93781 0 None 7 4 Human 10.2 pIC50 = 10.2 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445847 93988 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CNCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251079 93988 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CNCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
11214474 71009 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 514 6 2 4 6.7 O=C(Nc1nc2c(Cl)cccc2s1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL195790 71009 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 514 6 2 4 6.7 O=C(Nc1nc2c(Cl)cccc2s1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44445845 93807 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CCNC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL250056 93807 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CCNC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455845 97010 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 537 10 3 7 4.5 CC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270146 97010 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 537 10 3 7 4.5 CC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
44455846 97011 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 515 9 2 6 5.1 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270147 97011 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 515 9 2 6 5.1 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
44455458 166897 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 533 9 3 7 5.3 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2ccon2)cc(-c2ccon2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL429846 166897 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 533 9 3 7 5.3 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2ccon2)cc(-c2ccon2)c1 10.1016/j.bmcl.2007.11.067
11454941 70798 0 None - 1 Human 10.0 pIC50 = 10 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 505 7 2 6 4.7 Cc1nnnn1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL195555 70798 0 None - 1 Human 10.0 pIC50 = 10 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 505 7 2 6 4.7 Cc1nnnn1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
10050884 154115 10 None 1 3 Crab-eating macaque 9.8 pIC50 = 9.8 Functional
Antagonist activity at CCR3 receptor in cynomolgus monkey eosinophil assessed as as inhibition of chemotaxisAntagonist activity at CCR3 receptor in cynomolgus monkey eosinophil assessed as as inhibition of chemotaxis
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL399495 154115 10 None 1 3 Crab-eating macaque 9.8 pIC50 = 9.8 Functional
Antagonist activity at CCR3 receptor in cynomolgus monkey eosinophil assessed as as inhibition of chemotaxisAntagonist activity at CCR3 receptor in cynomolgus monkey eosinophil assessed as as inhibition of chemotaxis
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
44455459 94648 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL255398 94648 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
10140602 166065 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 479 7 2 6 3.4 C[C@H](CC(=O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL428071 166065 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 479 7 2 6 3.4 C[C@H](CC(=O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11398022 98178 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
CHEMBL277131 98178 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
44455484 166852 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 493 9 2 6 4.6 CC(C)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL429604 166852 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 493 9 2 6 4.6 CC(C)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455483 97380 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 537 10 3 7 3.8 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)(C)C(=O)O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL272068 97380 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 537 10 3 7 3.8 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)(C)C(=O)O)c1 10.1016/j.bmcl.2007.11.067
11385766 132275 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL370082 132275 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
11236950 94326 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 479 9 2 6 4.3 CN(CCCc1ccc(F)cc1)C[C@@H]1CCCC[C@H]1NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL253210 94326 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 479 9 2 6 4.3 CN(CCCc1ccc(F)cc1)C[C@@H]1CCCC[C@H]1NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
71460523 81082 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR3 receptor in human eosinophils assessed as inhibition of CCL11-induced degranulation after 4 hrs by ELISAAntagonist activity at CCR3 receptor in human eosinophils assessed as inhibition of CCL11-induced degranulation after 4 hrs by ELISA
ChEMBL 423 7 3 4 3.7 O=C(Nc1ccccc1OCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160099 81082 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR3 receptor in human eosinophils assessed as inhibition of CCL11-induced degranulation after 4 hrs by ELISAAntagonist activity at CCR3 receptor in human eosinophils assessed as inhibition of CCL11-induced degranulation after 4 hrs by ELISA
ChEMBL 423 7 3 4 3.7 O=C(Nc1ccccc1OCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
44455817 154639 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 538 9 3 8 3.6 CNC(=O)O[C@H](C[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)N1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL402331 154639 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 538 9 3 8 3.6 CNC(=O)O[C@H](C[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)N1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
10050884 154115 10 None -1 3 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-stimulated intracellular calcium fluxAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-stimulated intracellular calcium flux
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL399495 154115 10 None -1 3 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-stimulated intracellular calcium fluxAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-stimulated intracellular calcium flux
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
44445854 93649 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 522 7 2 7 3.3 CC(=O)c1sc(NC(=O)N[C@@H]2CS(=O)(=O)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249057 93649 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 522 7 2 7 3.3 CC(=O)c1sc(NC(=O)N[C@@H]2CS(=O)(=O)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
45267588 194360 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 5 2 4 4.5 Cc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c(O)c1 10.1016/j.bmc.2009.06.066
CHEMBL560275 194360 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 5 2 4 4.5 Cc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c(O)c1 10.1016/j.bmc.2009.06.066
44512617 193668 0 None 79 2 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells by functional inhibition curve analysisAntagonist activity at human CCR3 expressed in mouse B300-19 cells by functional inhibition curve analysis
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL551735 193668 0 None 79 2 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells by functional inhibition curve analysisAntagonist activity at human CCR3 expressed in mouse B300-19 cells by functional inhibition curve analysis
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44455658 166720 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 479 8 3 5 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nccn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL429323 166720 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 479 8 3 5 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nccn2C)c1 10.1016/j.bmcl.2007.11.067
44289715 169668 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 465 8 2 6 3.8 Cc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL444568 169668 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 465 8 2 6 3.8 Cc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11272103 123856 0 None -37 8 Human 9.0 pIC50 = 9 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL363840 123856 0 None -37 8 Human 9.0 pIC50 = 9 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
11363006 70092 0 None - 1 Human 9.0 pIC50 = 9 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 453 7 2 3 5.5 COc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
CHEMBL194601 70092 0 None - 1 Human 9.0 pIC50 = 9 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 453 7 2 3 5.5 COc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
44455539 166429 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 465 8 2 6 3.9 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL428775 166429 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 465 8 2 6 3.9 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
45271892 193670 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 515 5 1 5 4.3 O=C(C=C1CCN(C(=O)c2ccc3c(c2)OCO3)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL551739 193670 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 515 5 1 5 4.3 O=C(C=C1CCN(C(=O)c2ccc3c(c2)OCO3)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
71460523 81082 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 423 7 3 4 3.7 O=C(Nc1ccccc1OCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160099 81082 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 423 7 3 4 3.7 O=C(Nc1ccccc1OCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
45271891 193669 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 6 1 4 4.5 COc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)cc1 10.1016/j.bmc.2009.06.066
CHEMBL551738 193669 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 6 1 4 4.5 COc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)cc1 10.1016/j.bmc.2009.06.066
11363005 60182 0 None - 1 Human 8.0 pIC50 = 8 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 453 7 2 3 5.5 COc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL175634 60182 0 None - 1 Human 8.0 pIC50 = 8 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 453 7 2 3 5.5 COc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11329244 70772 10 None -20 7 Mouse 8.0 pIC50 = 8 Functional
Inhibition of eotaxin-induced chemotaxis of mouse eosinophilsInhibition of eotaxin-induced chemotaxis of mouse eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
CHEMBL195433 70772 10 None -20 7 Mouse 8.0 pIC50 = 8 Functional
Inhibition of eotaxin-induced chemotaxis of mouse eosinophilsInhibition of eotaxin-induced chemotaxis of mouse eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
45269392 194352 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 374 5 1 2 4.4 O=C(/C=C/c1ccccc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL560198 194352 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 374 5 1 2 4.4 O=C(/C=C/c1ccccc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
71449694 81086 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 437 8 3 4 3.9 O=C(Nc1ccccc1COCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160102 81086 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 437 8 3 4 3.9 O=C(Nc1ccccc1COCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
70694703 75794 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 578 5 2 3 6.1 O=C(Nc1cccc(Br)c1)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2057764 75794 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 578 5 2 3 6.1 O=C(Nc1cccc(Br)c1)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
44451981 160724 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 454 6 1 3 6.2 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1cccc(Oc2ccccc2)c1 10.1016/j.bmc.2007.10.003
CHEMBL412061 160724 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 454 6 1 3 6.2 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1cccc(Oc2ccccc2)c1 10.1016/j.bmc.2007.10.003
44282031 119310 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 488 8 2 5 3.2 CC(NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)N1CCCC1 10.1016/s0960-894x(01)00249-9
CHEMBL34839 119310 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 488 8 2 5 3.2 CC(NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)N1CCCC1 10.1016/s0960-894x(01)00249-9
11363005 60182 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 453 7 2 3 5.5 COc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL175634 60182 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 453 7 2 3 5.5 COc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44281673 109867 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 572 10 3 5 5.6 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@H](C(=O)Nc1ccccc1)c1ccccc1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL32410 109867 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 572 10 3 5 5.6 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@H](C(=O)Nc1ccccc1)c1ccccc1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
76331527 102888 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 486 6 1 3 6.6 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1OC1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084575 102888 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 486 6 1 3 6.6 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1OC1CCCCC1 10.1016/j.bmc.2008.08.006
71458677 81058 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 423 7 3 4 3.7 O=C(Nc1ccc(OCCO)cc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2159868 81058 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 423 7 3 4 3.7 O=C(Nc1ccc(OCCO)cc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
76316939 102892 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 513 5 1 3 5.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084579 102892 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 513 5 1 3 5.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCCCCC1 10.1016/j.bmc.2008.08.006
45270978 194839 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 489 5 1 3 4.7 O=C(C=C1CCN(C(=O)c2cccc(F)c2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL563536 194839 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 489 5 1 3 4.7 O=C(C=C1CCN(C(=O)c2cccc(F)c2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44282048 111146 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 520 9 3 5 4.2 COc1ccccc1NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(C#N)cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL32852 111146 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 520 9 3 5 4.2 COc1ccccc1NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(C#N)cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
44282385 99621 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 562 7 1 6 6.1 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)c1nc(C(=O)N2CCc3ccccc3C2)cs1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL287320 99621 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 562 7 1 6 6.1 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)c1nc(C(=O)N2CCc3ccccc3C2)cs1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
76327878 102884 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccncc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084571 102884 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccncc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
70686358 75793 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 578 5 2 3 6.1 O=C(Nc1ccccc1Br)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2057763 75793 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 578 5 2 3 6.1 O=C(Nc1ccccc1Br)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
70682102 75796 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 518 5 2 3 5.4 O=C(Nc1ccccc1F)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2057766 75796 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 518 5 2 3 5.4 O=C(Nc1ccccc1F)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
2729098 80084 2 None -11 2 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 362 4 1 2 4.4 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1 10.1016/j.bmc.2007.10.003
CHEMBL214726 80084 2 None -11 2 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 362 4 1 2 4.4 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1 10.1016/j.bmc.2007.10.003
76309741 102893 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ncccc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084580 102893 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ncccc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
44399469 165573 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibitory concentration against BaF3 cell line expressed recombinant human CCR3 using the LDH assayInhibitory concentration against BaF3 cell line expressed recombinant human CCR3 using the LDH assay
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL426089 165573 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibitory concentration against BaF3 cell line expressed recombinant human CCR3 using the LDH assayInhibitory concentration against BaF3 cell line expressed recombinant human CCR3 using the LDH assay
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
71449677 81053 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 448 5 2 4 2.3 CS(=O)(=O)N1CCC(NC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmcl.2012.09.035
CHEMBL2159863 81053 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 448 5 2 4 2.3 CS(=O)(=O)N1CCC(NC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmcl.2012.09.035
45271843 194696 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1ccc(O)c(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c1 10.1016/j.bmc.2009.06.066
CHEMBL562574 194696 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1ccc(O)c(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c1 10.1016/j.bmc.2009.06.066
45267629 194676 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 424 5 1 2 5.7 O=C(N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
CHEMBL562475 194676 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 424 5 1 2 5.7 O=C(N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
23509697 193281 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 440 6 2 4 3.6 COc1cccc(NC(=O)N2CCNC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL54273 193281 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 440 6 2 4 3.6 COc1cccc(NC(=O)N2CCNC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
44282006 123130 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 525 10 3 5 4.3 COc1ccc(C[C@H](NC(=O)c2cccc3ccccc23)C(=O)N[C@@H](C)C(=O)Nc2ccccc2OC)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL36195 123130 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 525 10 3 5 4.3 COc1ccc(C[C@H](NC(=O)c2cccc3ccccc23)C(=O)N[C@@H](C)C(=O)Nc2ccccc2OC)cc1 10.1016/s0960-894x(01)00249-9
44440402 93484 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of calcium fluxAntagonist activity at human CCR3 receptor assessed as inhibition of calcium flux
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL248179 93484 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of calcium fluxAntagonist activity at human CCR3 receptor assessed as inhibition of calcium flux
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44440402 93484 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of eotaxin-induced eosinophil shape changeAntagonist activity at human CCR3 receptor assessed as inhibition of eotaxin-induced eosinophil shape change
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL248179 93484 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of eotaxin-induced eosinophil shape changeAntagonist activity at human CCR3 receptor assessed as inhibition of eotaxin-induced eosinophil shape change
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
45270977 193481 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 409 4 1 3 3.2 CC(=O)N1CCC(=CC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmc.2009.06.066
CHEMBL550255 193481 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 409 4 1 3 3.2 CC(=O)N1CCC(=CC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmc.2009.06.066
70682100 75787 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 568 4 1 3 5.9 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057757 75787 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 568 4 1 3 5.9 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1016/j.bmcl.2012.06.042
11430170 123315 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 423 6 2 2 5.5 O=C(Nc1ccccc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL362466 123315 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 423 6 2 2 5.5 O=C(Nc1ccccc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
45271911 193387 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 362 5 1 2 3.9 O=C(Cc1ccccc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL549514 193387 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 362 5 1 2 3.9 O=C(Cc1ccccc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44452250 95787 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 362 4 1 2 4.8 O=C(Nc1ccccc1)C1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
CHEMBL260900 95787 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 362 4 1 2 4.8 O=C(Nc1ccccc1)C1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
44281793 99652 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 414 7 1 5 4.7 CCn1ccnc1[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL287538 99652 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 414 7 1 5 4.7 CCn1ccnc1[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
70688459 75786 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 568 5 1 3 6.7 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(Cc2c(Cl)cccc2Cl)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057756 75786 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 568 5 1 3 6.7 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(Cc2c(Cl)cccc2Cl)CC1 10.1016/j.bmcl.2012.06.042
44281891 125187 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 474 8 2 6 4.7 CCNC(=O)c1csc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
CHEMBL36473 125187 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 474 8 2 6 4.7 CCNC(=O)c1csc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
44281612 109137 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 510 9 3 5 4.2 C[C@H](NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccccc1 10.1016/s0960-894x(01)00249-9
CHEMBL32224 109137 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 510 9 3 5 4.2 C[C@H](NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccccc1 10.1016/s0960-894x(01)00249-9
10194663 81088 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 423 7 3 4 3.7 O=C(Nc1cccc(OCCO)c1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160104 81088 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 423 7 3 4 3.7 O=C(Nc1cccc(OCCO)c1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
70692659 75732 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 499 7 1 3 5.5 O=C(NCCCN1CCC(C(c2ccccc2)c2ccccc2)CC1)N1CCc2cc(F)ccc2C1=O 10.1016/j.bmcl.2012.06.042
CHEMBL2057490 75732 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 499 7 1 3 5.5 O=C(NCCCN1CCC(C(c2ccccc2)c2ccccc2)CC1)N1CCc2cc(F)ccc2C1=O 10.1016/j.bmcl.2012.06.042
11409583 69439 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 507 8 2 4 5.9 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1021/jm049530m
CHEMBL193575 69439 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 507 8 2 4 5.9 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1021/jm049530m
11454941 70798 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 505 7 2 6 4.7 Cc1nnnn1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL195555 70798 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 505 7 2 6 4.7 Cc1nnnn1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
11328714 78588 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113074 78588 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11488078 78591 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113077 78591 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11169258 140366 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 587 8 2 10 3.8 Cn1nnnc1-c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1021/jm049530m
CHEMBL382108 140366 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 587 8 2 10 3.8 Cn1nnnc1-c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1021/jm049530m
44401328 70752 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL195348 70752 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
71460525 81095 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 526 6 3 5 3.4 O=C(NC1CCN(S(=O)(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160111 81095 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 526 6 3 5 3.4 O=C(NC1CCN(S(=O)(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
44290039 178224 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL46905 178224 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
11953409 93781 0 None 7 4 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assayAntagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assay
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249854 93781 0 None 7 4 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assayAntagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assay
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44447144 168207 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 483 11 3 7 3.0 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(C)CCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL437396 168207 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 483 11 3 7 3.0 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(C)CCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
10474776 113158 36 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113158 36 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
44281975 99168 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 491 8 2 6 3.9 C[C@@H](NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)OC(C)(C)C 10.1016/s0960-894x(01)00249-9
CHEMBL284166 99168 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 491 8 2 6 3.9 C[C@@H](NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)OC(C)(C)C 10.1016/s0960-894x(01)00249-9
44452168 95407 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 464 5 1 2 6.6 O=C(NC1C[C@@H]2CC[C@@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2007.10.003
CHEMBL258996 95407 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 464 5 1 2 6.6 O=C(NC1C[C@@H]2CC[C@@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2007.10.003
24882359 192445 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 464 5 1 2 6.6 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2008.08.006
CHEMBL522295 192445 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 464 5 1 2 6.6 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2008.08.006
70696744 75733 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 464 5 1 2 6.6 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2012.06.042
CHEMBL2057491 75733 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 464 5 1 2 6.6 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2012.06.042
24882359 192445 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 464 5 1 2 6.6 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
CHEMBL522295 192445 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 464 5 1 2 6.6 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
3492 685 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
In vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assay
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
9868459 685 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
In vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assay
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
CHEMBL50593 685 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
In vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assay
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
11272103 123856 0 None -1995 8 Mouse 7.7 pIC50 = 7.7 Functional
Inhibition of eotaxin-induced chemotaxis of mouse eosinophilsInhibition of eotaxin-induced chemotaxis of mouse eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL363840 123856 0 None -1995 8 Mouse 7.7 pIC50 = 7.7 Functional
Inhibition of eotaxin-induced chemotaxis of mouse eosinophilsInhibition of eotaxin-induced chemotaxis of mouse eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
22393339 186154 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
In vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assay
ChEMBL 410 7 2 3 4.7 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(Cl)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL48873 186154 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
In vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assay
ChEMBL 410 7 2 3 4.7 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(Cl)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
23509693 190897 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 540 6 1 5 5.2 COc1cccc(NC(=O)N2CCN(C(=O)OC(C)(C)C)C(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51937 190897 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 540 6 1 5 5.2 COc1cccc(NC(=O)N2CCN(C(=O)OC(C)(C)C)C(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
71462227 81092 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 466 4 0 3 6.6 O=C1OC2(CCN(Cc3ccc4cc(F)ccc4c3)CC2)c2ccccc2N1Cc1ccccc1 10.1016/j.bmcl.2012.09.035
CHEMBL2160108 81092 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 466 4 0 3 6.6 O=C1OC2(CCN(Cc3ccc4cc(F)ccc4c3)CC2)c2ccccc2N1Cc1ccccc1 10.1016/j.bmcl.2012.09.035
45270135 193597 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 441 5 2 4 3.6 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)NS(=O)(=O)c1ccccc1 10.1016/j.bmc.2009.06.066
CHEMBL551205 193597 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 441 5 2 4 3.6 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)NS(=O)(=O)c1ccccc1 10.1016/j.bmc.2009.06.066
45268444 194344 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 458 6 1 3 5.6 O=C(C=C1CCC(Oc2ccccc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL560135 194344 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 458 6 1 3 5.6 O=C(C=C1CCC(Oc2ccccc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44282030 111142 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 461 8 1 7 3.5 CCOC(=O)C1COC([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)=N1 10.1016/s0960-894x(01)00249-9
CHEMBL32850 111142 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 461 8 1 7 3.5 CCOC(=O)C1COC([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)=N1 10.1016/s0960-894x(01)00249-9
76320670 102887 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 454 5 1 4 5.1 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-n1ccnc1 10.1016/j.bmc.2008.08.006
CHEMBL3084574 102887 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 454 5 1 4 5.1 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-n1ccnc1 10.1016/j.bmc.2008.08.006
45270980 193506 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 489 5 1 3 4.7 O=C(C=C1CCN(C(=O)c2ccc(F)cc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL550464 193506 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 489 5 1 3 4.7 O=C(C=C1CCN(C(=O)c2ccc(F)cc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44447361 94512 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 453 9 4 8 1.8 C[C@@H]([C@@H](O)c1ccccc1)N(C)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254503 94512 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 453 9 4 8 1.8 C[C@@H]([C@@H](O)c1ccccc1)N(C)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
23509695 189147 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCOC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51584 189147 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCOC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
76331526 102879 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 453 5 1 3 5.7 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-n1cccc1 10.1016/j.bmc.2008.08.006
CHEMBL3084566 102879 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 453 5 1 3 5.7 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-n1cccc1 10.1016/j.bmc.2008.08.006
76327880 102891 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 485 5 1 3 5.1 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084578 102891 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 485 5 1 3 5.1 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCCC1 10.1016/j.bmc.2008.08.006
44281943 99769 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 387 6 1 5 4.5 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)c1cnco1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL288554 99769 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 387 6 1 5 4.5 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)c1cnco1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
71453334 81080 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 407 6 2 3 4.5 COCc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160097 81080 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 407 6 2 3 4.5 COCc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
76316938 102880 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 499 5 1 3 5.5 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084567 102880 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 499 5 1 3 5.5 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
44512619 102894 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 516 5 1 4 4.2 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1cc[n+]([O-])cc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084581 102894 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 516 5 1 4 4.2 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1cc[n+]([O-])cc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
45270199 194744 0 None 47 2 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 516 5 1 4 4.2 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1cc[n+]([O-])cc1C(=O)N1CCCCC1 10.1016/j.bmc.2009.06.066
CHEMBL562897 194744 0 None 47 2 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 516 5 1 4 4.2 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1cc[n+]([O-])cc1C(=O)N1CCCCC1 10.1016/j.bmc.2009.06.066
44401561 123602 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL363373 123602 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
45271882 193589 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 366 4 1 2 4.1 O=C(N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccc(F)cc1 10.1016/j.bmc.2009.06.066
CHEMBL551134 193589 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 366 4 1 2 4.1 O=C(N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccc(F)cc1 10.1016/j.bmc.2009.06.066
71455029 81059 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 464 7 2 4 3.8 CN(C)C(=O)COc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2159869 81059 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 464 7 2 4 3.8 CN(C)C(=O)COc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
70696753 75792 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 500 5 2 3 5.3 O=C(Nc1ccccc1)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2057762 75792 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 500 5 2 3 5.3 O=C(Nc1ccccc1)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
44452009 95501 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 392 5 1 3 4.4 COc1ccc(C(=O)NC2CCN(Cc3ccc4cc(F)ccc4c3)CC2)cc1 10.1016/j.bmc.2007.10.003
CHEMBL259409 95501 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 392 5 1 3 4.4 COc1ccc(C(=O)NC2CCN(Cc3ccc4cc(F)ccc4c3)CC2)cc1 10.1016/j.bmc.2007.10.003
10474776 113158 36 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113158 36 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
71453337 81094 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 540 5 2 5 3.8 O=C(NC1CCN(S(=O)(=O)c2ccccc2O)CC1)N1CCCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmcl.2012.09.035
CHEMBL2160110 81094 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 540 5 2 5 3.8 O=C(NC1CCN(S(=O)(=O)c2ccccc2O)CC1)N1CCCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmcl.2012.09.035
44290039 178224 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL46905 178224 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
44282005 123236 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 520 9 3 5 4.2 COc1ccc(C[C@H](NC(=O)c2cccc3ccccc23)C(=O)N[C@@H](C)C(=O)Nc2ccc(C#N)cc2)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL36223 123236 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 520 9 3 5 4.2 COc1ccc(C[C@H](NC(=O)c2cccc3ccccc23)C(=O)N[C@@H](C)C(=O)Nc2ccc(C#N)cc2)cc1 10.1016/s0960-894x(01)00249-9
45269291 194766 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 427 5 2 4 3.2 O=C(N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)NS(=O)(=O)c1ccccc1 10.1016/j.bmc.2009.06.066
CHEMBL563019 194766 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 427 5 2 4 3.2 O=C(N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)NS(=O)(=O)c1ccccc1 10.1016/j.bmc.2009.06.066
45269385 194806 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 424 5 1 2 5.7 O=C(N[C@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
CHEMBL563319 194806 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 424 5 1 2 5.7 O=C(N[C@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
44281668 109933 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 500 8 3 4 4.4 C[C@H](NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1cccnc1 10.1016/s0960-894x(01)00249-9
CHEMBL32451 109933 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 500 8 3 4 4.4 C[C@H](NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1cccnc1 10.1016/s0960-894x(01)00249-9
44452168 95407 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 464 5 1 2 6.6 O=C(NC1C[C@@H]2CC[C@@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2007.10.003
CHEMBL258996 95407 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 464 5 1 2 6.6 O=C(NC1C[C@@H]2CC[C@@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2007.10.003
76320671 102889 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 471 5 1 3 5.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1N1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084576 102889 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 471 5 1 3 5.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1N1CCCCC1 10.1016/j.bmc.2008.08.006
71456839 81084 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 467 10 3 5 3.8 O=C(Nc1ccccc1OCCOCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160100 81084 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 467 10 3 5 3.8 O=C(Nc1ccccc1OCCOCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
44452220 160729 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 452 5 1 2 6.4 CC1(NC(=O)c2ccccc2-c2ccccc2)CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
CHEMBL412072 160729 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 452 5 1 2 6.4 CC1(NC(=O)c2ccccc2-c2ccccc2)CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
76313428 102877 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 465 5 1 3 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1cccnc1 10.1016/j.bmc.2008.08.006
CHEMBL3084564 102877 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 465 5 1 3 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1cccnc1 10.1016/j.bmc.2008.08.006
70688469 75834 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 534 5 2 3 5.9 O=C(Nc1ccccc1Cl)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2058070 75834 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 534 5 2 3 5.9 O=C(Nc1ccccc1Cl)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
44452119 95907 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1F 10.1016/j.bmc.2007.10.003
CHEMBL261574 95907 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1F 10.1016/j.bmc.2007.10.003
44281859 109337 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 463 9 2 6 3.2 CCOC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL32334 109337 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 463 9 2 6 3.2 CCOC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
44289926 176985 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 453 9 2 4 4.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL46404 176985 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 453 9 2 4 4.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
44289927 167764 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL43423 167764 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
45268462 194541 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c(O)c1 10.1016/j.bmc.2009.06.066
CHEMBL561535 194541 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c(O)c1 10.1016/j.bmc.2009.06.066
45269302 194442 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 531 7 1 5 4.5 COc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)cc1OC 10.1016/j.bmc.2009.06.066
CHEMBL560995 194442 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 531 7 1 5 4.5 COc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)cc1OC 10.1016/j.bmc.2009.06.066
70688470 75837 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 542 6 2 3 6.4 CC(C)c1ccccc1NC(=O)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2058073 75837 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 542 6 2 3 6.4 CC(C)c1ccccc1NC(=O)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
9892753 16323 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 516 8 3 4 5.5 CNC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm049530m
CHEMBL123611 16323 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 516 8 3 4 5.5 CNC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm049530m
44281667 115161 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 524 10 3 5 3.9 CC(NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)NCc1ccccc1 10.1016/s0960-894x(01)00249-9
CHEMBL33537 115161 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 524 10 3 5 3.9 CC(NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)NCc1ccccc1 10.1016/s0960-894x(01)00249-9
45273705 194125 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 376 5 1 2 4.3 O=C(Cc1ccccc1)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2009.06.066
CHEMBL557936 194125 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 376 5 1 2 4.3 O=C(Cc1ccccc1)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2009.06.066
10050884 154115 10 None -204 3 Mouse 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR3 receptor in mouse eosinophil assessed as as inhibition of chemotaxisAntagonist activity at CCR3 receptor in mouse eosinophil assessed as as inhibition of chemotaxis
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL399495 154115 10 None -204 3 Mouse 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR3 receptor in mouse eosinophil assessed as as inhibition of chemotaxisAntagonist activity at CCR3 receptor in mouse eosinophil assessed as as inhibition of chemotaxis
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
70684230 75836 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 530 6 2 4 5.3 COc1ccccc1NC(=O)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2058072 75836 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 530 6 2 4 5.3 COc1ccccc1NC(=O)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
70682099 75782 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 532 4 1 3 5.2 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057752 75782 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 532 4 1 3 5.2 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2012.06.042
10474776 113158 36 None - 1 Human 7.5 pIC50 = 7.5 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113158 36 None - 1 Human 7.5 pIC50 = 7.5 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
45268519 194599 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 409 5 0 2 6.4 O=C(c1ccccc1-c1ccccc1)C1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL561941 194599 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 409 5 0 2 6.4 O=C(c1ccccc1-c1ccccc1)C1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44281966 99351 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 403 6 1 5 4.9 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)c1nccs1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL285444 99351 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 403 6 1 5 4.9 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)c1nccs1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
44452361 96061 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 338 5 1 2 3.7 O=C(NC1CCN(C/C=C/c2ccc(F)cc2)CC1)c1ccccc1 10.1016/j.bmc.2007.10.003
CHEMBL262588 96061 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 338 5 1 2 3.7 O=C(NC1CCN(C/C=C/c2ccc(F)cc2)CC1)c1ccccc1 10.1016/j.bmc.2007.10.003
10474776 113158 36 None - 1 Human 7.5 pIC50 = 7.5 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113158 36 None - 1 Human 7.5 pIC50 = 7.5 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
11442439 123539 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 455 6 2 2 5.9 Cc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1F 10.1021/jm049530m
CHEMBL363166 123539 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 455 6 2 2 5.9 Cc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1F 10.1021/jm049530m
44386406 62158 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 461 9 2 6 3.3 C=C(NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)OCC 10.1016/s0960-894x(01)00249-9
CHEMBL178019 62158 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 461 9 2 6 3.3 C=C(NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)OCC 10.1016/s0960-894x(01)00249-9
6918497 112931 1 None -213 4 Mouse 6.5 pIC50 = 6.5 Functional
Inhibitory activity against I-Eotaxin induced [Ca2+] response in mouse CCR3 receptorInhibitory activity against I-Eotaxin induced [Ca2+] response in mouse CCR3 receptor
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL277930 112931 1 None -213 4 Mouse 6.5 pIC50 = 6.5 Functional
Inhibitory activity against I-Eotaxin induced [Ca2+] response in mouse CCR3 receptorInhibitory activity against I-Eotaxin induced [Ca2+] response in mouse CCR3 receptor
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL331897 112931 1 None -213 4 Mouse 6.5 pIC50 = 6.5 Functional
Inhibitory activity against I-Eotaxin induced [Ca2+] response in mouse CCR3 receptorInhibitory activity against I-Eotaxin induced [Ca2+] response in mouse CCR3 receptor
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
44452044 155546 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 392 5 1 3 4.4 COc1cccc(C(=O)NC2CCN(Cc3ccc4cc(F)ccc4c3)CC2)c1 10.1016/j.bmc.2007.10.003
CHEMBL406296 155546 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 392 5 1 3 4.4 COc1cccc(C(=O)NC2CCN(Cc3ccc4cc(F)ccc4c3)CC2)c1 10.1016/j.bmc.2007.10.003
70690518 75778 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 555 4 1 4 5.0 CN1CN(c2ccccc2)C2(CCN(C(=O)NC3C[C@H]4CC[C@H](C3)N4Cc3ccc4cc(F)ccc4c3)CC2)C1=O 10.1016/j.bmcl.2012.06.042
CHEMBL2057748 75778 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 555 4 1 4 5.0 CN1CN(c2ccccc2)C2(CCN(C(=O)NC3C[C@H]4CC[C@H](C3)N4Cc3ccc4cc(F)ccc4c3)CC2)C1=O 10.1016/j.bmcl.2012.06.042
10474776 113158 36 None - 1 Human 7.4 pIC50 = 7.4 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using [Ca2+] mobilization assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using [Ca2+] mobilization assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113158 36 None - 1 Human 7.4 pIC50 = 7.4 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using [Ca2+] mobilization assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using [Ca2+] mobilization assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
44451928 158617 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 438 5 1 2 6.0 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2007.10.003
CHEMBL409830 158617 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 438 5 1 2 6.0 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2007.10.003
44451928 158617 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 438 5 1 2 6.0 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
CHEMBL409830 158617 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 438 5 1 2 6.0 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
45268458 195068 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1cccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c1O 10.1016/j.bmc.2009.06.066
CHEMBL565165 195068 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1cccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c1O 10.1016/j.bmc.2009.06.066
71460524 81093 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 474 5 1 3 4.9 O=C(NC1CCN(Cc2ccccc2)CC1)N1CCCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmcl.2012.09.035
CHEMBL2160109 81093 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 474 5 1 3 4.9 O=C(NC1CCN(Cc2ccccc2)CC1)N1CCCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmcl.2012.09.035
70686357 75783 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 529 4 2 4 4.6 Nc1ccc(C(=O)N2CCCN(C(=O)NC3C[C@H]4CC[C@H](C3)N4Cc3ccc4cc(F)ccc4c3)CC2)cc1 10.1016/j.bmcl.2012.06.042
CHEMBL2057753 75783 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 529 4 2 4 4.6 Nc1ccc(C(=O)N2CCCN(C(=O)NC3C[C@H]4CC[C@H](C3)N4Cc3ccc4cc(F)ccc4c3)CC2)cc1 10.1016/j.bmcl.2012.06.042
44282280 119887 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 463 9 2 6 3.2 CCOC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL35341 119887 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 463 9 2 6 3.2 CCOC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
11329244 70772 10 None 20 7 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
CHEMBL195433 70772 10 None 20 7 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
11340670 126712 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 483 7 2 3 5.8 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)ccc1F 10.1021/jm049530m
CHEMBL365820 126712 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 483 7 2 3 5.8 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)ccc1F 10.1021/jm049530m
11397114 132948 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2cn[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL3706810 132948 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2cn[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44401123 135757 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 516 7 2 5 4.9 N#CC1=CC(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)CC=C1n1cccn1 10.1021/jm049530m
CHEMBL373347 135757 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 516 7 2 5 4.9 N#CC1=CC(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)CC=C1n1cccn1 10.1021/jm049530m
9847583 194792 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 471 5 1 3 4.5 O=C(C=C1CCN(C(=O)c2ccccc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL563189 194792 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 471 5 1 3 4.5 O=C(C=C1CCN(C(=O)c2ccccc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
45273624 193994 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 489 5 1 3 4.7 O=C(C=C1CCN(C(=O)c2ccccc2F)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL556500 193994 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 489 5 1 3 4.7 O=C(C=C1CCN(C(=O)c2ccccc2F)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
70696765 75835 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 545 6 2 5 5.2 O=C(Nc1ccccc1[N+](=O)[O-])[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2058071 75835 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 545 6 2 5 5.2 O=C(Nc1ccccc1[N+](=O)[O-])[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
25024651 115536 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of CCR3 in human eosinophil assessed as inhibition of eotaxin-induced Ca2+ influxInhibition of CCR3 in human eosinophil assessed as inhibition of eotaxin-induced Ca2+ influx
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355956 115536 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of CCR3 in human eosinophil assessed as inhibition of eotaxin-induced Ca2+ influxInhibition of CCR3 in human eosinophil assessed as inhibition of eotaxin-induced Ca2+ influx
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
44281706 111070 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 496 9 3 5 3.8 O=C(CNC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)Nc1ccccc1 10.1016/s0960-894x(01)00249-9
CHEMBL32806 111070 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 496 9 3 5 3.8 O=C(CNC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)Nc1ccccc1 10.1016/s0960-894x(01)00249-9
11227406 93909 1 None -107 4 Mouse 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL250689 93909 1 None -107 4 Mouse 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
71460504 81054 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 369 4 2 2 4.2 O=C(NC1CCCCC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2159864 81054 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 369 4 2 2 4.2 O=C(NC1CCCCC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
11227406 93909 1 None -107 4 Mouse 7.4 pIC50 = 7.4 Functional
Inhibition of eotaxin-induced chemotaxis of mouse eosinophilsInhibition of eotaxin-induced chemotaxis of mouse eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL250689 93909 1 None -107 4 Mouse 7.4 pIC50 = 7.4 Functional
Inhibition of eotaxin-induced chemotaxis of mouse eosinophilsInhibition of eotaxin-induced chemotaxis of mouse eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
71456816 81056 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 407 6 3 3 3.9 O=C(Nc1ccccc1CCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2159866 81056 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 407 6 3 3 3.9 O=C(Nc1ccccc1CCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
71455044 81089 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 450 8 2 4 4.3 CN(C)CCOc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160105 81089 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 450 8 2 4 4.3 CN(C)CCOc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
71453336 81090 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 436 7 3 4 3.2 NC(=O)COc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160106 81090 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 436 7 3 4 3.2 NC(=O)COc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
76327879 102890 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 527 6 1 3 6.3 CN(C(=O)c1ccccc1C(=O)N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)C1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084577 102890 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 527 6 1 3 6.3 CN(C(=O)c1ccccc1C(=O)N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)C1CCCCC1 10.1016/j.bmc.2008.08.006
70682098 75780 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 545 4 2 4 5.3 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCC(n2c(=O)[nH]c3c(F)cccc32)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057750 75780 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 545 4 2 4 5.3 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCC(n2c(=O)[nH]c3c(F)cccc32)CC1 10.1016/j.bmcl.2012.06.042
70682101 75788 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 530 4 2 4 4.7 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2ccc(O)cc2)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057758 75788 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 530 4 2 4 4.7 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2ccc(O)cc2)CC1 10.1016/j.bmcl.2012.06.042
44281852 99221 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 511 8 3 3 5.1 Cc1ccc(C(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)N[C@@H](C)C(=O)Nc2ccc(Cl)cc2)c(C)c1 10.1016/s0960-894x(01)00249-9
CHEMBL284531 99221 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 511 8 3 3 5.1 Cc1ccc(C(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)N[C@@H](C)C(=O)Nc2ccc(Cl)cc2)c(C)c1 10.1016/s0960-894x(01)00249-9
44281944 121279 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 529 9 3 4 5.0 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL35896 121279 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 529 9 3 4 5.0 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
70692666 75790 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 554 5 1 3 5.5 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)C2(c3ccccc3)CC2)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057760 75790 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 554 5 1 3 5.5 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)C2(c3ccccc3)CC2)CC1 10.1016/j.bmcl.2012.06.042
45273639 194751 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1cccc(O)c1C(=O)N1CCC(=CC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmc.2009.06.066
CHEMBL562922 194751 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1cccc(O)c1C(=O)N1CCC(=CC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmc.2009.06.066
44452172 95408 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 378 4 1 3 5.2 O=C(Nc1ccccc1)OC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
CHEMBL258997 95408 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 378 4 1 3 5.2 O=C(Nc1ccccc1)OC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
76324312 102881 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 514 5 1 4 4.3 CN1CCN(C(=O)c2ccccc2C(=O)N[C@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2008.08.006
CHEMBL3084568 102881 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 514 5 1 4 4.3 CN1CCN(C(=O)c2ccccc2C(=O)N[C@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2008.08.006
10474776 113158 36 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL33227 113158 36 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
9957612 162711 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 499 8 3 3 5.0 C[C@H](NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccccc1 10.1016/s0960-894x(01)00249-9
CHEMBL418588 162711 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 499 8 3 3 5.0 C[C@H](NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccccc1 10.1016/s0960-894x(01)00249-9
45273632 194030 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2cccc(O)c2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL556916 194030 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2cccc(O)c2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44455847 154907 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 501 9 2 6 4.7 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL403839 154907 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 501 9 2 6 4.7 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
45272697 193948 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 6 1 4 4.5 COc1ccccc1C(=O)N1CCC(=CC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmc.2009.06.066
CHEMBL556227 193948 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 6 1 4 4.5 COc1ccccc1C(=O)N1CCC(=CC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmc.2009.06.066
45273698 194752 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccc(O)cc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL562923 194752 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccc(O)cc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
45273689 194053 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 6 1 4 4.5 COc1cccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c1 10.1016/j.bmc.2009.06.066
CHEMBL557118 194053 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 6 1 4 4.5 COc1cccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c1 10.1016/j.bmc.2009.06.066
71455028 81055 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 363 4 2 2 4.4 O=C(Nc1ccccc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2159865 81055 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 363 4 2 2 4.4 O=C(Nc1ccccc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
71453335 81087 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 437 8 3 4 4.1 O=C(Nc1ccccc1OCCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160103 81087 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 437 8 3 4 4.1 O=C(Nc1ccccc1OCCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
11179592 69249 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 501 6 2 2 6.2 O=C(Nc1ccc(Br)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL193442 69249 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 501 6 2 2 6.2 O=C(Nc1ccc(Br)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11316656 69919 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 441 6 2 2 5.6 O=C(Nc1ccc(F)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL194141 69919 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 441 6 2 2 5.6 O=C(Nc1ccc(F)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44281755 99226 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 502 9 3 6 3.8 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](Cc2cscn2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL284576 99226 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 502 9 3 6 3.8 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](Cc2cscn2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
44281999 121343 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 459 8 1 7 4.6 CCOC(=O)c1coc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
CHEMBL35900 121343 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 459 8 1 7 4.6 CCOC(=O)c1coc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
71462226 81081 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 421 7 3 3 4.3 O=C(Nc1ccccc1CCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160098 81081 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 421 7 3 3 4.3 O=C(Nc1ccccc1CCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
70694702 75785 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 548 4 2 4 4.9 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2c(O)cccc2F)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057755 75785 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 548 4 2 4 4.9 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2c(O)cccc2F)CC1 10.1016/j.bmcl.2012.06.042
70690519 75779 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 527 4 2 4 5.2 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057749 75779 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 527 4 2 4 5.2 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1 10.1016/j.bmcl.2012.06.042
10474776 113158 36 None - 1 Human 7.3 pIC50 = 7.3 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113158 36 None - 1 Human 7.3 pIC50 = 7.3 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
45271905 193351 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 438 5 1 2 6.0 O=C(NC1CCCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
CHEMBL549302 193351 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 438 5 1 2 6.0 O=C(NC1CCCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
70690520 75791 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 550 5 1 4 4.6 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(S(=O)(=O)c2ccccc2)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057761 75791 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 550 5 1 4 4.6 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(S(=O)(=O)c2ccccc2)CC1 10.1016/j.bmcl.2012.06.042
9952288 110015 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 389 6 1 5 3.5 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C1=NCCO1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL32493 110015 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 389 6 1 5 3.5 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C1=NCCO1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
76324313 102886 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 465 5 1 3 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccn1 10.1016/j.bmc.2008.08.006
CHEMBL3084573 102886 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 465 5 1 3 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccn1 10.1016/j.bmc.2008.08.006
70690517 75777 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 541 4 2 4 4.6 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2012.06.042
CHEMBL2057747 75777 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 541 4 2 4 4.6 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2012.06.042
45268467 194568 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 505 5 2 4 4.4 O=C(C=C1CCN(C(=O)c2ccc(F)cc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL561740 194568 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 505 5 2 4 4.4 O=C(C=C1CCN(C(=O)c2ccc(F)cc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
6918497 112931 1 None 1 4 Human 8.2 pIC50 = 8.2 Functional
Inhibitory activity against I-Eotaxin induced [Ca2+] response in human CCR3 receptorInhibitory activity against I-Eotaxin induced [Ca2+] response in human CCR3 receptor
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL277930 112931 1 None 1 4 Human 8.2 pIC50 = 8.2 Functional
Inhibitory activity against I-Eotaxin induced [Ca2+] response in human CCR3 receptorInhibitory activity against I-Eotaxin induced [Ca2+] response in human CCR3 receptor
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL331897 112931 1 None 1 4 Human 8.2 pIC50 = 8.2 Functional
Inhibitory activity against I-Eotaxin induced [Ca2+] response in human CCR3 receptorInhibitory activity against I-Eotaxin induced [Ca2+] response in human CCR3 receptor
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
44455872 154977 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL404202 154977 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
44281987 99187 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 542 9 3 4 5.4 C[C@H](NC(=O)[C@H](Cc1ccncc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccc(-c2ccccc2)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL284313 99187 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 542 9 3 4 5.4 C[C@H](NC(=O)[C@H](Cc1ccncc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccc(-c2ccccc2)cc1 10.1016/s0960-894x(01)00249-9
44281794 167448 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 524 9 2 5 4.3 C[C@H](NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)N(C)c1ccccc1 10.1016/s0960-894x(01)00249-9
CHEMBL432088 167448 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 524 9 2 5 4.3 C[C@H](NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)N(C)c1ccccc1 10.1016/s0960-894x(01)00249-9
44452304 157303 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 348 5 1 2 4.7 Fc1ccc2cc(CN3CCC(NCc4ccccc4)CC3)ccc2c1 10.1016/j.bmc.2007.10.003
CHEMBL408368 157303 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 348 5 1 2 4.7 Fc1ccc2cc(CN3CCC(NCc4ccccc4)CC3)ccc2c1 10.1016/j.bmc.2007.10.003
71449695 81091 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 416 5 0 2 5.0 O=C1N(CCc2ccccc2)CCC12CCN(Cc1ccc3cc(F)ccc3c1)CC2 10.1016/j.bmcl.2012.09.035
CHEMBL2160107 81091 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 416 5 0 2 5.0 O=C1N(CCc2ccccc2)CCC12CCN(Cc1ccc3cc(F)ccc3c1)CC2 10.1016/j.bmcl.2012.09.035
9826988 75731 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 492 7 0 7 4.2 Cc1nnc2n(CCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)c(=O)c3ccccc3n12 10.1016/j.bmcl.2012.06.042
CHEMBL2057489 75731 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 492 7 0 7 4.2 Cc1nnc2n(CCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)c(=O)c3ccccc3n12 10.1016/j.bmcl.2012.06.042
76320667 102876 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 465 5 1 3 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccncc1 10.1016/j.bmc.2008.08.006
CHEMBL3084563 102876 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 465 5 1 3 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccncc1 10.1016/j.bmc.2008.08.006
24882359 192445 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 464 5 1 2 6.6 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2008.08.006
CHEMBL522295 192445 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 464 5 1 2 6.6 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2008.08.006
70694701 75784 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 582 4 1 3 6.3 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057754 75784 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 582 4 1 3 6.3 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1016/j.bmcl.2012.06.042
70696752 75789 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 530 4 2 4 4.7 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2ccccc2O)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057759 75789 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 530 4 2 4 4.7 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2ccccc2O)CC1 10.1016/j.bmcl.2012.06.042
44452086 157345 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccc(F)cc1 10.1016/j.bmc.2007.10.003
CHEMBL408407 157345 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccc(F)cc1 10.1016/j.bmc.2007.10.003
44452086 157345 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccc(F)cc1 10.1016/j.bmc.2009.06.066
CHEMBL408407 157345 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccc(F)cc1 10.1016/j.bmc.2009.06.066
44281775 115064 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 524 9 2 5 4.6 C[C@@H](C(=O)Nc1ccccc1)N(C)C(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL33534 115064 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 524 9 2 5 4.6 C[C@@H](C(=O)Nc1ccccc1)N(C)C(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
44281951 119722 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 475 8 1 7 5.1 CCOC(=O)c1csc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
CHEMBL35217 119722 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 475 8 1 7 5.1 CCOC(=O)c1csc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
44281686 111534 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 462 9 3 5 2.7 CCNC(=O)C(C)NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL32895 111534 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 462 9 3 5 2.7 CCNC(=O)C(C)NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
44452120 155688 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1cccc(F)c1 10.1016/j.bmc.2007.10.003
CHEMBL406468 155688 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1cccc(F)c1 10.1016/j.bmc.2007.10.003
76313429 102882 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 501 5 1 4 4.4 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084569 102882 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 501 5 1 4 4.4 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmc.2008.08.006
11953409 93781 0 None -7 4 Mouse 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophils
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249854 93781 0 None -7 4 Mouse 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophils
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
45269320 194917 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 521 5 2 4 4.9 O=C(C=C1CCN(C(=O)c2ccc(Cl)cc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL564022 194917 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 521 5 2 4 4.9 O=C(C=C1CCN(C(=O)c2ccc(Cl)cc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44281774 116167 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 501 9 3 4 5.1 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](CC2CCCCC2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL33708 116167 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 501 9 3 4 5.1 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](CC2CCCCC2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
71456840 81085 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 437 8 2 4 4.4 COCCOc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160101 81085 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 437 8 2 4 4.4 COCCOc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
44387842 130779 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 369 5 2 3 4.2 CC(=O)c1cccc(NC(=O)NN2CCCCC2Cc2ccc(F)cc2)c1 10.1021/jm049530m
CHEMBL368683 130779 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 369 5 2 3 4.2 CC(=O)c1cccc(NC(=O)NN2CCCCC2Cc2ccc(F)cc2)c1 10.1021/jm049530m
44452083 95730 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 392 5 1 3 4.4 COc1ccccc1C(=O)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
CHEMBL260649 95730 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 392 5 1 3 4.4 COc1ccccc1C(=O)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
44281872 108870 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 522 8 2 6 6.2 O=C(Nc1ccccc1)c1csc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
CHEMBL32191 108870 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 522 8 2 6 6.2 O=C(Nc1ccccc1)c1csc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
70684221 75776 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 461 3 1 2 5.4 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCc2cc(F)ccc2C1 10.1016/j.bmcl.2012.06.042
CHEMBL2057746 75776 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 461 3 1 2 5.4 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCc2cc(F)ccc2C1 10.1016/j.bmcl.2012.06.042
11227406 93909 1 None 107 4 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assayAntagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assay
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL250689 93909 1 None 107 4 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assayAntagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assay
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
70696751 75781 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 542 4 3 5 4.7 Nc1ccc2c(c1)[nH]c(=O)n2C1CCN(C(=O)NC2C[C@H]3CC[C@H](C2)N3Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057751 75781 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 542 4 3 5 4.7 Nc1ccc2c(c1)[nH]c(=O)n2C1CCN(C(=O)NC2C[C@H]3CC[C@H](C2)N3Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmcl.2012.06.042
11227406 93909 1 None 107 4 Human 8.1 pIC50 = 8.1 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL250689 93909 1 None 107 4 Human 8.1 pIC50 = 8.1 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44512617 193668 0 None 79 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL551735 193668 0 None 79 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
22393430 168137 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assay
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL43677 168137 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assay
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
44281754 112679 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 506 8 3 5 4.4 C[C@H](NC(=O)[C@H](Cc1cscn1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccc(Cl)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL33144 112679 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 506 8 3 5 4.4 C[C@H](NC(=O)[C@H](Cc1cscn1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccc(Cl)cc1 10.1016/s0960-894x(01)00249-9
44452248 95785 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 376 4 0 2 4.7 CN(C(=O)c1ccccc1)C1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
CHEMBL260899 95785 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 376 4 0 2 4.7 CN(C(=O)c1ccccc1)C1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
44295672 188170 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 439 6 1 3 5.0 COc1cccc(NC(=O)N2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50535 188170 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 439 6 1 3 5.0 COc1cccc(NC(=O)N2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
44452280 95366 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 398 5 1 3 3.9 O=S(=O)(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1 10.1016/j.bmc.2007.10.003
CHEMBL258790 95366 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 398 5 1 3 3.9 O=S(=O)(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1 10.1016/j.bmc.2007.10.003
76313430 102885 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1cnccc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084572 102885 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1cnccc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
76320668 102878 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 471 5 1 4 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1nccs1 10.1016/j.bmc.2008.08.006
CHEMBL3084565 102878 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 471 5 1 4 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1nccs1 10.1016/j.bmc.2008.08.006
71451489 81057 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 451 9 3 4 4.5 O=C(Nc1ccccc1OCCCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2159867 81057 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 451 9 3 4 4.5 O=C(Nc1ccccc1OCCCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
44282047 162617 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 520 9 3 5 4.2 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(C#N)cc2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL418041 162617 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 520 9 3 5 4.2 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(C#N)cc2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
45273619 194804 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 485 6 1 3 4.8 O=C(/C=C/C1CCN(C(=O)c2ccccc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL563303 194804 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 485 6 1 3 4.8 O=C(/C=C/C1CCN(C(=O)c2ccccc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
70688460 75795 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 578 5 2 3 6.1 O=C(Nc1ccc(Br)cc1)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2057765 75795 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 578 5 2 3 6.1 O=C(Nc1ccc(Br)cc1)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
76313415 105906 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 466 5 1 4 5.4 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1cncnc1 10.1016/j.bmc.2008.08.006
CHEMBL3084359 105906 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 466 5 1 4 5.4 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1cncnc1 10.1016/j.bmc.2008.08.006
CHEMBL3139342 105906 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 466 5 1 4 5.4 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1cncnc1 10.1016/j.bmc.2008.08.006
3536 3843 0 None -9 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 assessed as inhibition of CCL11-induced chemotaxis by cell based assayAntagonist activity at CCR3 assessed as inhibition of CCL11-induced chemotaxis by cell based assay
ChEMBL 515 5 1 2 7.3 CC[N+]1(CCC(CC1)NC(=O)C1c2cc(Cl)ccc2Oc2c1cc(Cl)cc2)CC1CCCCCC1 10.1021/jm300682j
44560289 3843 0 None -9 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 assessed as inhibition of CCL11-induced chemotaxis by cell based assayAntagonist activity at CCR3 assessed as inhibition of CCL11-induced chemotaxis by cell based assay
ChEMBL 515 5 1 2 7.3 CC[N+]1(CCC(CC1)NC(=O)C1c2cc(Cl)ccc2Oc2c1cc(Cl)cc2)CC1CCCCCC1 10.1021/jm300682j
CHEMBL1186993 3843 0 None -9 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 assessed as inhibition of CCL11-induced chemotaxis by cell based assayAntagonist activity at CCR3 assessed as inhibition of CCL11-induced chemotaxis by cell based assay
ChEMBL 515 5 1 2 7.3 CC[N+]1(CCC(CC1)NC(=O)C1c2cc(Cl)ccc2Oc2c1cc(Cl)cc2)CC1CCCCCC1 10.1021/jm300682j
44451983 158815 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 454 6 1 3 6.2 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1Oc1ccccc1 10.1016/j.bmc.2007.10.003
CHEMBL410041 158815 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 454 6 1 3 6.2 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1Oc1ccccc1 10.1016/j.bmc.2007.10.003
44452198 157429 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 388 5 1 2 4.8 O=C(/C=C/c1ccccc1)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
CHEMBL408486 157429 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 388 5 1 2 4.8 O=C(/C=C/c1ccccc1)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
44452198 157429 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 388 5 1 2 4.8 O=C(/C=C/c1ccccc1)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2009.06.066
CHEMBL408486 157429 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 388 5 1 2 4.8 O=C(/C=C/c1ccccc1)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2009.06.066
76320669 102883 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1cccnc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084570 102883 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1cccnc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
11753159 542 3 None 4 2 Human 7.0 pKd = 7 Functional
Antagonist activity at CCR3 receptor in human polymorphonuclear leukocytes assessed as inhibition of eotaxin-induced CD11b expression after 15 mins by flow cytometric analysisAntagonist activity at CCR3 receptor in human polymorphonuclear leukocytes assessed as inhibition of eotaxin-induced CD11b expression after 15 mins by flow cytometric analysis
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.124
7679 542 3 None 4 2 Human 7.0 pKd = 7 Functional
Antagonist activity at CCR3 receptor in human polymorphonuclear leukocytes assessed as inhibition of eotaxin-induced CD11b expression after 15 mins by flow cytometric analysisAntagonist activity at CCR3 receptor in human polymorphonuclear leukocytes assessed as inhibition of eotaxin-induced CD11b expression after 15 mins by flow cytometric analysis
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.124
CHEMBL2158814 542 3 None 4 2 Human 7.0 pKd = 7 Functional
Antagonist activity at CCR3 receptor in human polymorphonuclear leukocytes assessed as inhibition of eotaxin-induced CD11b expression after 15 mins by flow cytometric analysisAntagonist activity at CCR3 receptor in human polymorphonuclear leukocytes assessed as inhibition of eotaxin-induced CD11b expression after 15 mins by flow cytometric analysis
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.124
16040671 80867 0 None - 0 Human 7.9 pKd = 7.9 Functional
Antagonist activity at CCR3 in human eosinophils assessed as inhibition of CCL24-induced morphological changes by FACS flow cytometric analysisAntagonist activity at CCR3 in human eosinophils assessed as inhibition of CCL24-induced morphological changes by FACS flow cytometric analysis
ChEMBL 502 8 1 4 5.4 Cc1cc(Cl)ccc1OC1CCN(CC2CCN([C@@](C)(Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158791 80867 0 None - 0 Human 7.9 pKd = 7.9 Functional
Antagonist activity at CCR3 in human eosinophils assessed as inhibition of CCL24-induced morphological changes by FACS flow cytometric analysisAntagonist activity at CCR3 in human eosinophils assessed as inhibition of CCL24-induced morphological changes by FACS flow cytometric analysis
ChEMBL 502 8 1 4 5.4 Cc1cc(Cl)ccc1OC1CCN(CC2CCN([C@@](C)(Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
16681693 82160 1 None - 0 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human CCR3 assessed as inhibition of CCL11-induced calcium influx by cell based assayAntagonist activity at human CCR3 assessed as inhibition of CCL11-induced calcium influx by cell based assay
ChEMBL 487 5 1 5 3.6 Cc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)nn1 10.1021/jm300682j
CHEMBL2178580 82160 1 None - 0 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human CCR3 assessed as inhibition of CCL11-induced calcium influx by cell based assayAntagonist activity at human CCR3 assessed as inhibition of CCL11-induced calcium influx by cell based assay
ChEMBL 487 5 1 5 3.6 Cc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)nn1 10.1021/jm300682j
44399573 67694 0 None - 0 Human 7.0 pKi = 7.0 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 465 6 1 3 5.4 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)C1CCCCC1 10.1016/j.bmcl.2005.04.054
CHEMBL191418 67694 0 None - 0 Human 7.0 pKi = 7.0 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 465 6 1 3 5.4 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)C1CCCCC1 10.1016/j.bmcl.2005.04.054
44399538 67196 0 None - 0 Human 6.8 pKi = 6.8 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 7 1 4 5.7 O=C(NCC1CCCN(C2CCN(CCc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL189680 67196 0 None - 0 Human 6.8 pKi = 6.8 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 7 1 4 5.7 O=C(NCC1CCCN(C2CCN(CCc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
44399469 165573 0 None - 1 Human 7.6 pKi = 7.6 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL426089 165573 0 None - 1 Human 7.6 pKi = 7.6 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
44399385 67285 0 None - 0 Human 7.5 pKi = 7.5 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 498 6 2 3 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2[nH]ccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL190436 67285 0 None - 0 Human 7.5 pKi = 7.5 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 498 6 2 3 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2[nH]ccc2c1 10.1016/j.bmcl.2005.04.054
11540776 69118 0 None - 0 Human 7.5 pKi = 7.5 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2cccnc12 10.1016/j.bmcl.2005.04.054
CHEMBL193354 69118 0 None - 0 Human 7.5 pKi = 7.5 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2cccnc12 10.1016/j.bmcl.2005.04.054
44399272 67132 0 None - 0 Human 7.5 pKi = 7.5 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1nccc2ccccc12 10.1016/j.bmcl.2005.04.054
CHEMBL189206 67132 0 None - 0 Human 7.5 pKi = 7.5 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1nccc2ccccc12 10.1016/j.bmcl.2005.04.054
11540776 69118 0 None - 0 Human 7.4 pKi = 7.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2cccnc12 10.1016/j.bmcl.2005.04.054
CHEMBL193354 69118 0 None - 0 Human 7.4 pKi = 7.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2cccnc12 10.1016/j.bmcl.2005.04.054
44399482 165475 0 None - 0 Human 7.4 pKi = 7.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 498 6 2 3 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2[nH]ccc12 10.1016/j.bmcl.2005.04.054
CHEMBL425548 165475 0 None - 0 Human 7.4 pKi = 7.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 498 6 2 3 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2[nH]ccc12 10.1016/j.bmcl.2005.04.054
44399443 68838 0 None - 0 Human 6.4 pKi = 6.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3cc(Cl)ccc3Cl)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL192584 68838 0 None - 0 Human 6.4 pKi = 6.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3cc(Cl)ccc3Cl)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
44399574 67449 0 None - 0 Human 6.4 pKi = 6.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3cc(Cl)cc(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL190894 67449 0 None - 0 Human 6.4 pKi = 6.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3cc(Cl)cc(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
44399389 126984 0 None - 0 Human 7.3 pKi = 7.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 499 6 2 4 5.0 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2[nH]cnc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL366143 126984 0 None - 0 Human 7.3 pKi = 7.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 499 6 2 4 5.0 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2[nH]cnc2c1 10.1016/j.bmcl.2005.04.054
44399331 126995 0 None - 0 Human 7.3 pKi = 7.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 509 6 1 3 6.3 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ccccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL366199 126995 0 None - 0 Human 7.3 pKi = 7.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 509 6 1 3 6.3 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ccccc2c1 10.1016/j.bmcl.2005.04.054
44399395 67250 0 None - 0 Human 7.3 pKi = 7.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 6 1 4 6.0 CC1(N2CCCC(CNC(=O)c3ccc4ncccc4c3)C2)CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2005.04.054
CHEMBL190149 67250 0 None - 0 Human 7.3 pKi = 7.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 6 1 4 6.0 CC1(N2CCCC(CNC(=O)c3ccc4ncccc4c3)C2)CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2005.04.054
44399552 67121 0 None - 0 Human 6.3 pKi = 6.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 397 5 1 3 3.8 CC(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
CHEMBL189158 67121 0 None - 0 Human 6.3 pKi = 6.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 397 5 1 3 3.8 CC(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
44399524 134993 0 None - 0 Human 7.2 pKi = 7.2 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 509 6 1 3 6.3 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2ccccc12 10.1016/j.bmcl.2005.04.054
CHEMBL372868 134993 0 None - 0 Human 7.2 pKi = 7.2 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 509 6 1 3 6.3 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2ccccc12 10.1016/j.bmcl.2005.04.054
44399368 66858 0 None - 0 Human 7.2 pKi = 7.2 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 473 6 1 3 5.4 Cc1ccccc1C(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
CHEMBL187779 66858 0 None - 0 Human 7.2 pKi = 7.2 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 473 6 1 3 5.4 Cc1ccccc1C(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
44399303 67749 0 None - 0 Human 8.1 pKi = 8.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 6 1 4 5.9 CC1CN(Cc2ccc(Cl)c(Cl)c2)CCC1N1CCCC(CNC(=O)c2ccc3ncccc3c2)C1 10.1016/j.bmcl.2005.04.054
CHEMBL191464 67749 0 None - 0 Human 8.1 pKi = 8.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 6 1 4 5.9 CC1CN(Cc2ccc(Cl)c(Cl)c2)CCC1N1CCCC(CNC(=O)c2ccc3ncccc3c2)C1 10.1016/j.bmcl.2005.04.054
44399332 68940 0 None - 0 Human 7.1 pKi = 7.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 6 1 4 6.2 CC(c1ccc(Cl)c(Cl)c1)N1CCC(N2CCCC(CNC(=O)c3ccc4ncccc4c3)C2)CC1 10.1016/j.bmcl.2005.04.054
CHEMBL192757 68940 0 None - 0 Human 7.1 pKi = 7.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 6 1 4 6.2 CC(c1ccc(Cl)c(Cl)c1)N1CCC(N2CCCC(CNC(=O)c3ccc4ncccc4c3)C2)CC1 10.1016/j.bmcl.2005.04.054
44399290 67270 0 None - 0 Human 6.1 pKi = 6.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 538 6 1 4 5.2 O=C(NCC1CCCN(C2CCN(C(=O)Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL190312 67270 0 None - 0 Human 6.1 pKi = 6.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 538 6 1 4 5.2 O=C(NCC1CCCN(C2CCN(C(=O)Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
44399567 67434 0 None - 0 Human 7.1 pKi = 7.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccnc2ccccc12 10.1016/j.bmcl.2005.04.054
CHEMBL190852 67434 0 None - 0 Human 7.1 pKi = 7.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccnc2ccccc12 10.1016/j.bmcl.2005.04.054
44399407 67227 0 None - 0 Human 7.1 pKi = 7.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 487 7 1 3 5.3 Cc1ccccc1CC(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
CHEMBL189917 67227 0 None - 0 Human 7.1 pKi = 7.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 487 7 1 3 5.3 Cc1ccccc1CC(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
44399442 67312 0 None - 0 Human 7.0 pKi = 7.0 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 489 7 1 4 5.1 COc1ccccc1C(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
CHEMBL190646 67312 0 None - 0 Human 7.0 pKi = 7.0 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 489 7 1 4 5.1 COc1ccccc1C(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
44399537 67277 0 None - 0 Human 7.0 pKi = 7.0 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 476 6 1 4 5.0 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)cc3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL190362 67277 0 None - 0 Human 7.0 pKi = 7.0 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 476 6 1 4 5.0 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)cc3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
44399479 67240 0 None - 0 Human 7.0 pKi = 7 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 511 6 1 5 5.0 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cnnc2ccccc12 10.1016/j.bmcl.2005.04.054
CHEMBL190048 67240 0 None - 0 Human 7.0 pKi = 7 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 511 6 1 5 5.0 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cnnc2ccccc12 10.1016/j.bmcl.2005.04.054
3536 3843 0 None -9 2 Human 7.0 pIC50 = 7.0 Functional
Measuring antagonism of CCL11-induced chemotaxis <i>in vitro</i>.Measuring antagonism of CCL11-induced chemotaxis <i>in vitro</i>.
Guide to Pharmacology 515 5 1 2 7.3 CC[N+]1(CCC(CC1)NC(=O)C1c2cc(Cl)ccc2Oc2c1cc(Cl)cc2)CC1CCCCCC1 10854442
44560289 3843 0 None -9 2 Human 7.0 pIC50 = 7.0 Functional
Measuring antagonism of CCL11-induced chemotaxis <i>in vitro</i>.Measuring antagonism of CCL11-induced chemotaxis <i>in vitro</i>.
Guide to Pharmacology 515 5 1 2 7.3 CC[N+]1(CCC(CC1)NC(=O)C1c2cc(Cl)ccc2Oc2c1cc(Cl)cc2)CC1CCCCCC1 10854442
CHEMBL1186993 3843 0 None -9 2 Human 7.0 pIC50 = 7.0 Functional
Measuring antagonism of CCL11-induced chemotaxis <i>in vitro</i>.Measuring antagonism of CCL11-induced chemotaxis <i>in vitro</i>.
Guide to Pharmacology 515 5 1 2 7.3 CC[N+]1(CCC(CC1)NC(=O)C1c2cc(Cl)ccc2Oc2c1cc(Cl)cc2)CC1CCCCCC1 10854442
4382 820 0 None 25 2 Human 7.5 pIC50 = 7.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 23951310
9680 1867 4 None - 1 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 450 7 3 4 2.8 O=C(NCc1ccc(cc1)C(=O)N)NC[C@H]1OCCN(C1)Cc1ccc(c(c1)Cl)Cl 22931505
9825034 1867 4 None - 1 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 450 7 3 4 2.8 O=C(NCc1ccc(cc1)C(=O)N)NC[C@H]1OCCN(C1)Cc1ccc(c(c1)Cl)Cl 22931505
CHEMBL2178574 1867 4 None - 1 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 450 7 3 4 2.8 O=C(NCc1ccc(cc1)C(=O)N)NC[C@H]1OCCN(C1)Cc1ccc(c(c1)Cl)Cl 22931505
776 840 0 None -1 2 Human 8.4 pIC50 = 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10488147
776 840 0 None -1 2 Human 8.4 pIC50 = 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15207250
776 840 0 None -1 2 Human 8.4 pIC50 = 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16339911
754 817 0 None 5 2 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9346309
775 837 0 None 316 2 Human 8.7 pIC50 = 8.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15207250
775 837 0 None 316 2 Human 8.7 pIC50 = 8.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16339911
769 813 0 None 14 3 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10488147
769 813 0 None 14 3 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10854442
769 813 0 None 14 3 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12761559
769 813 0 None 14 3 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16339911
769 813 0 None 14 3 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276730
770 815 0 None 7 2 Human 9.5 pIC50 = 9.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16339911
770 815 0 None 7 2 Human 9.5 pIC50 = 9.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276730
773 1906 0 None -12 2 Human 7.2 pIC50 None 7.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9789057
10098735 3291 0 None - 1 Human 7.2 pIC50 None 7.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 537 10 2 5 6.1 COc1cc(NC(=O)N[C@H](C(C)C)CN2CCC(CC2)Cc2ccc(c(c2)Cl)Cl)cc(c1OC)OC 12070060
789 3291 0 None - 1 Human 7.2 pIC50 None 7.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 537 10 2 5 6.1 COc1cc(NC(=O)N[C@H](C(C)C)CN2CCC(CC2)Cc2ccc(c(c2)Cl)Cl)cc(c1OC)OC 12070060
11556309 4057 0 None - 1 Human 7.9 pIC50 None 7.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 502 5 2 5 3.9 O=C(C=C1CCN(CC1)C(=O)c1ncc(cc1O)C)N[C@@H]1CCN(C1)Cc1ccc2c(c1)ccc(c2)F 16339911
793 4057 0 None - 1 Human 7.9 pIC50 None 7.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 502 5 2 5 3.9 O=C(C=C1CCN(CC1)C(=O)c1ncc(cc1O)C)N[C@@H]1CCN(C1)Cc1ccc2c(c1)ccc(c2)F 16339911
788 2458 0 None - 1 Human 8.2 pIC50 None 8.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10640766
10304110 3297 0 None - 1 Human 8.3 pIC50 None 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 560 11 2 7 5.3 COc1cc(ccc1OC)c1cnc(nc1)SCC(=O)NCC[C@H]1NC[C@@H](C1)Cc1ccc(c(c1)Cl)Cl 12070060
792 3297 0 None - 1 Human 8.3 pIC50 None 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 560 11 2 7 5.3 COc1cc(ccc1OC)c1cnc(nc1)SCC(=O)NCC[C@H]1NC[C@@H](C1)Cc1ccc(c(c1)Cl)Cl 12070060
10255622 3295 0 None - 1 Human 8.4 pIC50 None 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 505 10 3 6 4.2 COc1cc(NC(=O)N[C@H](C(O)C)CN2CCC(CC2)Cc2ccc(cc2)Cl)cc(c1OC)OC 12070060
791 3295 0 None - 1 Human 8.4 pIC50 None 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 505 10 3 6 4.2 COc1cc(NC(=O)N[C@H](C(O)C)CN2CCC(CC2)Cc2ccc(cc2)Cl)cc(c1OC)OC 12070060
790 3292 0 None - 1 Human 9.0 pIC50 None 9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 552 10 2 4 6.3 COc1cc(NC(=O)N[C@H](C(C)C)C[N+]2(C)CCC(CC2)Cc2ccc(c(c2)Cl)Cl)cc(c1OC)OC 12070060
9915610 3292 0 None - 1 Human 9.0 pIC50 None 9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 552 10 2 4 6.3 COc1cc(NC(=O)N[C@H](C(C)C)C[N+]2(C)CCC(CC2)Cc2ccc(c(c2)Cl)Cl)cc(c1OC)OC 12070060




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
38347547 145922 5 None - 0 Human 5.9 pEC50 = 5.9 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 430 11 0 7 4.5 C=CCc1cc(OC)c(O[C@@H](C)[C@H](OC(C)=O)c2ccc(OC)c(OC)c2)c(OC)c1 10.1021/acs.jnatprod.6b00262
CHEMBL3922119 145922 5 None - 0 Human 5.9 pEC50 = 5.9 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 430 11 0 7 4.5 C=CCc1cc(OC)c(O[C@@H](C)[C@H](OC(C)=O)c2ccc(OC)c(OC)c2)c(OC)c1 10.1021/acs.jnatprod.6b00262
25751147 149428 2 None - 0 Human 5.8 pEC50 = 5.8 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 404 10 2 7 3.7 C=CCc1cc(OC)c(O[C@H](C)[C@@H](O)c2cc(OC)c(O)c(OC)c2)c(OC)c1 10.1021/acs.jnatprod.6b00262
CHEMBL3949874 149428 2 None - 0 Human 5.8 pEC50 = 5.8 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 404 10 2 7 3.7 C=CCc1cc(OC)c(O[C@H](C)[C@@H](O)c2cc(OC)c(O)c(OC)c2)c(OC)c1 10.1021/acs.jnatprod.6b00262
124396489 143931 2 None - 0 Human 5.8 pEC50 = 5.8 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 356 5 1 5 4.7 C/C=C/c1cc(OC)c2c(c1)[C@@H](C)[C@H](c1cc(OC)c(O)c(OC)c1)O2 10.1021/acs.jnatprod.6b00262
CHEMBL3906647 143931 2 None - 0 Human 5.8 pEC50 = 5.8 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 356 5 1 5 4.7 C/C=C/c1cc(OC)c2c(c1)[C@@H](C)[C@H](c1cc(OC)c(O)c(OC)c1)O2 10.1021/acs.jnatprod.6b00262
10474776 113158 36 None - 0 Human 6.1 pEC50 = 6.1 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1021/acs.jnatprod.6b00262
CHEMBL33227 113158 36 None - 0 Human 6.1 pEC50 = 6.1 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1021/acs.jnatprod.6b00262
11272103 123856 0 None - 0 Rat 11.0 pIC50 = 11 Binding
Inhibition of eotaxin-induced chemotaxis of rat eosinophilsInhibition of eotaxin-induced chemotaxis of rat eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL363840 123856 0 None - 0 Rat 11.0 pIC50 = 11 Binding
Inhibition of eotaxin-induced chemotaxis of rat eosinophilsInhibition of eotaxin-induced chemotaxis of rat eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44570583 190348 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 550 7 2 8 3.3 CN1CC(C)(NC(=O)Nc2cccc(-c3nnnn3C)c2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL505914 190348 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 550 7 2 8 3.3 CN1CC(C)(NC(=O)Nc2cccc(-c3nnnn3C)c2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL518571 190348 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 550 7 2 8 3.3 CN1CC(C)(NC(=O)Nc2cccc(-c3nnnn3C)c2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
44570583 190348 0 None - 0 Human 9.8 pIC50 = 9.8 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 550 7 2 8 3.3 CN1CC(C)(NC(=O)Nc2cccc(-c3nnnn3C)c2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL505914 190348 0 None - 0 Human 9.8 pIC50 = 9.8 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 550 7 2 8 3.3 CN1CC(C)(NC(=O)Nc2cccc(-c3nnnn3C)c2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL518571 190348 0 None - 0 Human 9.8 pIC50 = 9.8 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 550 7 2 8 3.3 CN1CC(C)(NC(=O)Nc2cccc(-c3nnnn3C)c2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
44593547 176292 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 538 10 2 8 3.3 CCN(CCCc1ccc(F)cc1)CC1OC(=O)N(C)CC1(C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2008.11.002
CHEMBL461445 176292 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 538 10 2 8 3.3 CCN(CCCc1ccc(F)cc1)CC1OC(=O)N(C)CC1(C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2008.11.002
44447136 94116 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 469 11 3 7 2.8 CCN(CCCc1ccc(F)cc1)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL251837 94116 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 469 11 3 7 2.8 CCN(CCCc1ccc(F)cc1)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447381 94450 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 511 12 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)[C@@H](C)CCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254095 94450 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 511 12 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)[C@@H](C)CCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447137 153619 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 483 12 3 7 3.2 CCCN(CCCc1ccc(F)cc1)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL398548 153619 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 483 12 3 7 3.2 CCCN(CCCc1ccc(F)cc1)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44570537 177585 0 None - 0 Human 9.6 pIC50 = 9.6 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 536 7 2 8 2.9 CN1C[C@@H](NC(=O)Nc2cccc(-c3nnnn3C)c2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL464902 177585 0 None - 0 Human 9.6 pIC50 = 9.6 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 536 7 2 8 2.9 CN1C[C@@H](NC(=O)Nc2cccc(-c3nnnn3C)c2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
10050884 154115 10 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2008.11.002
CHEMBL399495 154115 10 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2008.11.002
44447143 94151 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 469 11 4 7 2.7 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CNCCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL252035 94151 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 469 11 4 7 2.7 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CNCCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
10050884 154115 10 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.087
CHEMBL399495 154115 10 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.087
44447144 168207 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 483 11 3 7 3.0 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(C)CCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL437396 168207 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 483 11 3 7 3.0 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(C)CCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
10050884 154115 10 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL399495 154115 10 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
44455658 166720 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 8 3 5 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nccn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL429323 166720 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 8 3 5 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nccn2C)c1 10.1016/j.bmcl.2007.11.067
11488078 78591 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113077 78591 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44593553 177792 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 489 6 2 6 3.9 Cc1csc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1016/j.bmcl.2008.11.002
CHEMBL465272 177792 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 489 6 2 6 3.9 Cc1csc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1016/j.bmcl.2008.11.002
44447139 94117 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 495 12 3 7 3.2 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)CC1CC1 10.1016/j.bmcl.2007.11.087
CHEMBL251838 94117 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 495 12 3 7 3.2 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)CC1CC1 10.1016/j.bmcl.2007.11.087
44447135 94238 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 455 10 3 7 2.5 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(C)CCCc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
CHEMBL252631 94238 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 455 10 3 7 2.5 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(C)CCCc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
44447361 94512 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H]([C@@H](O)c1ccccc1)N(C)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254503 94512 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H]([C@@H](O)c1ccccc1)N(C)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447138 154279 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 481 11 3 7 3.0 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)C1CC1 10.1016/j.bmcl.2007.11.087
CHEMBL400378 154279 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 481 11 3 7 3.0 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)C1CC1 10.1016/j.bmcl.2007.11.087
44447382 166060 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 497 12 3 7 3.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)CCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL428062 166060 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 497 12 3 7 3.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)CCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
10050884 154115 10 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3/CCR2 chimeric receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3/CCR2 chimeric receptor in CHO cells
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.087
CHEMBL399495 154115 10 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3/CCR2 chimeric receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3/CCR2 chimeric receptor in CHO cells
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.087
44455841 154906 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 509 9 3 7 3.8 CC(C)[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL403838 154906 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 509 9 3 7 3.8 CC(C)[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11328714 78588 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113074 78588 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44593547 176292 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 538 10 2 8 3.3 CCN(CCCc1ccc(F)cc1)CC1OC(=O)N(C)CC1(C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2008.11.002
CHEMBL461445 176292 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 538 10 2 8 3.3 CCN(CCCc1ccc(F)cc1)CC1OC(=O)N(C)CC1(C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2008.11.002
44419331 82362 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 453 9 3 4 4.7 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL217987 82362 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 453 9 3 4 4.7 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
25032958 94112 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 481 10 4 8 2.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(C)[C@@H](C)[C@@H](O)c2ccccc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL251822 94112 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 481 10 4 8 2.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(C)[C@@H](C)[C@@H](O)c2ccccc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447145 94536 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 511 13 3 7 3.8 CCCN(CCCc1ccc(F)cc1)C[C@H](O)[C@@H](C)NC(=O)Nc1cc(CC)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254676 94536 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 511 13 3 7 3.8 CCCN(CCCc1ccc(F)cc1)C[C@H](O)[C@@H](C)NC(=O)Nc1cc(CC)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44455744 94987 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 495 8 3 7 3.5 Cc1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL257029 94987 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 495 8 3 7 3.5 Cc1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455817 154639 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 538 9 3 8 3.6 CNC(=O)O[C@H](C[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)N1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL402331 154639 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 538 9 3 8 3.6 CNC(=O)O[C@H](C[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)N1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
44455788 155078 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 536 10 2 7 4.3 CCc1cc(NC(=O)N[C@H](C)C[C@@H](N(C)C)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL404585 155078 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 536 10 2 7 4.3 CCc1cc(NC(=O)N[C@H](C)C[C@@H](N(C)C)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11329244 70772 10 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibition of [125I]eotaxin binding to human eosinophilsInhibition of [125I]eotaxin binding to human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
CHEMBL195433 70772 10 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibition of [125I]eotaxin binding to human eosinophilsInhibition of [125I]eotaxin binding to human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
11272103 123856 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibition of [125I]eotaxin binding to human eosinophilsInhibition of [125I]eotaxin binding to human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL363840 123856 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibition of [125I]eotaxin binding to human eosinophilsInhibition of [125I]eotaxin binding to human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
6918497 112931 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(03)00748-0
CHEMBL277930 112931 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(03)00748-0
CHEMBL331897 112931 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(03)00748-0
6918497 112931 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(01)00176-7
CHEMBL277930 112931 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(01)00176-7
CHEMBL331897 112931 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(01)00176-7
6918497 112931 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory activity against I-Eotaxin binding to human CCR3 receptorsInhibitory activity against I-Eotaxin binding to human CCR3 receptors
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL277930 112931 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory activity against I-Eotaxin binding to human CCR3 receptorsInhibitory activity against I-Eotaxin binding to human CCR3 receptors
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL331897 112931 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory activity against I-Eotaxin binding to human CCR3 receptorsInhibitory activity against I-Eotaxin binding to human CCR3 receptors
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
11236950 94326 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 479 9 2 6 4.3 CN(CCCc1ccc(F)cc1)C[C@@H]1CCCC[C@H]1NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL253210 94326 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 479 9 2 6 4.3 CN(CCCc1ccc(F)cc1)C[C@@H]1CCCC[C@H]1NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447146 94537 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 509 12 3 7 3.5 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)C2CC2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254677 94537 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 509 12 3 7 3.5 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)C2CC2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447147 94563 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 523 13 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)CC2CC2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254881 94563 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 523 13 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)CC2CC2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44445886 93784 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 544 7 3 6 3.9 CNC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL249857 93784 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 544 7 3 6 3.9 CNC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
44455844 96966 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 509 10 3 7 4.0 CCC[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL269933 96966 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 509 10 3 7 4.0 CCC[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455791 155079 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 522 9 3 7 3.3 CC(=O)N[C@H](C[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)N1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL404586 155079 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 522 9 3 7 3.3 CC(=O)N[C@H](C[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)N1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
44289927 167764 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL43423 167764 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
11698698 122724 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 481 8 2 6 4.2 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3cccc(Cl)c3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL361369 122724 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 481 8 2 6 4.2 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3cccc(Cl)c3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44289927 167764 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43423 167764 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44390955 123173 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 493 8 2 6 4.3 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CCC2(C)C)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL362179 123173 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 493 8 2 6 4.3 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CCC2(C)C)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44419344 141241 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 495 11 2 4 5.9 CCCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL386073 141241 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 495 11 2 4 5.9 CCCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
11272103 123856 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL363840 123856 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
44445865 154316 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 544 7 3 6 3.9 CNC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL400589 154316 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 544 7 3 6 3.9 CNC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
44455461 155082 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 551 10 3 7 4.2 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)C(=O)O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL404618 155082 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 551 10 3 7 4.2 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)C(=O)O)c1 10.1016/j.bmcl.2007.11.067
44390838 127988 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL366710 127988 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11398022 98178 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
CHEMBL277131 98178 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
11272103 123856 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL363840 123856 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
11397114 132948 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2cn[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL3706810 132948 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2cn[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
10459751 99710 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 533 9 2 10 2.7 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
CHEMBL288009 99710 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 533 9 2 10 2.7 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
44289701 100637 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 508 9 3 7 2.8 CNC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
CHEMBL295081 100637 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 508 9 3 7 2.8 CNC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
44455793 94783 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 483 9 3 5 4.4 CC(=O)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL256068 94783 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 483 9 3 5 4.4 CC(=O)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
44455625 97141 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 565 9 3 7 6.2 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nccs2)cc(-c2nccs2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270806 97141 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 565 9 3 7 6.2 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nccs2)cc(-c2nccs2)c1 10.1016/j.bmcl.2007.11.067
11227406 93909 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]eotaxin binding to human eosinophilsInhibition of [125I]eotaxin binding to human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL250689 93909 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]eotaxin binding to human eosinophilsInhibition of [125I]eotaxin binding to human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44419295 82802 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 497 11 3 5 4.4 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCO)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL218568 82802 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 497 11 3 5 4.4 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCO)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
44419298 137611 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 509 11 2 5 5.0 CC(=O)CN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL376737 137611 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 509 11 2 5 5.0 CC(=O)CN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
11329244 70772 10 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL195433 70772 10 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445863 94019 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 559 9 2 7 3.7 COCC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL251275 94019 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 559 9 2 7 3.7 COCC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
44445872 94077 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 533 9 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CCF)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251622 94077 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 533 9 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CCF)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445868 166422 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 567 9 2 7 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(Cc3ccco3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL428761 166422 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 567 9 2 7 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(Cc3ccco3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
11329244 70772 10 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
CHEMBL195433 70772 10 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
11156406 124651 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL364508 124651 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44290100 178045 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 481 9 3 7 3.0 Cn1nnnc1-c1cc(CO)cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL46747 178045 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 481 9 3 7 3.0 Cn1nnnc1-c1cc(CO)cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44419345 82741 0 None - 0 Human 9.0 pIC50 = 9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 493 11 2 4 5.6 C=CCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL218262 82741 0 None - 0 Human 9.0 pIC50 = 9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 493 11 2 4 5.6 C=CCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
11272103 123856 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.087
CHEMBL363840 123856 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.087
44445842 155037 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 488 7 2 6 4.3 CC(=O)c1sc(NC(=O)N[C@@H]2COCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL404416 155037 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 488 7 2 6 4.3 CC(=O)c1sc(NC(=O)N[C@@H]2COCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455686 95048 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 523 9 3 7 4.3 CC(C)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL257293 95048 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 523 9 3 7 4.3 CC(C)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455871 97097 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 495 9 3 7 3.6 CC[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270583 97097 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 495 9 3 7 3.6 CC[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11272103 123856 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL363840 123856 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
44455511 154488 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 9 2 6 4.0 CCc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL401545 154488 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 9 2 6 4.0 CCc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44295462 187825 0 None - 0 Human 9.0 pIC50 = 9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 519 12 3 7 4.3 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50194 187825 0 None - 0 Human 9.0 pIC50 = 9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 519 12 3 7 4.3 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/s0960-894x(02)00206-8
44295536 187851 0 None - 0 Human 9.0 pIC50 = 9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 12 3 4 5.3 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50233 187851 0 None - 0 Human 9.0 pIC50 = 9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 12 3 4 5.3 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
9892753 16323 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 516 8 3 4 5.5 CNC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm049530m
CHEMBL123611 16323 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 516 8 3 4 5.5 CNC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm049530m
11213416 132950 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2nc[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL3706812 132950 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2nc[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11169258 140366 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 587 8 2 10 3.8 Cn1nnnc1-c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1021/jm049530m
CHEMBL382108 140366 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 587 8 2 10 3.8 Cn1nnnc1-c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1021/jm049530m
11966688 12266 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 518 7 2 4 6.0 CC(=O)c1cccc(NC(=O)Nc2cc3c(cc2C[N+]2(C)CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
CHEMBL1185532 12266 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 518 7 2 4 6.0 CC(=O)c1cccc(NC(=O)Nc2cc3c(cc2C[N+]2(C)CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
CHEMBL419599 12266 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 518 7 2 4 6.0 CC(=O)c1cccc(NC(=O)Nc2cc3c(cc2C[N+]2(C)CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
9892753 16323 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 516 8 3 4 5.5 CNC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL123611 16323 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 516 8 3 4 5.5 CNC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
11730796 116328 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 499 7 3 4 5.2 CNC(=O)c1cccc(NC(=O)Nc2cccc(C#N)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL337962 116328 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 499 7 3 4 5.2 CNC(=O)c1cccc(NC(=O)Nc2cccc(C#N)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44570617 177801 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 531 7 2 7 4.1 CC(=O)c1sc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2008.11.002
CHEMBL465291 177801 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 531 7 2 7 4.1 CC(=O)c1sc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2008.11.002
44445885 168442 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 558 8 3 6 4.3 CCNC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL439253 168442 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 558 8 3 6 4.3 CCNC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
44455483 97380 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 537 10 3 7 3.8 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)(C)C(=O)O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL272068 97380 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 537 10 3 7 3.8 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)(C)C(=O)O)c1 10.1016/j.bmcl.2007.11.067
44455458 166897 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 533 9 3 7 5.3 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2ccon2)cc(-c2ccon2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL429846 166897 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 533 9 3 7 5.3 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2ccon2)cc(-c2ccon2)c1 10.1016/j.bmcl.2007.11.067
44400941 68522 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 426 6 3 3 3.9 O=C(NC1C=CC=CN1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL192240 68522 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 426 6 3 3 3.9 O=C(NC1C=CC=CN1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11409583 69439 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 507 8 2 4 5.9 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1021/jm049530m
CHEMBL193575 69439 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 507 8 2 4 5.9 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1021/jm049530m
44445901 159660 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 501 7 2 6 4.2 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2008.11.002
CHEMBL410959 159660 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 501 7 2 6 4.2 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2008.11.002
44447375 94332 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 527 12 4 8 2.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)[C@@H](C)[C@@H](O)Cc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL253244 94332 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 527 12 4 8 2.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)[C@@H](C)[C@@H](O)Cc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44445854 93649 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 522 7 2 7 3.3 CC(=O)c1sc(NC(=O)N[C@@H]2CS(=O)(=O)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249057 93649 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 522 7 2 7 3.3 CC(=O)c1sc(NC(=O)N[C@@H]2CS(=O)(=O)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445891 93984 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 533 9 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CCF)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251044 93984 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 533 9 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CCF)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445915 154890 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 599 8 2 7 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C3CCOCC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL403742 154890 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 599 8 2 7 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C3CCOCC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445888 155118 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 526 8 2 7 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CC#N)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL404857 155118 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 526 8 2 7 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CC#N)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445901 159660 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 501 7 2 6 4.2 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL410959 159660 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 501 7 2 6 4.2 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455818 94997 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 523 10 3 7 4.2 CC(C)C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL257073 94997 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 523 10 3 7 4.2 CC(C)C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455510 95146 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 8 2 6 4.2 Cc1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL257737 95146 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 8 2 6 4.2 Cc1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455790 95278 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 480 8 3 7 3.2 C[C@H](C[C@@H](N)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL258322 95278 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 480 8 3 7 3.2 C[C@H](C[C@@H](N)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44289926 176985 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 453 9 2 4 4.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL46404 176985 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 453 9 2 4 4.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
44390883 63743 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.8 CCc1cc(NC(=O)N[C@@H]2CCCN(CCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180746 63743 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.8 CCc1cc(NC(=O)N[C@@H]2CCCN(CCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11167549 78590 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 480 6 2 4 6.1 O=C(Nc1ccc2ncsc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113076 78590 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 480 6 2 4 6.1 O=C(Nc1ccc2ncsc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44290018 166151 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 465 9 2 6 4.0 CCn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL42826 166151 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 465 9 2 6 4.0 CCn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44289741 170163 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 519 8 2 6 4.5 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(F)(F)F)c1 10.1016/j.bmcl.2004.01.059
CHEMBL44522 170163 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 519 8 2 6 4.5 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(F)(F)F)c1 10.1016/j.bmcl.2004.01.059
44289926 176985 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 453 9 2 4 4.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2004.01.059
CHEMBL46404 176985 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 453 9 2 4 4.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2004.01.059
44419296 140918 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 511 12 3 5 4.8 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCCO)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL384199 140918 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 511 12 3 5 4.8 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCCO)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
44445884 93782 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 559 9 2 7 3.7 COCC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL249855 93782 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 559 9 2 7 3.7 COCC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
44445867 93856 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 526 8 2 7 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CC#N)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL250437 93856 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 526 8 2 7 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CC#N)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
16747712 154315 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(C)=O)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL400588 154315 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(C)=O)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445870 166711 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 9 2 7 4.1 CC(=O)CN1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL429303 166711 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 9 2 7 4.1 CC(=O)CN1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
44455539 166429 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 8 2 6 3.9 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL428775 166429 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 8 2 6 3.9 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
10096657 64523 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 8 2 6 3.9 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2C)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL182086 64523 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 8 2 6 3.9 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2C)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11306550 78593 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 497 6 3 3 6.0 O=C(Nc1ccc2[nH]nc(Cl)c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113079 78593 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 497 6 3 3 6.0 O=C(Nc1ccc2[nH]nc(Cl)c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44419328 82895 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 411 8 3 3 4.5 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL219048 82895 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 411 8 3 3 4.5 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
44445895 94013 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 584 8 2 7 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C3CCN(C)CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251220 94013 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 584 8 2 7 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C3CCN(C)CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455482 97379 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 533 9 3 9 3.2 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2ccnn2)cc(-n2ccnn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL272067 97379 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 533 9 3 9 3.2 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2ccnn2)cc(-n2ccnn2)c1 10.1016/j.bmcl.2007.11.067
11363005 60182 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL175634 60182 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11442162 70324 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 444 6 2 4 5.2 Cc1csc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1021/jm049530m
CHEMBL195044 70324 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 444 6 2 4 5.2 Cc1csc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1021/jm049530m
11454941 70798 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cc1nnnn1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL195555 70798 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cc1nnnn1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44445864 94046 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 558 8 3 6 4.3 CCNC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL251446 94046 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 558 8 3 6 4.3 CCNC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
44445916 154891 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 599 8 2 7 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C3CCOCC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL403743 154891 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 599 8 2 7 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C3CCOCC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455820 94998 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 551 11 3 7 4.9 CCC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL257074 94998 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 551 11 3 7 4.9 CCC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
44455869 97096 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 507 9 2 7 4.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270582 97096 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 507 9 2 7 4.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44289715 169668 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 8 2 6 3.8 Cc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL444568 169668 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 8 2 6 3.8 Cc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11340670 126712 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 483 7 2 3 5.8 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)ccc1F 10.1021/jm049530m
CHEMBL365820 126712 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 483 7 2 3 5.8 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)ccc1F 10.1021/jm049530m
44289715 169668 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 465 8 2 6 3.8 Cc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
CHEMBL444568 169668 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 465 8 2 6 3.8 Cc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
44445887 93785 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)CN(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249858 93785 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)CN(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445866 154424 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)CN(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL401159 154424 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)CN(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455847 154907 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 501 9 2 6 4.7 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL403839 154907 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 501 9 2 6 4.7 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
10322255 62198 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL178230 62198 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44390945 62620 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 507 9 2 6 4.5 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2C(C)C)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL178503 62620 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 507 9 2 6 4.5 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2C(C)C)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11154845 60393 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 6 2 2 5.8 Cc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL176077 60393 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 6 2 2 5.8 Cc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11454015 132951 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2cc[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL3706813 132951 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2cc[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
16126667 82653 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 425 8 2 3 4.9 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2C)c1 10.1016/j.bmcl.2006.08.012
CHEMBL218174 82653 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 425 8 2 3 4.9 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2C)c1 10.1016/j.bmcl.2006.08.012
44445839 154982 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 488 7 2 6 4.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCO[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL404213 154982 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 488 7 2 6 4.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCO[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455846 97011 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 515 9 2 6 5.1 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270147 97011 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 515 9 2 6 5.1 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
44455765 154821 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 543 8 2 6 4.6 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(Br)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL403331 154821 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 543 8 2 6 4.6 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(Br)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11751629 78594 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 464 6 3 3 5.4 O=C(Nc1ccc2c(c1)CCN2)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113080 78594 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 464 6 3 3 5.4 O=C(Nc1ccc2c(c1)CCN2)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
10458976 94569 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 509 9 3 7 3.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254930 94569 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 509 9 3 7 3.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44445873 154425 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CC(=O)N(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL401160 154425 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CC(=O)N(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455766 95241 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 8 2 6 4.3 C[C@H](C[C@@H](C)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL258156 95241 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 8 2 6 4.3 C[C@H](C[C@@H](C)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455745 154762 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 559 8 3 7 4.0 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(Br)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL402983 154762 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 559 8 3 7 4.0 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(Br)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455711 168168 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 509 9 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL437031 168168 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 509 9 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44390938 62626 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 483 8 2 6 3.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3F)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL178506 62626 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 483 8 2 6 3.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3F)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11351206 69080 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 441 6 2 2 5.6 O=C(Nc1ccccc1F)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL193330 69080 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 441 6 2 2 5.6 O=C(Nc1ccccc1F)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11477384 132949 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 490 6 3 2 6.6 Cc1[nH]c2cc(NC(=O)N[C@@H]3CCCC[C@H]3CN3CCC[C@@H](Cc4ccc(F)cc4)C3)ccc2c1C 10.1021/jm049530m
CHEMBL3706811 132949 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 490 6 3 2 6.6 Cc1[nH]c2cc(NC(=O)N[C@@H]3CCCC[C@H]3CN3CCC[C@@H](Cc4ccc(F)cc4)C3)ccc2c1C 10.1021/jm049530m
44419301 83668 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 491 10 2 4 5.1 C#CCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL220765 83668 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 491 10 2 4 5.1 C#CCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
11953409 93781 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249854 93781 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445845 93807 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CCNC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL250056 93807 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CCNC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44390837 63217 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 9 2 6 4.0 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180042 63217 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 9 2 6 4.0 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11419003 70564 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 430 6 2 4 4.9 O=C(Nc1nccs1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL195129 70564 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 430 6 2 4 4.9 O=C(Nc1nccs1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44401328 70752 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL195348 70752 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
11373714 126653 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 427 6 2 4 4.2 Cn1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1021/jm049530m
CHEMBL365732 126653 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 427 6 2 4 4.2 Cn1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1021/jm049530m
9680 1867 4 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 450 7 3 4 2.8 O=C(NCc1ccc(cc1)C(=O)N)NC[C@H]1OCCN(C1)Cc1ccc(c(c1)Cl)Cl 10.1021/jm300682j
9825034 1867 4 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 450 7 3 4 2.8 O=C(NCc1ccc(cc1)C(=O)N)NC[C@H]1OCCN(C1)Cc1ccc(c(c1)Cl)Cl 10.1021/jm300682j
CHEMBL2178574 1867 4 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 450 7 3 4 2.8 O=C(NCc1ccc(cc1)C(=O)N)NC[C@H]1OCCN(C1)Cc1ccc(c(c1)Cl)Cl 10.1021/jm300682j
22393282 100736 0 None - 1 Human 8.0 pIC50 = 8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL295832 100736 0 None - 1 Human 8.0 pIC50 = 8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
22393282 100736 0 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
CHEMBL295832 100736 0 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
11385178 124287 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 441 6 2 2 5.6 O=C(Nc1cccc(F)c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL364263 124287 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 441 6 2 2 5.6 O=C(Nc1cccc(F)c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
22393282 100736 0 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL295832 100736 0 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
44440398 92901 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 584 8 0 5 6.3 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(C2CCCCC2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL245310 92901 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 584 8 0 5 6.3 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(C2CCCCC2)n1C 10.1016/j.bmcl.2007.05.035
44440420 93099 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 608 9 0 6 5.8 COc1ccc(-n2c(=O)c(CN(CCc3ccc(Cl)cc3)C3CCN(C(=O)c4c(F)cccc4F)CC3)c(C)n2C)cc1 10.1016/j.bmcl.2007.05.035
CHEMBL246347 93099 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 608 9 0 6 5.8 COc1ccc(-n2c(=O)c(CN(CCc3ccc(Cl)cc3)C3CCN(C(=O)c4c(F)cccc4F)CC3)c(C)n2C)cc1 10.1016/j.bmcl.2007.05.035
44440424 148728 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 621 9 0 6 5.8 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(N(C)C)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL394443 148728 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 621 9 0 6 5.8 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(N(C)C)cc2)n1C 10.1016/j.bmcl.2007.05.035
44440426 148731 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 613 8 0 6 5.8 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2cnccc2Cl)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL394444 148731 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 613 8 0 6 5.8 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2cnccc2Cl)n1C 10.1016/j.bmcl.2007.05.035
44440411 149558 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2cccc(F)c2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL395090 149558 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2cccc(F)c2)n1C 10.1016/j.bmcl.2007.05.035
44440414 150491 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 594 8 1 6 5.5 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(O)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL395851 150491 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 594 8 1 6 5.5 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(O)cc2)n1C 10.1016/j.bmcl.2007.05.035
44440417 150494 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 623 9 0 7 5.7 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc([N+](=O)[O-])cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL395852 150494 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 623 9 0 7 5.7 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc([N+](=O)[O-])cc2)n1C 10.1016/j.bmcl.2007.05.035
44295264 186892 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 8 2 3 5.6 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(-c2ccco2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL49404 186892 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 8 2 3 5.6 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(-c2ccco2)c1 10.1016/s0960-894x(02)00206-8
44295664 188110 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 10 2 3 5.5 CCC[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50423 188110 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 10 2 3 5.5 CCC[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
44295405 188493 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 8 3 3 4.7 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(-c2ncc[nH]2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50988 188493 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 8 3 3 4.7 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(-c2ncc[nH]2)c1 10.1016/s0960-894x(02)00206-8
22393436 188721 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 375 7 2 2 4.1 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NC1CCCCC1 10.1016/s0960-894x(02)00206-8
CHEMBL51229 188721 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 375 7 2 2 4.1 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NC1CCCCC1 10.1016/s0960-894x(02)00206-8
44295567 190059 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 465 10 3 4 4.7 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@H](O)C(C)C)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51815 190059 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 465 10 3 4 4.7 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@H](O)C(C)C)c1 10.1016/s0960-894x(02)00206-8
9979012 79392 0 None - 0 Human 6.0 pIC50 = 6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 411 7 1 5 4.4 O=C(CSc1nc2ccccc2s1)NCC1CCCN(Cc2ccccc2)C1 10.1016/s0960-894x(01)00176-7
CHEMBL21199 79392 0 None - 0 Human 6.0 pIC50 = 6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 411 7 1 5 4.4 O=C(CSc1nc2ccccc2s1)NCC1CCCN(Cc2ccccc2)C1 10.1016/s0960-894x(01)00176-7
44273640 98471 0 None - 0 Human 6.0 pIC50 = 6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 417 7 1 5 4.8 O=C(CSc1nc2ccccc2s1)NCC1CCCN(CC2CCCCC2)C1 10.1016/s0960-894x(01)00176-7
CHEMBL279450 98471 0 None - 0 Human 6.0 pIC50 = 6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 417 7 1 5 4.8 O=C(CSc1nc2ccccc2s1)NCC1CCCN(CC2CCCCC2)C1 10.1016/s0960-894x(01)00176-7
57401421 67523 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 486 6 1 3 5.1 O=C(NCCCN1CCC(c2ccc(F)cc2)CC1)C1=Cc2cc(Br)ccc2OCC1 10.1016/j.bmcl.2011.09.013
CHEMBL1910161 67523 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 486 6 1 3 5.1 O=C(NCCCN1CCC(c2ccc(F)cc2)CC1)C1=Cc2cc(Br)ccc2OCC1 10.1016/j.bmcl.2011.09.013
44440435 93006 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 563 8 0 6 4.6 Cc1c(CN(CCc2ccccn2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL245956 93006 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 563 8 0 6 4.6 Cc1c(CN(CCc2ccccn2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44295529 186717 0 None - 0 Human 6.0 pIC50 = 6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 368 8 1 2 4.3 O=C(NCCCCN1CCC(Cc2ccccc2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL49296 186717 0 None - 0 Human 6.0 pIC50 = 6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 368 8 1 2 4.3 O=C(NCCCCN1CCC(Cc2ccccc2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
44349617 117615 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 336 4 0 2 4.0 Fc1ccc(CCCN2CCC3C(C2)c2cccc4c2N3CC4)cc1 10.1021/jm0201767
CHEMBL340770 117615 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 336 4 0 2 4.0 Fc1ccc(CCCN2CCC3C(C2)c2cccc4c2N3CC4)cc1 10.1021/jm0201767
5481702 204109 1 None - 0 Human 5.0 pIC50 = 5 Binding
Compound concentration that causes 50 % inhibition of binding of specific radioligand to human CCR3 receptorCompound concentration that causes 50 % inhibition of binding of specific radioligand to human CCR3 receptor
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL83338 204109 1 None - 0 Human 5.0 pIC50 = 5 Binding
Compound concentration that causes 50 % inhibition of binding of specific radioligand to human CCR3 receptorCompound concentration that causes 50 % inhibition of binding of specific radioligand to human CCR3 receptor
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44442590 93339 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells
ChEMBL 606 11 6 5 3.8 Cc1ccc(CNC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)NC(C)C)C(=O)NC(C)(C)C)c(C)c1 10.1016/j.bmcl.2007.07.028
CHEMBL247455 93339 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells
ChEMBL 606 11 6 5 3.8 Cc1ccc(CNC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)NC(C)C)C(=O)NC(C)(C)C)c(C)c1 10.1016/j.bmcl.2007.07.028
44295435 189061 0 None - 0 Human 5.0 pIC50 = 5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 415 6 1 4 2.7 O=S(=O)(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51512 189061 0 None - 0 Human 5.0 pIC50 = 5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 415 6 1 4 2.7 O=S(=O)(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
44346194 15373 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 501 9 2 5 5.4 COc1cc(NC(=O)N[C@H](C)CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
CHEMBL121905 15373 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 501 9 2 5 5.4 COc1cc(NC(=O)N[C@H](C)CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
11006582 11351 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 483 6 2 4 5.5 C[N+]1(Cc2cc3c(cc2NC(=O)Nc2cccc(C#N)c2)OCO3)CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL1180359 11351 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 483 6 2 4 5.5 C[N+]1(Cc2cc3c(cc2NC(=O)Nc2cccc(C#N)c2)OCO3)CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL123616 11351 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 483 6 2 4 5.5 C[N+]1(Cc2cc3c(cc2NC(=O)Nc2cccc(C#N)c2)OCO3)CCC(Cc2ccccc2)CC1 10.1021/jm0201767
11059789 16593 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 472 7 3 4 5.3 N#Cc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL124438 16593 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 472 7 3 4 5.3 N#Cc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
10983981 16669 1 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 505 8 2 5 5.7 COC(=O)c1cccc(NC(=O)Nc2cccc(OC)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL124821 16669 1 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 505 8 2 5 5.7 COC(=O)c1cccc(NC(=O)Nc2cccc(OC)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
10895831 117909 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 461 8 2 3 6.0 COc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL341074 117909 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 461 8 2 3 6.0 COc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44295486 101029 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 502 5 2 3 4.0 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)Nc1cccc(I)c1 10.1016/s0960-894x(02)00206-8
CHEMBL297945 101029 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 502 5 2 3 4.0 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)Nc1cccc(I)c1 10.1016/s0960-894x(02)00206-8
20576924 188650 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 364 5 0 3 4.0 O=C(CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51163 188650 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 364 5 0 3 4.0 O=C(CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
45270199 194744 0 None - 0 Mouse 6.0 pIC50 = 6.0 Binding
Inhibition of mouse CCR3Inhibition of mouse CCR3
ChEMBL 516 5 1 4 4.2 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1cc[n+]([O-])cc1C(=O)N1CCCCC1 10.1016/j.bmc.2009.06.066
CHEMBL562897 194744 0 None - 0 Mouse 6.0 pIC50 = 6.0 Binding
Inhibition of mouse CCR3Inhibition of mouse CCR3
ChEMBL 516 5 1 4 4.2 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1cc[n+]([O-])cc1C(=O)N1CCCCC1 10.1016/j.bmc.2009.06.066
44295408 188213 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 381 6 1 3 3.7 O=C(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)C1CCCCC1 10.1016/s0960-894x(02)00206-8
CHEMBL50591 188213 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 381 6 1 3 3.7 O=C(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)C1CCCCC1 10.1016/s0960-894x(02)00206-8
11101888 112807 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 421 5 2 2 6.0 O=C(Nc1cc(F)ccc1F)Nc1ccccc1CN1CCC(c2ccccc2)CC1 10.1021/jm0201767
CHEMBL331530 112807 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 421 5 2 2 6.0 O=C(Nc1cc(F)ccc1F)Nc1ccccc1CN1CCC(c2ccccc2)CC1 10.1021/jm0201767
10983308 17794 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 454 7 3 4 5.1 N#Cc1cccc(NC(=O)Nc2cc(CO)ccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL126174 17794 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 454 7 3 4 5.1 N#Cc1cccc(NC(=O)Nc2cc(CO)ccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
57392726 67529 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 490 8 0 5 4.2 COc1ccc(OC)c(S(=O)(=O)N2CCC(CN3CCC(Cc4ccc(F)cc4)CC3)CC2)c1 10.1016/j.bmcl.2011.09.013
CHEMBL1910167 67529 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 490 8 0 5 4.2 COc1ccc(OC)c(S(=O)(=O)N2CCC(CN3CCC(Cc4ccc(F)cc4)CC3)CC2)c1 10.1016/j.bmcl.2011.09.013
44346153 15328 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 519 8 3 5 4.1 C[C@H](O)[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
CHEMBL121637 15328 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 519 8 3 5 4.1 C[C@H](O)[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
44346154 168096 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 489 7 2 4 4.7 C[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
CHEMBL436363 168096 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 489 7 2 4 4.7 C[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
44440437 145930 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 600 9 0 8 4.9 Cc1ccnc(C)c1C(=O)N1CCC(N(CCc2ccc([N+](=O)[O-])cc2)Cc2c(C)n(C)n(-c3ccc(F)cc3)c2=O)CC1 10.1016/j.bmcl.2007.05.035
CHEMBL392218 145930 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 600 9 0 8 4.9 Cc1ccnc(C)c1C(=O)N1CCC(N(CCc2ccc([N+](=O)[O-])cc2)Cc2c(C)n(C)n(-c3ccc(F)cc3)c2=O)CC1 10.1016/j.bmcl.2007.05.035
23657036 145931 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 572 9 0 8 4.3 Cc1c(CN(CCc2ccc([N+](=O)[O-])cc2)C2CCN(C(=O)c3ccccn3)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL392219 145931 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 572 9 0 8 4.3 Cc1c(CN(CCc2ccc([N+](=O)[O-])cc2)C2CCN(C(=O)c3ccccn3)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44390848 121875 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3cccc(F)c3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL360062 121875 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3cccc(F)c3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
9868532 60164 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
CHEMBL175502 60164 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
11396995 69959 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 459 6 2 2 5.7 O=C(Nc1ccc(F)c(F)c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL194384 69959 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 459 6 2 2 5.7 O=C(Nc1ccc(F)c(F)c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44387837 123314 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 448 6 2 3 5.3 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
CHEMBL362465 123314 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 448 6 2 3 5.3 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
44419303 141315 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 517 11 2 4 5.7 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC(F)F)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL386493 141315 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 517 11 2 4 5.7 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC(F)F)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
44390843 63848 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 477 9 2 7 3.5 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(OC)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180860 63848 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 477 9 2 7 3.5 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(OC)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44295374 101120 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 404 9 2 3 4.8 N#Cc1cccc(NC(=O)NCCCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL298681 101120 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 404 9 2 3 4.8 N#Cc1cccc(NC(=O)NCCCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
44295352 188099 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 380 9 1 3 4.2 COc1cccc(C(=O)NCCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50400 188099 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 380 9 1 3 4.2 COc1cccc(C(=O)NCCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
44295372 188574 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 419 7 2 2 5.2 O=C(NCCCN1CCC(Cc2ccccc2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51113 188574 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 419 7 2 2 5.2 O=C(NCCCN1CCC(Cc2ccccc2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00206-8
10623381 16722 0 None - 1 Human 4.9 pIC50 = 4.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 448 8 2 3 5.3 NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL125111 16722 0 None - 1 Human 4.9 pIC50 = 4.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 448 8 2 3 5.3 NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
44349204 17026 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 350 5 0 2 3.8 CC1C2=C(CC=CC2)C(=O)N1CC1CCN(CCc2ccccc2)CC1 10.1021/jm0201767
CHEMBL125643 17026 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 350 5 0 2 3.8 CC1C2=C(CC=CC2)C(=O)N1CC1CCN(CCc2ccccc2)CC1 10.1021/jm0201767
11037869 16544 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 459 7 2 3 6.1 CC(=O)c1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
CHEMBL124317 16544 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 459 7 2 3 6.1 CC(=O)c1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
11037869 16544 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 459 7 2 3 6.1 CC(=O)c1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL124317 16544 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 459 7 2 3 6.1 CC(=O)c1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44419314 82888 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL218997 82888 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
44593553 177792 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 489 6 2 6 3.9 Cc1csc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1016/j.bmcl.2008.11.002
CHEMBL465272 177792 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 489 6 2 6 3.9 Cc1csc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1016/j.bmcl.2008.11.002
44390891 63643 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NC[C@H]2CCCN(CCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180694 63643 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NC[C@H]2CCCN(CCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
44295544 188343 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 375 8 1 3 4.0 N#Cc1ccc(C(=O)NCCCCN2CCC(Cc3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL50801 188343 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 375 8 1 3 4.0 N#Cc1ccc(C(=O)NCCCCN2CCC(Cc3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
11826382 17090 1 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 443 8 2 3 5.5 COc1ccc(NC(=O)NCc2ccccc2CN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
CHEMBL125695 17090 1 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 443 8 2 3 5.5 COc1ccc(NC(=O)NCc2ccccc2CN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
44419305 82219 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 535 10 2 4 6.0 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC(F)(F)F)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL217928 82219 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 535 10 2 4 6.0 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC(F)(F)F)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
44390867 62250 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 7 2 6 3.4 CCc1cc(NC(=O)N[C@@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL178278 62250 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 7 2 6 3.4 CCc1cc(NC(=O)N[C@@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11396851 60174 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
CHEMBL175559 60174 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
11247999 77616 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL2096763 77616 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
10972522 16949 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 456 7 2 3 5.8 N#Cc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL125549 16949 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 456 7 2 3 5.8 N#Cc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
11004663 117099 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 438 7 2 3 5.7 N#Cc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL340080 117099 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 438 7 2 3 5.7 N#Cc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
10917990 16317 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 491 7 2 5 5.7 COc1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
CHEMBL123580 16317 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 491 7 2 5 5.7 COc1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
11729258 16666 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 409 8 0 3 5.1 N#CC(CCCN1CCN(Cc2ccccc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL124808 16666 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 409 8 0 3 5.1 N#CC(CCCN1CCN(Cc2ccccc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
44419323 83720 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 390 8 3 3 4.5 N#Cc1cccc(NC(=O)NCCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL220800 83720 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 390 8 3 3 4.5 N#Cc1cccc(NC(=O)NCCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
11609863 16667 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 343 6 1 2 4.6 OC1(c2ccc(Cl)cc2)CCN(CCCCc2ccccc2)CC1 10.1021/jm0201767
CHEMBL124813 16667 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 343 6 1 2 4.6 OC1(c2ccc(Cl)cc2)CCN(CCCCc2ccccc2)CC1 10.1021/jm0201767
44390851 123341 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NC[C@H]2CCCN(CCCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL362613 123341 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NC[C@H]2CCCN(CCCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
44442599 93216 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells
ChEMBL 585 9 5 5 3.3 Cc1cc(Br)ccc1CNC[C@H](NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1N)C(=O)NC(C)(C)C 10.1016/j.bmcl.2007.07.028
CHEMBL246804 93216 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells
ChEMBL 585 9 5 5 3.3 Cc1cc(Br)ccc1CNC[C@H](NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1N)C(=O)NC(C)(C)C 10.1016/j.bmcl.2007.07.028
44295145 191001 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 502 5 2 3 4.0 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)Nc1ccc(I)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51953 191001 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 502 5 2 3 4.0 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)Nc1ccc(I)cc1 10.1016/s0960-894x(02)00206-8
11059385 157851 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 448 8 1 2 5.6 O=C(Cc1ccc(F)cc1)Nc1ccccc1CCN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL409001 157851 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 448 8 1 2 5.6 O=C(Cc1ccc(F)cc1)Nc1ccccc1CCN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44440419 93098 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 603 8 0 6 5.6 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(C#N)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL246346 93098 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 603 8 0 6 5.6 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(C#N)cc2)n1C 10.1016/j.bmcl.2007.05.035
44440393 93483 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 586 10 0 5 6.8 Cc1c(CN(CCCCc2ccccc2)C2CCN(C(=O)c3cccc4ccccc34)CC2)c(=O)n(-c2ccccc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL248178 93483 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 586 10 0 5 6.8 Cc1c(CN(CCCCc2ccccc2)C2CCN(C(=O)c3cccc4ccccc34)CC2)c(=O)n(-c2ccccc2)n1C 10.1016/j.bmcl.2007.05.035
44445851 154044 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 573 7 2 7 5.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)OC(C)(C)C)C[C@@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL399133 154044 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 573 7 2 7 5.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)OC(C)(C)C)C[C@@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44295354 188572 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 8 2 3 4.2 CN(C)c1ccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51110 188572 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 8 2 3 4.2 CN(C)c1ccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
23509664 193277 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 421 6 1 3 4.9 COc1cccc(NC(=O)N2CCC(CN3CCC(Cc4ccccc4)CC3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL54251 193277 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 421 6 1 3 4.9 COc1cccc(NC(=O)N2CCC(CN3CCC(Cc4ccccc4)CC3)CC2)c1 10.1016/s0960-894x(02)00206-8
9907041 167266 2 None - 0 Human 4.8 pIC50 = 4.8 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 363 7 2 5 2.2 CCOC(=O)[C@H](Cc1ccc(O)cc1)NS(=O)(=O)c1ccc(C)cc1 10.1016/s0960-894x(01)00248-7
CHEMBL430745 167266 2 None - 0 Human 4.8 pIC50 = 4.8 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 363 7 2 5 2.2 CCOC(=O)[C@H](Cc1ccc(O)cc1)NS(=O)(=O)c1ccc(C)cc1 10.1016/s0960-894x(01)00248-7
10974378 113798 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 664 12 3 4 7.4 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)NC1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL333063 113798 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 664 12 3 4 7.4 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)NC1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
71458114 79206 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 4.9 CC(=O)c1cccc(NC(=O)NCCCN2CC3CCC2[C@@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
CHEMBL2114958 79206 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 4.9 CC(=O)c1cccc(NC(=O)NCCCN2CC3CCC2[C@@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
10983419 116958 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 461 7 3 3 5.6 O=C(Nc1ccccc1)Nc1cccc(C(=O)O)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL339884 116958 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 461 7 3 3 5.6 O=C(Nc1ccccc1)Nc1cccc(C(=O)O)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44295480 189019 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 439 6 1 3 5.2 COc1cccc(NC(=O)N2CCCCC2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51480 189019 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 439 6 1 3 5.2 COc1cccc(NC(=O)N2CCCCC2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
20613253 112843 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 446 7 1 2 6.4 Cc1ccc(C(=O)NC(CC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
CHEMBL331702 112843 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 446 7 1 2 6.4 Cc1ccc(C(=O)NC(CC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
44281525 109215 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 314 6 2 5 1.7 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1ccccn1 10.1016/s0960-894x(01)00248-7
CHEMBL32282 109215 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 314 6 2 5 1.7 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1ccccn1 10.1016/s0960-894x(01)00248-7
10928228 16616 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 435 6 2 2 6.1 O=C(Nc1cc(F)ccc1F)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL124583 16616 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 435 6 2 2 6.1 O=C(Nc1cc(F)ccc1F)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
10874167 170275 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 457 7 2 4 5.2 O=C(NCc1ccc2c(c1)OCO2)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL445379 170275 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 457 7 2 4 5.2 O=C(NCc1ccc2c(c1)OCO2)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
44281789 110862 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 454 8 1 5 4.8 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)OCc1ccccc1)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL32692 110862 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 454 8 1 5 4.8 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)OCc1ccccc1)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
11026634 112832 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 443 8 2 3 5.8 COc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL331634 112832 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 443 8 2 3 5.8 COc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
22022826 16272 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 472 7 1 2 6.5 Cc1ccc(C(=O)NC(CN2C3CCC2CC(Cc2ccc(Cl)c(Cl)c2)C3)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
CHEMBL123308 16272 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 472 7 1 2 6.5 Cc1ccc(C(=O)NC(CN2C3CCC2CC(Cc2ccc(Cl)c(Cl)c2)C3)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
44419322 83954 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 362 6 3 3 3.7 N#Cc1cccc(NC(=O)NCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL221901 83954 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 362 6 3 3 3.7 N#Cc1cccc(NC(=O)NCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
15907328 162811 31 None - 0 Human 4.7 pIC50 = 4.7 Binding
Evaluated for its inhibitory activity against human Chemokine receptor type 3 expressed in chinese hamster ovary cellsEvaluated for its inhibitory activity against human Chemokine receptor type 3 expressed in chinese hamster ovary cells
ChEMBL 301 3 1 2 3.8 OC1(c2ccc(Cl)cc2)CCN(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL419244 162811 31 None - 0 Human 4.7 pIC50 = 4.7 Binding
Evaluated for its inhibitory activity against human Chemokine receptor type 3 expressed in chinese hamster ovary cellsEvaluated for its inhibitory activity against human Chemokine receptor type 3 expressed in chinese hamster ovary cells
ChEMBL 301 3 1 2 3.8 OC1(c2ccc(Cl)cc2)CCN(Cc2ccccc2)CC1 10.1021/jm0201767
44447374 94291 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 499 11 4 8 2.2 CCN(C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](C)[C@@H](O)Cc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
CHEMBL253034 94291 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 499 11 4 8 2.2 CCN(C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](C)[C@@H](O)Cc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
44289763 164499 0 None - 1 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 412 7 2 3 4.3 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccc(F)cc3F)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL42264 164499 0 None - 1 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 412 7 2 3 4.3 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccc(F)cc3F)C2)c1 10.1016/j.bmcl.2004.01.059
22143196 183405 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of CCR3 at 10 uMInhibition of CCR3 at 10 uM
ChEMBL 509 7 5 6 2.0 CSc1ccc(C(=O)NC2CCNCC2NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2N)cc1 10.1016/j.bmcl.2008.12.062
CHEMBL481790 183405 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of CCR3 at 10 uMInhibition of CCR3 at 10 uM
ChEMBL 509 7 5 6 2.0 CSc1ccc(C(=O)NC2CCNCC2NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2N)cc1 10.1016/j.bmcl.2008.12.062
209394 116132 10 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 297 6 1 3 2.6 CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL33693 116132 10 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 297 6 1 3 2.6 CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
11814253 116455 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 635 10 3 3 8.2 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1cccc(C(F)(F)F)c1 10.1021/jm0201767
CHEMBL338624 116455 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 635 10 3 3 8.2 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1cccc(C(F)(F)F)c1 10.1021/jm0201767
12000105 83826 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 453 10 2 3 5.7 CCCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL221067 83826 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 453 10 2 3 5.7 CCCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
11227406 93909 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm300682j
CHEMBL250689 93909 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm300682j
11272103 123856 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2008.11.002
CHEMBL363840 123856 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2008.11.002
44445876 93653 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 501 7 2 6 4.2 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249060 93653 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 501 7 2 6 4.2 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445856 93828 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 557 8 2 6 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL250262 93828 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 557 8 2 6 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
11227406 93909 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL250689 93909 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
44445892 93985 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CC(=O)N(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251045 93985 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CC(=O)N(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445840 94015 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 488 7 2 6 4.3 CC(=O)c1sc(NC(=O)N[C@@H]2CCOC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251232 94015 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 488 7 2 6 4.3 CC(=O)c1sc(NC(=O)N[C@@H]2CCOC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445894 154193 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 612 8 2 7 4.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C3CCN(C(C)=O)CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL399893 154193 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 612 8 2 7 4.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C3CCN(C(C)=O)CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
21362425 154464 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 584 8 2 7 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C3CCN(C)CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL401394 154464 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 584 8 2 7 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C3CCN(C)CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
11227406 93909 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL250689 93909 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
44455509 165873 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 493 9 2 6 4.4 CCc1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL427728 165873 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 493 9 2 6 4.4 CCc1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455560 168713 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 517 9 2 8 3.8 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2ccnn2)cc(-n2ccnn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL441334 168713 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 517 9 2 8 3.8 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2ccnn2)cc(-n2ccnn2)c1 10.1016/j.bmcl.2007.11.067
11363006 70092 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
CHEMBL194601 70092 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
11227406 93909 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL250689 93909 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44401123 135757 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 516 7 2 5 4.9 N#CC1=CC(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)CC=C1n1cccn1 10.1021/jm049530m
CHEMBL373347 135757 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 516 7 2 5 4.9 N#CC1=CC(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)CC=C1n1cccn1 10.1021/jm049530m
11017618 11365 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 501 6 2 4 5.7 C[N+]1(Cc2cc3c(cc2NC(=O)Nc2cccc(C#N)c2)OCO3)CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL1180385 11365 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 501 6 2 4 5.7 C[N+]1(Cc2cc3c(cc2NC(=O)Nc2cccc(C#N)c2)OCO3)CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL124689 11365 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 501 6 2 4 5.7 C[N+]1(Cc2cc3c(cc2NC(=O)Nc2cccc(C#N)c2)OCO3)CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
11762511 16386 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 474 7 3 3 5.3 CNC(=O)c1cccc(NC(=O)Nc2ccccc2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL123837 16386 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 474 7 3 3 5.3 CNC(=O)c1cccc(NC(=O)Nc2ccccc2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
11134936 16566 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 504 8 3 4 5.3 CNC(=O)c1cccc(NC(=O)Nc2cccc(OC)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL124334 16566 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 504 8 3 4 5.3 CNC(=O)c1cccc(NC(=O)Nc2cccc(OC)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
11038430 16644 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 502 8 3 4 5.2 CC(=O)c1cccc(NC(=O)Nc2cccc(C(N)=O)c2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL124722 16644 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 502 8 3 4 5.2 CC(=O)c1cccc(NC(=O)Nc2cccc(C(N)=O)c2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44570581 177841 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 536 10 2 8 3.1 CN1C[C@@H](NC(=O)Nc2cccc(-c3nnnn3C)c2)[C@H](CN(CCCc2ccc(F)cc2)C2CC2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL465942 177841 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 536 10 2 8 3.1 CN1C[C@@H](NC(=O)Nc2cccc(-c3nnnn3C)c2)[C@H](CN(CCCc2ccc(F)cc2)C2CC2)OC1=O 10.1016/j.bmcl.2008.11.002
44445847 93988 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CNCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251079 93988 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CNCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445878 154061 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 557 8 2 6 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL399150 154061 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 557 8 2 6 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445880 154697 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 8 2 6 4.5 CCC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL402707 154697 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 8 2 6 4.5 CCC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
21362416 93650 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 612 8 2 7 4.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C3CCN(C(C)=O)CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249058 93650 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 612 8 2 7 4.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C3CCN(C(C)=O)CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44390927 62671 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 493 9 2 6 4.3 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2CC)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL178671 62671 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 493 9 2 6 4.3 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2CC)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44390894 121845 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 9 2 6 4.0 CCc1cc(NC(=O)NC[C@H]2CCCN(CCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL360039 121845 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 9 2 6 4.0 CCc1cc(NC(=O)NC[C@H]2CCCN(CCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11179351 124094 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 490 7 2 5 5.0 O=C(Nc1ccc(-n2cncn2)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL364068 124094 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 490 7 2 5 5.0 O=C(Nc1ccc(-n2cncn2)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44419300 83589 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 499 11 2 4 5.4 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCF)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL220713 83589 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 499 11 2 4 5.4 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCF)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
795 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(03)00748-0
796 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(03)00748-0
9913085 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(03)00748-0
CHEMBL20921 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(03)00748-0
795 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(01)00176-7
796 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(01)00176-7
9913085 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(01)00176-7
CHEMBL20921 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(01)00176-7
44445875 93651 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 531 9 3 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CCO)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249059 93651 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 531 9 3 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CCO)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445859 154248 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 545 7 2 7 4.3 COC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL400173 154248 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 545 7 2 7 4.3 COC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
44401561 123602 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL363373 123602 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
11750808 125675 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 431 6 2 5 4.3 O=C(Nc1nncs1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL364977 125675 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 431 6 2 5 4.3 O=C(Nc1nncs1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44346210 167392 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 531 10 3 6 4.7 COc1cc(NC(=O)N[C@@H](CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)[C@H](C)O)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
CHEMBL431670 167392 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 531 10 3 6 4.7 COc1cc(NC(=O)N[C@@H](CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)[C@H](C)O)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
44455845 97010 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 537 10 3 7 4.5 CC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270146 97010 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 537 10 3 7 4.5 CC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
44289713 165555 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 527 9 2 6 5.2 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2ccccc2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL42599 165555 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 527 9 2 6 5.2 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2ccccc2)c1 10.1016/j.bmcl.2004.01.059
44419335 83726 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 465 10 2 3 5.7 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC2CC2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL220819 83726 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 465 10 2 3 5.7 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC2CC2)c1 10.1016/j.bmcl.2006.08.012
44447140 94118 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 523 11 3 7 4.2 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)C1CCCCC1 10.1016/j.bmcl.2007.11.087
CHEMBL251839 94118 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 523 11 3 7 4.2 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)C1CCCCC1 10.1016/j.bmcl.2007.11.087
44447154 94254 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 559 13 3 7 4.6 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)Cc2ccccc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL252792 94254 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 559 13 3 7 4.6 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)Cc2ccccc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447380 94449 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 483 11 3 7 3.2 CCN(C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](C)CCc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
CHEMBL254093 94449 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 483 11 3 7 3.2 CCN(C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](C)CCc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
44445907 94392 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 409 7 2 3 4.6 CC(=O)c1cccc(NC(=O)N/C=C/CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL253676 94392 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 409 7 2 3 4.6 CC(=O)c1cccc(NC(=O)N/C=C/CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
44445883 154698 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 555 8 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C3CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL402708 154698 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 555 8 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C3CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44290039 178224 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL46905 178224 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
11430170 123315 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 423 6 2 2 5.5 O=C(Nc1ccccc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL362466 123315 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 423 6 2 2 5.5 O=C(Nc1ccccc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11385766 132275 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL370082 132275 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44290039 178224 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL46905 178224 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44290039 178224 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL46905 178224 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44445849 94016 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 573 7 2 7 5.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)OC(C)(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251243 94016 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 573 7 2 7 5.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)OC(C)(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445889 154327 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 567 9 2 7 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CN(Cc3ccco3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL400649 154327 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 567 9 2 7 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CN(Cc3ccco3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44289919 100684 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 493 9 2 7 3.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL295415 100684 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 493 9 2 7 3.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455683 154549 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 531 9 3 7 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL401879 154549 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 531 9 3 7 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
44455485 154960 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 507 9 2 6 5.0 CC(C)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL404122 154960 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 507 9 2 6 5.0 CC(C)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455484 166852 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 493 9 2 6 4.6 CC(C)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL429604 166852 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 493 9 2 6 4.6 CC(C)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44387842 130779 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 369 5 2 3 4.2 CC(=O)c1cccc(NC(=O)NN2CCCCC2Cc2ccc(F)cc2)c1 10.1021/jm049530m
CHEMBL368683 130779 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 369 5 2 3 4.2 CC(=O)c1cccc(NC(=O)NN2CCCCC2Cc2ccc(F)cc2)c1 10.1021/jm049530m
10457573 116547 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 473 8 2 3 6.2 CC(=O)c1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL339110 116547 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 473 8 2 3 6.2 CC(=O)c1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44289919 100684 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 493 9 2 7 3.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
CHEMBL295415 100684 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 493 9 2 7 3.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
44445893 153878 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 541 9 2 6 5.0 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CC3CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL398889 153878 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 541 9 2 6 5.0 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CC3CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455459 94648 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL255398 94648 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
44455460 94649 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 533 9 3 7 5.3 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2ncco2)cc(-c2ncco2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL255399 94649 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 533 9 3 7 5.3 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2ncco2)cc(-c2ncco2)c1 10.1016/j.bmcl.2007.11.067
44455767 95277 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 483 9 3 5 4.4 CC(=O)c1cc(NC(=O)N[C@@H](C)C[C@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL258309 95277 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 483 9 3 5 4.4 CC(=O)c1cc(NC(=O)N[C@@H](C)C[C@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
11487192 69332 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 428 6 2 4 4.8 Cc1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)no1 10.1021/jm049530m
CHEMBL193526 69332 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 428 6 2 4 4.8 Cc1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)no1 10.1021/jm049530m
44445896 153999 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 531 9 3 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CCO)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL399088 153999 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 531 9 3 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CCO)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445855 154247 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 583 8 2 6 5.3 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C3CCCC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL400172 154247 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 583 8 2 6 5.3 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C3CCCC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
11113940 79172 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 509 8 1 6 5.9 CCOc1ccc2nc(SCC(=O)NC3CCN(Cc4ccc(Cl)c(Cl)c4)CC3)sc2c1 10.1016/s0960-894x(01)00176-7
CHEMBL21143 79172 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 509 8 1 6 5.9 CCOc1ccc2nc(SCC(=O)NC3CCN(Cc4ccc(Cl)c(Cl)c4)CC3)sc2c1 10.1016/s0960-894x(01)00176-7
44440402 93484 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL248179 93484 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44295648 101530 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 9 3 4 4.1 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@H](C)O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL301601 101530 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 9 3 4 4.1 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@H](C)O)c1 10.1016/s0960-894x(02)00206-8
44295555 101584 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 447 8 2 4 3.7 CS(=O)(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL301974 101584 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 447 8 2 4 3.7 CS(=O)(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
22393430 168137 0 None - 1 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL43677 168137 0 None - 1 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
22393339 186154 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 410 7 2 3 4.7 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(Cl)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL48873 186154 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 410 7 2 3 4.7 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(Cl)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
44295306 188296 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 415 8 2 3 5.0 CSc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50726 188296 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 415 8 2 3 5.0 CSc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
22393469 188785 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 7 2 3 4.2 N#Cc1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51286 188785 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 7 2 3 4.2 N#Cc1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
44295566 193047 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 11 3 4 5.1 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@@H](O)CC(C)C)c1 10.1016/s0960-894x(02)00206-8
CHEMBL53444 193047 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 11 3 4 5.1 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@@H](O)CC(C)C)c1 10.1016/s0960-894x(02)00206-8
22393430 168137 0 None - 1 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43677 168137 0 None - 1 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
44440429 93210 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 580 8 0 5 5.4 Cc1c(CN(CCc2ccc(F)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL246768 93210 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 580 8 0 5 5.4 Cc1c(CN(CCc2ccc(F)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44440445 146214 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 577 8 0 6 4.3 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3cccc[n+]3[O-])CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL392430 146214 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 577 8 0 6 4.3 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3cccc[n+]3[O-])CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44295674 101162 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 483 10 2 3 6.0 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2Cc2ccccc2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL298999 101162 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 483 10 2 3 6.0 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2Cc2ccccc2)c1 10.1016/s0960-894x(02)00206-8
22393362 101219 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 7 2 2 5.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccccc1C(F)(F)F 10.1016/s0960-894x(02)00206-8
CHEMBL299385 101219 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 7 2 2 5.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccccc1C(F)(F)F 10.1016/s0960-894x(02)00206-8
9842640 166820 0 None - 1 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 376 7 2 3 4.0 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL42948 166820 0 None - 1 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 376 7 2 3 4.0 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
44295267 187649 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 431 8 2 3 4.0 C[S+]([O-])c1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL49938 187649 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 431 8 2 3 4.0 C[S+]([O-])c1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
44295406 187780 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 8 2 3 6.0 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(-c2cccs2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50129 187780 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 8 2 3 6.0 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(-c2cccs2)c1 10.1016/s0960-894x(02)00206-8
44295664 188110 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 10 2 3 5.5 CCC[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50423 188110 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 10 2 3 5.5 CCC[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
22393307 188185 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3F)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50557 188185 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3F)CC2)c1 10.1016/s0960-894x(02)00206-8
44295304 188539 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 9 3 4 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2C(C)(C)O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51052 188539 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 9 3 4 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2C(C)(C)O)c1 10.1016/s0960-894x(02)00206-8
22393366 191922 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 411 8 2 3 4.5 CC(=O)c1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL52094 191922 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 411 8 2 3 4.5 CC(=O)c1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
9842640 166820 0 None - 1 Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 376 7 2 3 4.0 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL42948 166820 0 None - 1 Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 376 7 2 3 4.0 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/j.bmcl.2004.01.059
44349614 117946 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 402 5 0 3 3.6 O=C1CC2(CCc3ccccc32)C(=O)N1CC1CCN(CCc2ccccc2)CC1 10.1021/jm0201767
CHEMBL341144 117946 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 402 5 0 3 3.6 O=C1CC2(CCc3ccccc32)C(=O)N1CC1CCN(CCc2ccccc2)CC1 10.1021/jm0201767
44281791 115771 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 406 7 1 5 4.0 CC(C)OC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33589 115771 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 406 7 1 5 4.0 CC(C)OC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
11103845 12020 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 455 6 3 3 5.5 C[N+]1(Cc2cc(O)ccc2NC(=O)Nc2cccc(C#N)c2)CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL1184106 12020 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 455 6 3 3 5.5 C[N+]1(Cc2cc(O)ccc2NC(=O)Nc2cccc(C#N)c2)CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL332591 12020 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 455 6 3 3 5.5 C[N+]1(Cc2cc(O)ccc2NC(=O)Nc2cccc(C#N)c2)CCC(Cc2ccccc2)CC1 10.1021/jm0201767
11812807 16401 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 477 8 3 4 5.5 COc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL123917 16401 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 477 8 3 4 5.5 COc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44447161 94443 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 547 12 3 8 2.3 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)S(C)(=O)=O)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254055 94443 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 547 12 3 8 2.3 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)S(C)(=O)=O)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447153 153398 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 617 13 3 7 5.6 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)CC23CC4CC(CC(C4)C2)C3)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL398344 153398 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 617 13 3 7 5.6 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)CC23CC4CC(CC(C4)C2)C3)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44419314 82888 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL218997 82888 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
11828215 113961 1 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 613 12 3 3 7.1 O=C(NCCc1ccc(F)cc1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL333422 113961 1 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 613 12 3 3 7.1 O=C(NCCc1ccc(F)cc1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11104005 116857 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 602 12 3 4 6.2 O=C(NCCN1CCCCC1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL339752 116857 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 602 12 3 4 6.2 O=C(NCCN1CCCCC1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11813735 117642 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 562 12 3 4 5.3 CN(C)CCNC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL340797 117642 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 562 12 3 4 5.3 CN(C)CCNC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11730610 16506 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 485 7 2 5 5.7 CC(=O)c1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccccc4)CC2)OCO3)c1 10.1021/jm0201767
CHEMBL124272 16506 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 485 7 2 5 5.7 CC(=O)c1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccccc4)CC2)OCO3)c1 10.1021/jm0201767
44390949 64074 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCC2CCN(CCCc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL181311 64074 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCC2CCN(CCCc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.11.006
44512617 193668 0 None - 0 Mouse 6.6 pIC50 = 6.6 Binding
Inhibition of mouse CCR3Inhibition of mouse CCR3
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL551735 193668 0 None - 0 Mouse 6.6 pIC50 = 6.6 Binding
Inhibition of mouse CCR3Inhibition of mouse CCR3
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44295686 162451 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 407 5 1 3 4.6 COc1cccc(NC(=O)N2CCC(N3CCC(Cc4ccccc4)CC3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL417547 162451 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 407 5 1 3 4.6 COc1cccc(NC(=O)N2CCC(N3CCC(Cc4ccccc4)CC3)CC2)c1 10.1016/s0960-894x(02)00206-8
10995218 16438 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 549 12 4 4 5.1 O=C(NCCCO)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL124127 16438 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 549 12 4 4 5.1 O=C(NCCCO)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
9982077 16410 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 468 6 2 5 5.4 N#Cc1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccccc4)CC2)OCO3)c1 10.1021/jm0201767
CHEMBL123962 16410 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 468 6 2 5 5.4 N#Cc1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccccc4)CC2)OCO3)c1 10.1021/jm0201767
44447373 94237 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(C)[C@H](C)[C@@H](O)c1ccccc1 10.1016/j.bmcl.2007.11.087
CHEMBL252628 94237 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(C)[C@H](C)[C@@H](O)c1ccccc1 10.1016/j.bmcl.2007.11.087
10863252 170790 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 447 7 3 3 5.5 O=C(Nc1ccccc1)Nc1ccccc1C(O)CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL446164 170790 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 447 7 3 3 5.5 O=C(Nc1ccccc1)Nc1ccccc1C(O)CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44295479 101086 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 425 6 1 3 4.6 COc1cccc(NC(=O)N2CCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL298414 101086 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 425 6 1 3 4.6 COc1cccc(NC(=O)N2CCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
11285792 866 30 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from CCR3 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
801 866 30 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from CCR3 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
CHEMBL2110727 866 30 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from CCR3 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
DB11758 866 30 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from CCR3 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
10983106 16748 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 443 8 2 3 5.5 COc1cccc(NC(=O)NCc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL125282 16748 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 443 8 2 3 5.5 COc1cccc(NC(=O)NCc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
11124782 117965 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 587 11 3 3 7.3 O=C(NCC1CCCCC1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL341306 117965 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 587 11 3 3 7.3 O=C(NCC1CCCCC1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
22393396 167707 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3cccc(F)c3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43391 167707 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3cccc(F)c3)C2)c1 10.1016/j.bmcl.2004.01.059
11732727 16471 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 429 7 3 3 5.3 O=C(Nc1ccccc1)Nc1ccccc1C(O)CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL124206 16471 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 429 7 3 3 5.3 O=C(Nc1ccccc1)Nc1ccccc1C(O)CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
44440396 152533 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 579 8 0 6 5.2 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccccn2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL397599 152533 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 579 8 0 6 5.2 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccccn2)n1C 10.1016/j.bmcl.2007.05.035
44440427 93209 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 609 9 0 7 5.2 COc1ccncc1-n1c(=O)c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(C)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL246766 93209 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 609 9 0 7 5.2 COc1ccncc1-n1c(=O)c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(C)n1C 10.1016/j.bmcl.2007.05.035
44295499 188768 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 453 7 1 3 5.4 COc1cccc(NC(=O)N2CCCC(CCN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51267 188768 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 453 7 1 3 5.4 COc1cccc(NC(=O)N2CCCC(CCN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
44440422 93100 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 622 9 1 6 5.5 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(C(=O)O)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL246348 93100 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 622 9 1 6 5.5 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(C(=O)O)cc2)n1C 10.1016/j.bmcl.2007.05.035
44440440 93211 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 577 8 1 6 4.8 Cc1c(CN(CCc2ccc(N)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL246769 93211 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 577 8 1 6 4.8 Cc1c(CN(CCc2ccc(N)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44440434 152829 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 563 8 0 6 4.6 Cc1c(CN(CCc2cccnc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL397853 152829 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 563 8 0 6 4.6 Cc1c(CN(CCc2cccnc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44295409 101194 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 355 5 1 3 3.2 CC(C)(C)C(=O)NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3 10.1016/s0960-894x(02)00206-8
CHEMBL299226 101194 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 355 5 1 3 3.2 CC(C)(C)C(=O)NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3 10.1016/s0960-894x(02)00206-8
44295433 186477 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCO[C@@H](CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL49117 186477 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCO[C@@H](CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
23497297 16695 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 483 6 3 5 5.4 O=C(Nc1ccc2c[nH]nc2c1)Nc1cc2c(cc1CN1CCC(Cc3ccccc3)CC1)OCO2 10.1021/jm0201767
CHEMBL124966 16695 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 483 6 3 5 5.4 O=C(Nc1ccc2c[nH]nc2c1)Nc1cc2c(cc1CN1CCC(Cc3ccccc3)CC1)OCO2 10.1021/jm0201767
11001953 113634 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 327 7 2 4 2.2 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)Cc1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL33290 113634 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 327 7 2 4 2.2 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)Cc1ccccc1 10.1016/s0960-894x(01)00248-7
11825113 16707 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 381 8 3 3 3.6 O=C(NCCCO)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL125026 16707 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 381 8 3 3 3.6 O=C(NCCCO)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
11762865 16384 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 503 9 2 2 7.1 O=C(NCC(c1ccccc1)c1ccccc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL123807 16384 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 503 9 2 2 7.1 O=C(NCC(c1ccccc1)c1ccccc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
44570714 189202 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of CCR3 at 10 uMInhibition of CCR3 at 10 uM
ChEMBL 565 9 5 6 3.6 CSc1ccc(C(=O)NC2CCC(NC(C)C)CC2NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2N)cc1 10.1016/j.bmcl.2008.12.062
CHEMBL516224 189202 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of CCR3 at 10 uMInhibition of CCR3 at 10 uM
ChEMBL 565 9 5 6 3.6 CSc1ccc(C(=O)NC2CCC(NC(C)C)CC2NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2N)cc1 10.1016/j.bmcl.2008.12.062
11048458 117974 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 440 6 3 4 5.4 N#Cc1cccc(NC(=O)Nc2ccc(O)cc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL341343 117974 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 440 6 3 4 5.4 N#Cc1cccc(NC(=O)Nc2ccc(O)cc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
71449114 78537 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 435 7 2 3 5.3 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCCC(Cc3ccccc3)C2)c1 10.1021/jm049530m
CHEMBL2112987 78537 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 435 7 2 3 5.3 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCCC(Cc3ccccc3)C2)c1 10.1021/jm049530m
10928173 76190 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 431 6 1 5 4.8 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00176-7
CHEMBL20612 76190 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 431 6 1 5 4.8 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00176-7
10950225 116971 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 438 7 2 3 5.3 N#Cc1cccc(NC(=O)NCc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL339934 116971 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 438 7 2 3 5.3 N#Cc1cccc(NC(=O)NCc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
76316987 103060 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 9 2 6 3.9 Cn1nnnc1-c1cccc(NC(=O)NC[C@@H]2CCCN(CCCCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL3085295 103060 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 9 2 6 3.9 Cn1nnnc1-c1cccc(NC(=O)NC[C@@H]2CCCN(CCCCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
11408397 77605 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL2096695 77605 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
22393329 100657 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL295229 100657 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44390970 63733 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 533 8 2 6 4.4 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2C(F)(F)F)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180728 63733 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 533 8 2 6 4.4 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2C(F)(F)F)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44390971 122605 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 541 9 2 6 5.0 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2c2ccccc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL361130 122605 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 541 9 2 6 5.0 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2c2ccccc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44387856 130920 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 447 7 2 3 5.5 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
CHEMBL369073 130920 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 447 7 2 3 5.5 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
11465468 166484 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
CHEMBL428881 166484 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
44281521 99936 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 370 7 1 5 3.1 CCOC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1ccc(C)cc1C 10.1016/s0960-894x(01)00248-7
CHEMBL290104 99936 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 370 7 1 5 3.1 CCOC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1ccc(C)cc1C 10.1016/s0960-894x(01)00248-7
10255492 117658 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 502 8 3 4 5.2 CC(=O)c1cccc(NC(=O)Nc2ccc(C(N)=O)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL340853 117658 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 502 8 3 4 5.2 CC(=O)c1cccc(NC(=O)Nc2ccc(C(N)=O)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
11733617 160707 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 485 7 3 4 4.9 N#Cc1cccc(NC(=O)Nc2cccc(C(N)=O)c2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL411956 160707 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 485 7 3 4 4.9 N#Cc1cccc(NC(=O)Nc2cccc(C(N)=O)c2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44289910 100741 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 529 8 2 6 4.2 Cn1nnnc1-c1cc(Br)cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL295898 100741 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 529 8 2 6 4.2 Cn1nnnc1-c1cc(Br)cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44290019 100752 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 479 9 2 6 4.5 CC(C)n1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL295970 100752 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 479 9 2 6 4.5 CC(C)n1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44447149 94503 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 551 12 3 7 4.7 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)C2CCCCC2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254470 94503 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 551 12 3 7 4.7 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)C2CCCCC2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44445862 94018 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 555 8 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C3CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251274 94018 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 555 8 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C3CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44390954 63537 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 483 8 2 6 3.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)c(F)c3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180351 63537 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 483 8 2 6 3.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)c(F)c3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44445861 93855 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 8 2 6 4.5 CCC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL250436 93855 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 8 2 6 4.5 CCC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
44447378 154301 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 527 12 4 8 2.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)[C@@H](C)[C@H](O)Cc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL400467 154301 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 527 12 4 8 2.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)[C@@H](C)[C@H](O)Cc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44390838 127988 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL366710 127988 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44419299 141158 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 510 11 3 5 3.9 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC(N)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL385607 141158 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 510 11 3 5 3.9 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC(N)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
11953409 93781 0 None - 0 Mouse 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 mins
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249854 93781 0 None - 0 Mouse 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 mins
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445877 93779 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 583 8 2 6 5.3 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C3CCCC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249851 93779 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 583 8 2 6 5.3 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C3CCCC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44390964 62269 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 481 8 2 6 4.2 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(Cl)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL178287 62269 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 481 8 2 6 4.2 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(Cl)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44289877 165488 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 5 4.3 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cccc(-c2nnco2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL42562 165488 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 5 4.3 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cccc(-c2nnco2)c1 10.1016/j.bmcl.2004.01.059
11213457 94325 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 465 9 3 6 3.9 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CNCCCc2ccc(F)cc2)c1 10.1016/j.bmcl.2007.11.087
CHEMBL253209 94325 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 465 9 3 6 3.9 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CNCCCc2ccc(F)cc2)c1 10.1016/j.bmcl.2007.11.087
44390919 121539 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 447 8 2 6 3.5 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccccc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL359609 121539 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 447 8 2 6 3.5 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccccc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44419306 140855 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 495 9 2 4 5.0 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL383879 140855 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 495 9 2 4 5.0 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
44295434 101097 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCO[C@H](CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL298505 101097 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCO[C@H](CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
44295362 161672 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 369 7 2 2 4.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccccc1 10.1016/s0960-894x(02)00206-8
CHEMBL416305 161672 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 369 7 2 2 4.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccccc1 10.1016/s0960-894x(02)00206-8
22393419 164877 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 399 8 2 3 4.3 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL42388 164877 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 399 8 2 3 4.3 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
23509697 193281 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 440 6 2 4 3.6 COc1cccc(NC(=O)N2CCNC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL54273 193281 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 440 6 2 4 3.6 COc1cccc(NC(=O)N2CCNC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
22393419 164877 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 399 8 2 3 4.3 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL42388 164877 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 399 8 2 3 4.3 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
9951883 168127 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 381 8 2 3 4.2 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL43666 168127 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 381 8 2 3 4.2 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
22393378 188374 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 397 9 2 2 4.0 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NCCc1ccccc1 10.1016/s0960-894x(02)00206-8
CHEMBL50829 188374 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 397 9 2 2 4.0 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NCCc1ccccc1 10.1016/s0960-894x(02)00206-8
9951883 168127 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 381 8 2 3 4.2 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43666 168127 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 381 8 2 3 4.2 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/j.bmcl.2004.01.059
11734303 168012 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 547 9 3 3 6.5 CC(C)(C)NC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL435812 168012 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 547 9 3 3 6.5 CC(C)(C)NC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11396966 78595 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 457 6 2 2 6.1 O=C(Nc1cccc(Cl)c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113082 78595 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 457 6 2 2 6.1 O=C(Nc1cccc(Cl)c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44289762 165382 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 380 7 2 3 3.8 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL42507 165382 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 380 7 2 3 3.8 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
11059280 116405 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 442 6 2 3 5.8 N#Cc1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL338389 116405 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 442 6 2 3 5.8 N#Cc1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
11037958 75618 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 465 6 1 5 5.5 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1021/jm300682j
CHEMBL20532 75618 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 465 6 1 5 5.5 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1021/jm300682j
11037958 75618 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 465 6 1 5 5.5 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1016/s0960-894x(01)00176-7
CHEMBL20532 75618 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 465 6 1 5 5.5 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1016/s0960-894x(01)00176-7
44440394 93290 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 578 8 0 5 5.8 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccccc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL247160 93290 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 578 8 0 5 5.8 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccccc2)n1C 10.1016/j.bmcl.2007.05.035
9927733 116400 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 336 6 2 3 3.1 CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL33838 116400 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 336 6 2 3 3.1 CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
9888454 101409 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 421 6 1 3 4.9 COc1cccc(NC(=O)N2CCCC(CN3CCC(Cc4ccccc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL300726 101409 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 421 6 1 3 4.9 COc1cccc(NC(=O)N2CCCC(CN3CCC(Cc4ccccc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
44281522 111024 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 391 6 1 4 3.2 CN(C)C(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL32784 111024 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 391 6 1 4 3.2 CN(C)C(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
11133428 16549 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 413 7 2 2 5.5 O=C(NCc1ccccc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL124321 16549 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 413 7 2 2 5.5 O=C(NCc1ccccc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
10863284 18371 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 449 7 2 2 6.1 O=C(Nc1ccc(F)cc1)Nc1ccccc1CCN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL127590 18371 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 449 7 2 2 6.1 O=C(Nc1ccc(F)cc1)Nc1ccccc1CCN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44390931 122417 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NCC2CCN(CCc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL360653 122417 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NCC2CCN(CCc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.11.006
76320703 103061 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 423 6 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NC[C@@H]2CCCN(Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL3085296 103061 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 423 6 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NC[C@@H]2CCCN(Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
10875472 113160 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 568 10 3 4 6.6 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1ccncc1 10.1021/jm0201767
CHEMBL332277 113160 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 568 10 3 4 6.6 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1ccncc1 10.1021/jm0201767
9981262 64524 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCC2CCCN(CCCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL182087 64524 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCC2CCCN(CCCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
10874195 163804 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 459 8 3 4 5.3 COc1cccc(NC(=O)Nc2cc(CO)ccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL421273 163804 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 459 8 3 4 5.3 COc1cccc(NC(=O)Nc2cc(CO)ccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
11112528 16634 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 417 6 2 2 5.9 O=C(Nc1ccccc1)Nc1ccccc1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL124669 16634 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 417 6 2 2 5.9 O=C(Nc1ccccc1)Nc1ccccc1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44295487 168597 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 444 5 2 3 4.5 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)Nc1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL440477 168597 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 444 5 2 3 4.5 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)Nc1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00206-8
11145481 113069 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 496 8 2 3 5.9 O=C(Nc1cccc(CN2CCC(Cc3ccccc3)CC2)c1)NC1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL332227 113069 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 496 8 2 3 5.9 O=C(Nc1cccc(CN2CCC(Cc3ccccc3)CC2)c1)NC1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
22393395 168299 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccccc3F)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43818 168299 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccccc3F)C2)c1 10.1016/j.bmcl.2004.01.059
44390857 63299 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 490 9 2 7 3.6 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(N(C)C)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180082 63299 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 490 9 2 7 3.6 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(N(C)C)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
10939210 16729 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 445 8 2 2 5.6 O=C(NCCc1ccc(F)cc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL125167 16729 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 445 8 2 2 5.6 O=C(NCCc1ccc(F)cc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
11722772 98133 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 307 7 0 1 5.0 c1ccc(CCCCN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
CHEMBL276784 98133 0 None - 1 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 307 7 0 1 5.0 c1ccc(CCCCN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
77033 113296 75 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 313 6 2 4 2.3 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL33242 113296 75 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 313 6 2 4 2.3 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
22966052 83809 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL220866 83809 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
44289959 99953 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 5.0 CC(=O)c1cccc(NC(=O)NCCCN2CC3(Cc4ccc(F)cc4)CCC2CC3)c1 10.1016/j.bmcl.2004.01.059
CHEMBL290276 99953 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 5.0 CC(=O)c1cccc(NC(=O)NCCCN2CC3(Cc4ccc(F)cc4)CCC2CC3)c1 10.1016/j.bmcl.2004.01.059
44290040 171898 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL44817 171898 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44295259 162005 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 393 6 1 3 3.6 O=C(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL416835 162005 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 393 6 1 3 3.6 O=C(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
9935588 16720 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 496 8 2 3 5.9 O=C(Nc1ccccc1CN1CCC(Cc2ccccc2)CC1)NC1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL125108 16720 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 496 8 2 3 5.9 O=C(Nc1ccccc1CN1CCC(Cc2ccccc2)CC1)NC1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
10874991 163806 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 517 9 2 3 6.7 O=C(NCC(c1ccccc1)c1ccccc1)Nc1ccccc1CN1CCC(C(=O)c2ccccc2)CC1 10.1021/jm0201767
CHEMBL421274 163806 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 517 9 2 3 6.7 O=C(NCC(c1ccccc1)c1ccccc1)Nc1ccccc1CN1CCC(C(=O)c2ccccc2)CC1 10.1021/jm0201767
44445874 94078 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 541 9 2 6 5.0 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CC3CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251623 94078 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 541 9 2 6 5.0 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CC3CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455792 95279 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 8 2 6 3.9 C[C@@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL258323 95279 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 8 2 6 3.9 C[C@@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11214474 71009 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 514 6 2 4 6.7 O=C(Nc1nc2c(Cl)cccc2s1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL195790 71009 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 514 6 2 4 6.7 O=C(Nc1nc2c(Cl)cccc2s1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11442439 123539 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 455 6 2 2 5.9 Cc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1F 10.1021/jm049530m
CHEMBL363166 123539 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 455 6 2 2 5.9 Cc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1F 10.1021/jm049530m
9804542 129762 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
CHEMBL367992 129762 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
44419340 83955 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 451 10 2 3 5.4 C=CCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL221903 83955 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 451 10 2 3 5.4 C=CCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
10140602 166065 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 7 2 6 3.4 C[C@H](CC(=O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL428071 166065 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 7 2 6 3.4 C[C@H](CC(=O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
20636465 83675 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 495 9 4 4 4.3 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2C(=N)N)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL220766 83675 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 495 9 4 4 4.3 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2C(=N)N)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
44346153 15328 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 519 8 3 5 4.1 C[C@H](O)[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
CHEMBL121637 15328 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 519 8 3 5 4.1 C[C@H](O)[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
11259591 125003 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 455 6 2 2 5.9 Cc1ccc(F)cc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL364673 125003 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 455 6 2 2 5.9 Cc1ccc(F)cc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44346194 15373 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 501 9 2 5 5.4 COc1cc(NC(=O)N[C@H](C)CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
CHEMBL121905 15373 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 501 9 2 5 5.4 COc1cc(NC(=O)N[C@H](C)CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
44445879 93780 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 545 7 2 7 4.3 COC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL249852 93780 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 545 7 2 7 4.3 COC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
44440412 150489 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccccc2F)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL395850 150489 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccccc2F)n1C 10.1016/j.bmcl.2007.05.035
44295554 187760 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 415 8 2 3 5.0 CSc1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL50094 187760 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 415 8 2 3 5.0 CSc1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
23509693 190897 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 540 6 1 5 5.2 COc1cccc(NC(=O)N2CCN(C(=O)OC(C)(C)C)C(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51937 190897 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 540 6 1 5 5.2 COc1cccc(NC(=O)N2CCN(C(=O)OC(C)(C)C)C(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
10029075 116332 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 503 7 2 5 5.9 CC(=O)c1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
CHEMBL337990 116332 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 503 7 2 5 5.9 CC(=O)c1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
44440423 146177 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 635 9 1 6 5.7 CC(=O)Nc1ccc(-n2c(=O)c(CN(CCc3ccc(Cl)cc3)C3CCN(C(=O)c4c(F)cccc4F)CC3)c(C)n2C)cc1 10.1016/j.bmcl.2007.05.035
CHEMBL392405 146177 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 635 9 1 6 5.7 CC(=O)Nc1ccc(-n2c(=O)c(CN(CCc3ccc(Cl)cc3)C3CCN(C(=O)c4c(F)cccc4F)CC3)c(C)n2C)cc1 10.1016/j.bmcl.2007.05.035
22393428 188069 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 383 8 2 2 4.0 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NCc1ccccc1 10.1016/s0960-894x(02)00206-8
CHEMBL50354 188069 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 383 8 2 2 4.0 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NCc1ccccc1 10.1016/s0960-894x(02)00206-8
22393333 188815 4 None - 0 Human 6.4 pIC50 = 6.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 351 7 2 2 4.2 O=C(NCCCN1CCC(Cc2ccccc2)CC1)Nc1ccccc1 10.1016/s0960-894x(02)00206-8
CHEMBL51307 188815 4 None - 0 Human 6.4 pIC50 = 6.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 351 7 2 2 4.2 O=C(NCCCN1CCC(Cc2ccccc2)CC1)Nc1ccccc1 10.1016/s0960-894x(02)00206-8
44281523 99227 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 453 8 2 4 4.4 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)NCc1ccccc1)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL284577 99227 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 453 8 2 4 4.4 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)NCc1ccccc1)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
11282712 78126 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)NC2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1021/jm049530m
CHEMBL2112049 78126 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)NC2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1021/jm049530m
22393315 168117 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 376 7 2 3 4.0 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccccc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43655 168117 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 376 7 2 3 4.0 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccccc3)C2)c1 10.1016/j.bmcl.2004.01.059
11134412 164089 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 465 7 3 3 5.6 O=C(Nc1cc(F)ccc1F)Nc1ccccc1C(O)CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL421634 164089 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 465 7 3 3 5.6 O=C(Nc1cc(F)ccc1F)Nc1ccccc1C(O)CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
10864223 16705 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 517 8 2 5 5.9 COC(=O)c1ccc(NC(=O)Nc2cccc(C(C)=O)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL125012 16705 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 517 8 2 5 5.9 COC(=O)c1ccc(NC(=O)Nc2cccc(C(C)=O)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44447142 94232 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 589 12 3 7 5.0 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)CC12CC3CC(CC(C3)C1)C2 10.1016/j.bmcl.2007.11.087
CHEMBL252610 94232 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 589 12 3 7 5.0 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)CC12CC3CC(CC(C3)C1)C2 10.1016/j.bmcl.2007.11.087
9845853 127953 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 435 7 2 3 5.3 COc1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
CHEMBL366654 127953 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 435 7 2 3 5.3 COc1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
44593546 178180 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 531 6 2 6 4.9 CN1CC(C)(NC(=O)Nc2nc(C(C)(C)C)cs2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL468695 178180 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 531 6 2 6 4.9 CN1CC(C)(NC(=O)Nc2nc(C(C)(C)C)cs2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
44445853 154045 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 473 7 3 6 3.5 CC(=O)c1sc(NC(=O)N[C@@H]2CNC[C@@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL399134 154045 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 473 7 3 6 3.5 CC(=O)c1sc(NC(=O)N[C@@H]2CNC[C@@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
11144348 16407 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 424 6 2 3 5.7 N#Cc1cccc(NC(=O)Nc2cccc(CN3CCC(Cc4ccccc4)CC3)c2)c1 10.1021/jm0201767
CHEMBL123957 16407 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 424 6 2 3 5.7 N#Cc1cccc(NC(=O)Nc2cccc(CN3CCC(Cc4ccccc4)CC3)c2)c1 10.1021/jm0201767
11048445 16587 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 439 6 3 3 5.7 O=C(Nc1ccc2[nH]ncc2c1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL124390 16587 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 439 6 3 3 5.7 O=C(Nc1ccc2[nH]ncc2c1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
11091447 168824 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 439 6 3 3 5.7 O=C(Nc1ccc2c[nH]nc2c1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL442210 168824 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 439 6 3 3 5.7 O=C(Nc1ccc2c[nH]nc2c1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
6918497 112931 1 None - 0 Mouse 6.3 pIC50 = 6.3 Binding
Inhibitory activity against I-Eotaxin alpha binding to mouse CCR3 receptorsInhibitory activity against I-Eotaxin alpha binding to mouse CCR3 receptors
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL277930 112931 1 None - 0 Mouse 6.3 pIC50 = 6.3 Binding
Inhibitory activity against I-Eotaxin alpha binding to mouse CCR3 receptorsInhibitory activity against I-Eotaxin alpha binding to mouse CCR3 receptors
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL331897 112931 1 None - 0 Mouse 6.3 pIC50 = 6.3 Binding
Inhibitory activity against I-Eotaxin alpha binding to mouse CCR3 receptorsInhibitory activity against I-Eotaxin alpha binding to mouse CCR3 receptors
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
10916572 18331 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 408 8 0 2 6.2 N#CC(CCCN1CCC(Cc2ccccc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL127395 18331 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 408 8 0 2 6.2 N#CC(CCCN1CCC(Cc2ccccc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11102400 117591 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 449 6 2 3 5.7 O=C(Nc1cc(F)ccc1F)Nc1ccccc1CN1CCC(C(=O)c2ccccc2)CC1 10.1021/jm0201767
CHEMBL340656 117591 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 449 6 2 3 5.7 O=C(Nc1cc(F)ccc1F)Nc1ccccc1CN1CCC(C(=O)c2ccccc2)CC1 10.1021/jm0201767
10906911 17806 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 477 8 3 4 5.4 COc1cccc(NC(=O)Nc2ccc(CO)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL126220 17806 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 477 8 3 4 5.4 COc1cccc(NC(=O)Nc2ccc(CO)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
68826395 103031 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 5.0 CC(=O)c1cccc(NC(=O)NCCCN2[C@H]3CC[C@@H]2C[C@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
CHEMBL3085118 103031 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 5.0 CC(=O)c1cccc(NC(=O)NCCCN2[C@H]3CC[C@@H]2C[C@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
10984360 96501 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 537 8 1 7 5.7 CCOC(=O)c1ccc2nc(SCC(=O)NC3CCN(Cc4ccc(Cl)c(Cl)c4)CC3)sc2c1 10.1016/s0960-894x(01)00176-7
CHEMBL266181 96501 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 537 8 1 7 5.7 CCOC(=O)c1ccc2nc(SCC(=O)NC3CCN(Cc4ccc(Cl)c(Cl)c4)CC3)sc2c1 10.1016/s0960-894x(01)00176-7
44295375 167590 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 419 6 2 4 3.5 CN(C)c1ccc(NC(=O)NCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL433086 167590 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 419 6 2 4 3.5 CN(C)c1ccc(NC(=O)NCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)cc1 10.1016/s0960-894x(02)00206-8
9840971 99278 41 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 342 7 1 5 2.5 CCOC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL284954 99278 41 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 342 7 1 5 2.5 CCOC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
11733139 16724 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 454 7 3 4 5.2 N#Cc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL125132 16724 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 454 7 3 4 5.2 N#Cc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
44289699 167252 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 409 6 2 3 3.9 CC(=O)c1cccc(NC(=O)NCCCN2C[C@@H]3Cc4ccc(F)cc4C[C@H]3C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43066 167252 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 409 6 2 3 3.9 CC(=O)c1cccc(NC(=O)NCCCN2C[C@@H]3Cc4ccc(F)cc4C[C@H]3C2)c1 10.1016/j.bmcl.2004.01.059
10474776 113158 36 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(03)00748-0
CHEMBL33227 113158 36 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(03)00748-0
44390842 123319 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL362490 123319 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
44295485 101402 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 497 12 3 4 5.4 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccc(F)cc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL300699 101402 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 497 12 3 4 5.4 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccc(F)cc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
22393287 167401 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL43173 167401 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
11316656 69919 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 441 6 2 2 5.6 O=C(Nc1ccc(F)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL194141 69919 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 441 6 2 2 5.6 O=C(Nc1ccc(F)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
10474776 113158 36 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113158 36 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
22393287 167401 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43173 167401 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
44593553 177792 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 489 6 2 6 3.9 Cc1csc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1016/j.bmcl.2008.11.002
CHEMBL465272 177792 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 489 6 2 6 3.9 Cc1csc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1016/j.bmcl.2008.11.002
44593546 178180 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 531 6 2 6 4.9 CN1CC(C)(NC(=O)Nc2nc(C(C)(C)C)cs2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL468695 178180 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 531 6 2 6 4.9 CN1CC(C)(NC(=O)Nc2nc(C(C)(C)C)cs2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
44390911 63476 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 515 8 2 6 4.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(Cl)cc3Cl)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180229 63476 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 515 8 2 6 4.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(Cl)cc3Cl)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44390859 131268 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccccc3F)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL369331 131268 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccccc3F)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44447369 94174 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H]([C@H](O)c1ccccc1)N(C)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL252222 94174 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H]([C@H](O)c1ccccc1)N(C)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44419308 140998 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 509 10 2 4 5.4 CCC(=O)N1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL384649 140998 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 509 10 2 4 5.4 CCC(=O)N1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
44455872 154977 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL404202 154977 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
44295622 101021 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 465 10 3 4 4.7 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@@H](O)C(C)C)c1 10.1016/s0960-894x(02)00206-8
CHEMBL297904 101021 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 465 10 3 4 4.7 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@@H](O)C(C)C)c1 10.1016/s0960-894x(02)00206-8
44295286 187715 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 431 8 2 3 4.0 C[S+]([O-])c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50034 187715 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 431 8 2 3 4.0 C[S+]([O-])c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
44295672 188170 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 439 6 1 3 5.0 COc1cccc(NC(=O)N2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50535 188170 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 439 6 1 3 5.0 COc1cccc(NC(=O)N2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
44295641 188739 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 453 9 4 5 3.4 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2C(C)(O)O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51244 188739 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 453 9 4 5 3.4 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2C(C)(O)O)c1 10.1016/s0960-894x(02)00206-8
23509695 189147 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCOC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51584 189147 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCOC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
44295364 193283 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL54290 193283 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
22257689 16404 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 446 7 1 2 6.0 Cc1ccc(C(=O)NC(CN2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
CHEMBL123943 16404 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 446 7 1 2 6.0 Cc1ccc(C(=O)NC(CN2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
44346211 163341 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 537 10 2 5 6.5 COc1cc(NC(=O)NC(CC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C(C)C)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
CHEMBL420709 163341 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 537 10 2 5 6.5 COc1cc(NC(=O)NC(CC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C(C)C)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
44295130 100727 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 362 6 2 3 3.6 N#Cc1cccc(NC(=O)NCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL295726 100727 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 362 6 2 3 3.6 N#Cc1cccc(NC(=O)NCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
44295528 101437 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 336 4 0 2 4.0 Fc1ccc(CCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL300905 101437 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 336 4 0 2 4.0 Fc1ccc(CCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)cc1 10.1016/s0960-894x(02)00206-8
22393370 189263 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 390 7 2 3 4.3 Cc1ccc(CC2CCN(CCCNC(=O)Nc3cccc(C#N)c3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51676 189263 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 390 7 2 3 4.3 Cc1ccc(CC2CCN(CCCNC(=O)Nc3cccc(C#N)c3)CC2)cc1 10.1016/s0960-894x(02)00206-8
22393398 193248 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 390 8 2 3 4.4 N#Cc1cccc(NC(=O)NCCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL54143 193248 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 390 8 2 3 4.4 N#Cc1cccc(NC(=O)NCCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
10979426 17780 1 None - 0 Human 4.3 pIC50 = 4.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 298 7 3 2 2.7 O=C(NCCCO)NC(Cc1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL126106 17780 1 None - 0 Human 4.3 pIC50 = 4.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 298 7 3 2 2.7 O=C(NCCCO)NC(Cc1ccccc1)c1ccccc1 10.1021/jm0201767
44295102 187368 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 405 7 1 4 3.4 COc1ccc(C(=O)NCCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL49702 187368 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 405 7 1 4 3.4 COc1ccc(C(=O)NCCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)cc1 10.1016/s0960-894x(02)00206-8
10985078 114240 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 635 10 3 3 8.2 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm0201767
CHEMBL333865 114240 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 635 10 3 3 8.2 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm0201767
11081509 18357 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 492 6 2 3 6.9 N#Cc1cccc(NC(=O)Nc2c(CN3CCC(Cc4ccc(F)cc4)CC3)ccc3ccccc23)c1 10.1021/jm0201767
CHEMBL127534 18357 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 492 6 2 3 6.9 N#Cc1cccc(NC(=O)Nc2c(CN3CCC(Cc4ccc(F)cc4)CC3)ccc3ccccc23)c1 10.1021/jm0201767
11004826 17805 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 447 7 3 3 5.4 O=C(Nc1ccccc1)Nc1cccc(CO)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL126218 17805 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 447 7 3 3 5.4 O=C(Nc1ccccc1)Nc1cccc(CO)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44295470 188241 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 425 5 1 3 4.8 COc1cccc(NC(=O)N2CCCC(N3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50645 188241 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 425 5 1 3 4.8 COc1cccc(NC(=O)N2CCCC(N3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
22022834 112838 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 472 7 1 2 6.4 Cc1ccc(C(=O)NC(CN2CC3CCC2CC3Cc2ccc(Cl)c(Cl)c2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
CHEMBL331672 112838 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 472 7 1 2 6.4 Cc1ccc(C(=O)NC(CN2CC3CCC2CC3Cc2ccc(Cl)c(Cl)c2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
11072275 16618 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 632 10 3 5 5.9 COC(=O)N1CCC(NC(=O)NCC(CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)(c2ccccc2)c2ccccc2)CC1 10.1021/jm0201767
CHEMBL124585 16618 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 632 10 3 5 5.9 COC(=O)N1CCC(NC(=O)NCC(CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)(c2ccccc2)c2ccccc2)CC1 10.1021/jm0201767
25024651 115536 0 None 39 3 Human 6.3 pIC50 = 6.3 Binding
Inhibition of CCR3 in human eosinophil assessed as inhibition of shape change by autofluorescence assayInhibition of CCR3 in human eosinophil assessed as inhibition of shape change by autofluorescence assay
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355956 115536 0 None 39 3 Human 6.3 pIC50 = 6.3 Binding
Inhibition of CCR3 in human eosinophil assessed as inhibition of shape change by autofluorescence assayInhibition of CCR3 in human eosinophil assessed as inhibition of shape change by autofluorescence assay
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
10257335 99979 4 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 565 6 2 4 3.5 CCOC(=O)[C@H](Cc1cc(I)c(O)c(I)c1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL290565 99979 4 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 565 6 2 4 3.5 CCOC(=O)[C@H](Cc1cc(I)c(O)c(I)c1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
11227406 93909 1 None - 0 Mouse 7.3 pIC50 = 7.3 Binding
Displacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 mins
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL250689 93909 1 None - 0 Mouse 7.3 pIC50 = 7.3 Binding
Displacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 mins
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
44390858 63572 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 423 6 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NCC2CCN(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180534 63572 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 423 6 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NCC2CCN(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.11.006
10928826 17618 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 472 7 3 4 5.3 N#Cc1cccc(NC(=O)Nc2ccc(CO)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL125884 17618 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 472 7 3 4 5.3 N#Cc1cccc(NC(=O)Nc2ccc(CO)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
9951882 178590 0 None - 1 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 381 8 2 3 4.2 COc1cccc(NC(=O)NCCCN2CCCC(Cc3ccccc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL47220 178590 0 None - 1 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 381 8 2 3 4.2 COc1cccc(NC(=O)NCCCN2CCCC(Cc3ccccc3)C2)c1 10.1016/j.bmcl.2004.01.059
44295230 188528 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 379 5 1 3 3.2 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51038 188528 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 379 5 1 3 3.2 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
44290041 172159 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 409 6 2 3 3.9 CC(=O)c1cccc(NC(=O)NCCCN2C[C@H]3Cc4ccc(F)cc4C[C@H]3C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL45064 172159 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 409 6 2 3 3.9 CC(=O)c1cccc(NC(=O)NCCCN2C[C@H]3Cc4ccc(F)cc4C[C@H]3C2)c1 10.1016/j.bmcl.2004.01.059
44281790 168647 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 420 6 1 5 4.4 CC(C)(C)OC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL440844 168647 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 420 6 1 5 4.4 CC(C)(C)OC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
11082578 117567 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 603 10 3 3 7.5 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1cc(F)ccc1F 10.1021/jm0201767
CHEMBL340491 117567 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 603 10 3 3 7.5 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1cc(F)ccc1F 10.1021/jm0201767
44447366 94173 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(C)[C@H](C)[C@H](O)c1ccccc1 10.1016/j.bmcl.2007.11.087
CHEMBL252221 94173 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(C)[C@H](C)[C@H](O)c1ccccc1 10.1016/j.bmcl.2007.11.087
44447141 94150 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 523 11 3 7 3.4 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)CC(F)(F)F 10.1016/j.bmcl.2007.11.087
CHEMBL252034 94150 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 523 11 3 7 3.4 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)CC(F)(F)F 10.1016/j.bmcl.2007.11.087
9818195 109875 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 311 7 1 3 3.0 CCOC(=O)[C@H](CCc1ccccc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL32413 109875 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 311 7 1 3 3.0 CCOC(=O)[C@H](CCc1ccccc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
10995329 17997 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 563 13 4 4 5.5 O=C(NCCCCO)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL126978 17997 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 563 13 4 4 5.5 O=C(NCCCCO)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
44419327 82804 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 393 8 3 3 4.4 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL218581 82804 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 393 8 3 3 4.4 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
44447155 154384 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 511 11 3 7 2.9 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)C(C)=O)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL401002 154384 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 511 11 3 7 2.9 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)C(C)=O)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44445843 93806 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 587 7 2 7 5.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)OC(C)(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL250054 93806 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 587 7 2 7 5.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)OC(C)(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44390978 64241 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NCC2CCCN(CCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL181575 64241 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NCC2CCCN(CCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
3492 685 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
9868459 685 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
CHEMBL50593 685 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
11179592 69249 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 501 6 2 2 6.2 O=C(Nc1ccc(Br)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL193442 69249 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 501 6 2 2 6.2 O=C(Nc1ccc(Br)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44440431 145929 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 607 9 0 7 5.2 Cc1c(CN(CCc2ccc([N+](=O)[O-])cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL392217 145929 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 607 9 0 7 5.2 Cc1c(CN(CCc2ccc([N+](=O)[O-])cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44445890 154410 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 9 2 7 4.1 CC(=O)CN1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL401115 154410 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 9 2 7 4.1 CC(=O)CN1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
11226588 94327 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 547 10 2 6 5.2 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN(CCCc2ccc(F)cc2)CC(F)(F)F)c1 10.1016/j.bmcl.2007.11.087
CHEMBL253211 94327 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 547 10 2 6 5.2 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN(CCCc2ccc(F)cc2)CC(F)(F)F)c1 10.1016/j.bmcl.2007.11.087
44295201 170776 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 11 3 4 5.1 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@H](O)CC(C)C)c1 10.1016/s0960-894x(02)00206-8
CHEMBL446144 170776 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 11 3 4 5.1 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@H](O)CC(C)C)c1 10.1016/s0960-894x(02)00206-8
44295328 193079 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 7 2 2 5.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL53673 193079 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 7 2 2 5.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00206-8
11026367 16305 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 429 7 2 3 5.8 COc1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL123511 16305 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 429 7 2 3 5.8 COc1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
11060510 16325 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 533 10 3 3 6.1 CC(C)NC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL123622 16325 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 533 10 3 3 6.1 CC(C)NC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11004681 16653 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 439 6 3 3 5.7 O=C(Nc1cccc(CN2CCC(Cc3ccccc3)CC2)c1)Nc1ccc2[nH]ncc2c1 10.1021/jm0201767
CHEMBL124748 16653 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 439 6 3 3 5.7 O=C(Nc1cccc(CN2CCC(Cc3ccccc3)CC2)c1)Nc1ccc2[nH]ncc2c1 10.1021/jm0201767
7072714 109967 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 490 11 3 6 3.5 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL32468 109967 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 490 11 3 6 3.5 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 10.1016/s0960-894x(01)00248-7
44440413 93155 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 612 8 0 5 6.4 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(Cl)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL246549 93155 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 612 8 0 5 6.4 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(Cl)cc2)n1C 10.1016/j.bmcl.2007.05.035
10983980 17862 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 505 8 2 5 5.7 COC(=O)c1ccc(NC(=O)Nc2cccc(OC)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL126520 17862 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 505 8 2 5 5.7 COC(=O)c1ccc(NC(=O)Nc2cccc(OC)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44295463 161455 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 429 7 1 4 3.1 O=S(=O)(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL415950 161455 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 429 7 1 4 3.1 O=S(=O)(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
44419314 82888 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL218997 82888 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
44346154 168096 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 489 7 2 4 4.7 C[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
CHEMBL436363 168096 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 489 7 2 4 4.7 C[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
11511522 67525 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 491 8 0 6 3.1 COc1ccc(OC)c(S(=O)(=O)N2CCC(CN3CCN(Cc4ccc(F)cc4)CC3)CC2)c1 10.1016/j.bmcl.2011.09.013
CHEMBL1910163 67525 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 491 8 0 6 3.1 COc1ccc(OC)c(S(=O)(=O)N2CCC(CN3CCN(Cc4ccc(F)cc4)CC3)CC2)c1 10.1016/j.bmcl.2011.09.013
44295407 189049 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 433 6 1 3 4.3 O=C(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)C12CC3CC(CC(C3)C1)C2 10.1016/s0960-894x(02)00206-8
CHEMBL51507 189049 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 433 6 1 3 4.3 O=C(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)C12CC3CC(CC(C3)C1)C2 10.1016/s0960-894x(02)00206-8
9845853 127953 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 435 7 2 3 5.3 COc1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
CHEMBL366654 127953 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 435 7 2 3 5.3 COc1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
10929194 17791 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 500 7 2 5 5.6 COC(=O)c1ccc(NC(=O)Nc2cccc(C#N)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL126163 17791 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 500 7 2 5 5.6 COC(=O)c1ccc(NC(=O)Nc2cccc(C#N)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44295065 183709 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 405 7 1 4 3.4 COc1ccccc1C(=O)NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3 10.1016/s0960-894x(02)00206-8
CHEMBL48401 183709 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 405 7 1 4 3.4 COc1ccccc1C(=O)NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3 10.1016/s0960-894x(02)00206-8
10474776 113158 36 None - 0 Human 8.2 pIC50 = 8.2 Binding
Agonistic activity against C-C chemokine receptor type 3 by displacing [125I]-MCP-4 radioligand, using CCR3 binding assayAgonistic activity against C-C chemokine receptor type 3 by displacing [125I]-MCP-4 radioligand, using CCR3 binding assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113158 36 None - 0 Human 8.2 pIC50 = 8.2 Binding
Agonistic activity against C-C chemokine receptor type 3 by displacing [125I]-MCP-4 radioligand, using CCR3 binding assayAgonistic activity against C-C chemokine receptor type 3 by displacing [125I]-MCP-4 radioligand, using CCR3 binding assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
22966050 83721 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 455 10 3 4 4.2 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCO)c1 10.1016/j.bmcl.2006.08.012
CHEMBL220801 83721 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 455 10 3 4 4.2 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCO)c1 10.1016/j.bmcl.2006.08.012
44295282 101187 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 414 8 2 4 4.2 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(02)00206-8
CHEMBL299170 101187 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 414 8 2 4 4.2 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(02)00206-8
44295591 187634 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 465 11 3 4 4.9 CCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL49921 187634 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 465 11 3 4 4.9 CCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
44593555 188198 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR3 at 10 uMInhibition of CCR3 at 10 uM
ChEMBL 642 10 4 6 4.9 CSc1ccc(C(=O)NC2CC(NC(=O)OCc3ccccc3)CCC2NC(=O)CNC(=O)c2cccc(C(F)(F)F)c2)cc1 10.1016/j.bmcl.2008.12.062
CHEMBL505722 188198 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR3 at 10 uMInhibition of CCR3 at 10 uM
ChEMBL 642 10 4 6 4.9 CSc1ccc(C(=O)NC2CC(NC(=O)OCc3ccccc3)CCC2NC(=O)CNC(=O)c2cccc(C(F)(F)F)c2)cc1 10.1016/j.bmcl.2008.12.062
10874762 16625 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 500 7 2 5 5.6 COC(=O)c1cccc(NC(=O)Nc2cccc(C#N)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL124628 16625 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 500 7 2 5 5.6 COC(=O)c1cccc(NC(=O)Nc2cccc(C#N)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44290020 178448 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 435 8 2 4 4.5 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cccc(-n2ccnc2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL47122 178448 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 435 8 2 4 4.5 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cccc(-n2ccnc2)c1 10.1016/j.bmcl.2004.01.059
68826395 103031 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 5.0 CC(=O)c1cccc(NC(=O)NCCCN2[C@H]3CC[C@@H]2C[C@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
CHEMBL3085118 103031 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 5.0 CC(=O)c1cccc(NC(=O)NCCCN2[C@H]3CC[C@@H]2C[C@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
44445850 93648 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 473 7 3 6 3.5 CC(=O)c1sc(NC(=O)N[C@@H]2CNC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249056 93648 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 473 7 3 6 3.5 CC(=O)c1sc(NC(=O)N[C@@H]2CNC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44390898 64234 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 9 2 6 4.2 CCc1cc(NC(=O)N[C@@H]2CCCN(CCCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL181528 64234 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 9 2 6 4.2 CCc1cc(NC(=O)N[C@@H]2CCCN(CCCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44290029 178568 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 436 8 2 4 4.9 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cccc(-c2cnco2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL47211 178568 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 436 8 2 4 4.9 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cccc(-c2cnco2)c1 10.1016/j.bmcl.2004.01.059
22393474 96102 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 7 2 2 5.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(C(F)(F)F)c1 10.1016/s0960-894x(02)00206-8
CHEMBL262918 96102 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 7 2 2 5.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(C(F)(F)F)c1 10.1016/s0960-894x(02)00206-8
44295288 188759 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 447 8 2 4 3.7 CS(=O)(=O)c1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51259 188759 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 447 8 2 4 3.7 CS(=O)(=O)c1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
44295510 101376 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 401 5 2 4 3.3 N#Cc1cccc(NC(=O)NCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)c1 10.1016/s0960-894x(02)00206-8
CHEMBL300472 101376 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 401 5 2 4 3.3 N#Cc1cccc(NC(=O)NCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)c1 10.1016/s0960-894x(02)00206-8
10591473 64556 10 None - 1 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 279 5 0 1 4.2 c1ccc(CCN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
CHEMBL18222 64556 10 None - 1 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 279 5 0 1 4.2 c1ccc(CCN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
11812728 16572 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 471 7 2 5 4.8 O=C(NCc1ccc2c(c1)OCO2)Nc1ccccc1CN1CCC(C(=O)c2ccccc2)CC1 10.1021/jm0201767
CHEMBL124336 16572 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 471 7 2 5 4.8 O=C(NCc1ccc2c(c1)OCO2)Nc1ccccc1CN1CCC(C(=O)c2ccccc2)CC1 10.1021/jm0201767
10000888 75624 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 397 6 1 5 4.2 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccccc2)CC1 10.1016/s0960-894x(01)00176-7
CHEMBL20539 75624 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 397 6 1 5 4.2 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccccc2)CC1 10.1016/s0960-894x(01)00176-7
10142792 93308 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells
ChEMBL 521 9 5 5 2.8 Cc1ccc(CNC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2N)C(=O)NC(C)(C)C)c(C)c1 10.1016/j.bmcl.2007.07.028
CHEMBL247245 93308 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells
ChEMBL 521 9 5 5 2.8 Cc1ccc(CNC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2N)C(=O)NC(C)(C)C)c(C)c1 10.1016/j.bmcl.2007.07.028
11069916 16381 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 424 6 2 3 5.7 N#Cc1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL123791 16381 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 424 6 2 3 5.7 N#Cc1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
10993686 116437 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 429 7 2 3 5.8 COc1ccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
CHEMBL338543 116437 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 429 7 2 3 5.8 COc1ccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
57394442 67527 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 407 8 2 3 4.2 O=C(NCCCCN1CCC(Oc2ccc(F)cc2)C1)Nc1ccc(F)c(F)c1 10.1016/j.bmcl.2011.09.013
CHEMBL1910165 67527 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 407 8 2 3 4.2 O=C(NCCCCN1CCC(Oc2ccc(F)cc2)C1)Nc1ccc(F)c(F)c1 10.1016/j.bmcl.2011.09.013
11072063 16428 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 597 11 3 4 7.2 COc1ccc(NC(=O)NCC(CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)(c2ccccc2)c2ccccc2)cc1 10.1021/jm0201767
CHEMBL124084 16428 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 597 11 3 4 7.2 COc1ccc(NC(=O)NCC(CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)(c2ccccc2)c2ccccc2)cc1 10.1021/jm0201767
11026461 16759 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 434 8 2 3 4.7 O=C(NCCN1CCCCC1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL125325 16759 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 434 8 2 3 4.7 O=C(NCCN1CCCCC1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
11005432 167795 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 487 8 2 5 5.6 COC(=O)c1ccc(CN2CCC(Cc3ccccc3)CC2)c(NC(=O)Nc2cccc(OC)c2)c1 10.1021/jm0201767
CHEMBL434437 167795 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 487 8 2 5 5.6 COC(=O)c1ccc(CN2CCC(Cc3ccccc3)CC2)c(NC(=O)Nc2cccc(OC)c2)c1 10.1021/jm0201767
11385474 78127 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)NC2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1021/jm049530m
CHEMBL2112050 78127 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)NC2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1021/jm049530m
44346023 14926 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 406 7 1 2 5.7 Cc1ccc(C(=O)NC(CC2CCN(Cc3ccc(C)c(C)c3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
CHEMBL120957 14926 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 406 7 1 2 5.7 Cc1ccc(C(=O)NC(CC2CCN(Cc3ccc(C)c(C)c3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
10873705 98877 7 None - 0 Human 7.1 pIC50 = 7.1 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 431 6 1 5 4.8 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccc(Cl)cc2)CC1 10.1016/s0960-894x(01)00176-7
CHEMBL282285 98877 7 None - 0 Human 7.1 pIC50 = 7.1 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 431 6 1 5 4.8 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccc(Cl)cc2)CC1 10.1016/s0960-894x(01)00176-7
44440421 93097 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 593 8 1 6 5.3 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(N)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL246339 93097 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 593 8 1 6 5.3 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(N)cc2)n1C 10.1016/j.bmcl.2007.05.035
3492 685 0 None - 1 Human 8.1 pIC50 = 8.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
9868459 685 0 None - 1 Human 8.1 pIC50 = 8.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
CHEMBL50593 685 0 None - 1 Human 8.1 pIC50 = 8.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
9800669 109011 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 392 7 1 5 3.7 CCOC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL32210 109011 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 392 7 1 5 3.7 CCOC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
11070954 16600 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 485 7 3 4 4.9 N#Cc1cccc(NC(=O)Nc2ccc(C(N)=O)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL124473 16600 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 485 7 3 4 4.9 N#Cc1cccc(NC(=O)Nc2ccc(C(N)=O)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
10962347 18311 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 516 8 3 4 5.5 CNC(=O)c1ccc(NC(=O)Nc2cccc(C(C)=O)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL127281 18311 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 516 8 3 4 5.5 CNC(=O)c1ccc(NC(=O)Nc2cccc(C(C)=O)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
11763035 168752 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 517 8 2 5 5.9 COC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL441656 168752 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 517 8 2 5 5.9 COC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
11753159 542 3 None 1 2 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at CCR3 assessed as inhibition of eotaxin bindingAntagonist activity at CCR3 assessed as inhibition of eotaxin binding
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1021/jm300682j
7679 542 3 None 1 2 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at CCR3 assessed as inhibition of eotaxin bindingAntagonist activity at CCR3 assessed as inhibition of eotaxin binding
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1021/jm300682j
CHEMBL2158814 542 3 None 1 2 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at CCR3 assessed as inhibition of eotaxin bindingAntagonist activity at CCR3 assessed as inhibition of eotaxin binding
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1021/jm300682j
44346210 167392 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 531 10 3 6 4.7 COc1cc(NC(=O)N[C@@H](CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)[C@H](C)O)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
CHEMBL431670 167392 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 531 10 3 6 4.7 COc1cc(NC(=O)N[C@@H](CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)[C@H](C)O)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
44295536 187851 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 12 3 4 5.3 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50233 187851 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 12 3 4 5.3 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
9885355 99940 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 363 6 2 4 3.5 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL290119 99940 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 363 6 2 4 3.5 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
44295353 188100 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 350 8 1 2 4.2 O=C(NCCCCN1CCC(Cc2ccccc2)CC1)c1ccccc1 10.1016/s0960-894x(02)00206-8
CHEMBL50401 188100 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 350 8 1 2 4.2 O=C(NCCCCN1CCC(Cc2ccccc2)CC1)c1ccccc1 10.1016/s0960-894x(02)00206-8
71454583 79285 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 4.9 CC(=O)c1cccc(NC(=O)NCCCN2CC3CCC2[C@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
CHEMBL2115412 79285 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 4.9 CC(=O)c1cccc(NC(=O)NCCCN2CC3CCC2[C@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
11015975 16319 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 459 8 3 4 5.3 COc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL123585 16319 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 459 8 3 4 5.3 COc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
44295118 188456 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 405 7 1 4 3.4 COc1cccc(C(=O)NCCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50937 188456 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 405 7 1 4 3.4 COc1cccc(C(=O)NCCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)c1 10.1016/s0960-894x(02)00206-8
57398008 67526 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 393 9 2 3 4.5 COc1ccc(Cl)cc1NC(=O)NCCCCN(C)Cc1ccc(F)cc1 10.1016/j.bmcl.2011.09.013
CHEMBL1910164 67526 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 393 9 2 3 4.5 COc1ccc(Cl)cc1NC(=O)NCCCCN(C)Cc1ccc(F)cc1 10.1016/j.bmcl.2011.09.013
44390893 64043 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 515 8 2 6 4.5 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(C(F)(F)F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL181302 64043 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 515 8 2 6 4.5 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(C(F)(F)F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
132072454 179144 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at human CCR3 expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human CCR3 expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 558 6 2 8 4.7 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN(C#N)[C@H](c3[nH]c4ccccc4c3CCn3cc(-c4cccc(Cl)c4)nn3)C[C@@H]21 10.1016/j.bmc.2020.115546
CHEMBL4744046 179144 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at human CCR3 expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human CCR3 expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 558 6 2 8 4.7 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN(C#N)[C@H](c3[nH]c4ccccc4c3CCn3cc(-c4cccc(Cl)c4)nn3)C[C@@H]21 10.1016/j.bmc.2020.115546
44295558 101493 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 365 4 1 3 2.8 O=C(NCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL301332 101493 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 365 4 1 3 2.8 O=C(NCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
10934382 16597 26 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 265 4 0 1 4.1 c1ccc(CC2CCN(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
CHEMBL124457 16597 26 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 265 4 0 1 4.1 c1ccc(CC2CCN(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
11828013 17225 1 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 581 11 3 3 6.9 O=C(NCc1ccccc1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL125753 17225 1 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 581 11 3 3 6.9 O=C(NCc1ccccc1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11049424 116604 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 505 9 3 3 5.3 CNC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL339349 116604 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 505 9 3 3 5.3 CNC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
9972570 69488 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 308 7 0 2 3.8 c1ccc(CCCCN2CCN(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
CHEMBL19375 69488 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 308 7 0 2 3.8 c1ccc(CCCCN2CCN(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
10458117 16409 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 486 6 2 5 5.5 N#Cc1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
CHEMBL123961 16409 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 486 6 2 5 5.5 N#Cc1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
44346178 113757 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 423 8 1 4 5.0 Cc1ccc(C(=O)NC(CC2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
CHEMBL333040 113757 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 423 8 1 4 5.0 Cc1ccc(C(=O)NC(CC2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
44447377 94390 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 499 11 4 8 2.2 CCN(C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](C)[C@H](O)Cc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
CHEMBL253666 94390 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 499 11 4 8 2.2 CCN(C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](C)[C@H](O)Cc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
44295327 187799 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 414 8 2 4 4.2 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccccc1[N+](=O)[O-] 10.1016/s0960-894x(02)00206-8
CHEMBL50158 187799 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 414 8 2 4 4.2 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccccc1[N+](=O)[O-] 10.1016/s0960-894x(02)00206-8
44447150 94504 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 551 12 3 7 3.9 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)CC(F)(F)F)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254471 94504 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 551 12 3 7 3.9 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)CC(F)(F)F)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44295326 168510 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 414 8 2 4 4.2 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc([N+](=O)[O-])c1 10.1016/s0960-894x(02)00206-8
CHEMBL439744 168510 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 414 8 2 4 4.2 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc([N+](=O)[O-])c1 10.1016/s0960-894x(02)00206-8
44387850 60190 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 430 6 2 3 5.2 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
CHEMBL175679 60190 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 430 6 2 3 5.2 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
11236236 77606 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 448 6 2 3 5.3 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL2096696 77606 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 448 6 2 3 5.3 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
11224689 77617 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 448 6 2 3 5.3 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL2096764 77617 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 448 6 2 3 5.3 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
10939698 161121 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 475 7 2 4 5.7 COC(=O)c1cccc(NC(=O)Nc2ccccc2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL413113 161121 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 475 7 2 4 5.7 COC(=O)c1cccc(NC(=O)Nc2ccccc2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44570582 177842 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 477 10 2 6 3.9 CCCN(CCCc1ccc(F)cc1)C[C@@H]1OC(=O)N(C)C[C@H]1NC(=O)Nc1nc(C)cs1 10.1016/j.bmcl.2008.11.002
CHEMBL465943 177842 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 477 10 2 6 3.9 CCCN(CCCc1ccc(F)cc1)C[C@@H]1OC(=O)N(C)C[C@H]1NC(=O)Nc1nc(C)cs1 10.1016/j.bmcl.2008.11.002
44445846 93987 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 587 7 2 7 5.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)OC(C)(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251078 93987 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 587 7 2 7 5.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)OC(C)(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44390882 122286 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 461 8 2 6 3.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(C)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL360529 122286 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 461 8 2 6 3.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(C)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44295543 101516 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 427 7 2 2 4.7 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NC12CC3CC(CC(C3)C1)C2 10.1016/s0960-894x(02)00206-8
CHEMBL301503 101516 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 427 7 2 2 4.7 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NC12CC3CC(CC(C3)C1)C2 10.1016/s0960-894x(02)00206-8
11811443 16439 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 399 6 2 2 5.8 O=C(Nc1ccccc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL124134 16439 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 399 6 2 2 5.8 O=C(Nc1ccccc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
6995527 111407 6 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 221 4 1 3 1.4 CCOC(=O)[C@H](C)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL32878 111407 6 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 221 4 1 3 1.4 CCOC(=O)[C@H](C)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
9889700 118083 13 None - 1 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 444 7 1 3 5.9 N#CC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL34166 118083 13 None - 1 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 444 7 1 3 5.9 N#CC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11762084 16735 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 446 8 2 3 4.5 O=C(NCCc1ccc(F)cc1)Nc1ccccc1CN1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL125220 16735 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 446 8 2 3 4.5 O=C(NCCc1ccc(F)cc1)Nc1ccccc1CN1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
11060814 16991 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 567 10 3 3 7.2 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1ccccc1 10.1021/jm0201767
CHEMBL125618 16991 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 567 10 3 3 7.2 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1ccccc1 10.1021/jm0201767
66615627 80866 0 None 158 2 Human 9.7 pKi = 9.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 536 8 1 4 6.1 Cc1c(OC2CCN(CC3CCN([C@@](C)(Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158790 80866 0 None 158 2 Human 9.7 pKi = 9.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 536 8 1 4 6.1 Cc1c(OC2CCN(CC3CCN([C@@](C)(Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
59296081 83669 0 None 7 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 608 9 3 7 2.9 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(S(=O)(=O)N3CCC3)ccc12 10.1016/j.bmcl.2012.09.112
CHEMBL2207654 83669 0 None 7 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 608 9 3 7 2.9 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(S(=O)(=O)N3CCC3)ccc12 10.1016/j.bmcl.2012.09.112
66615619 80859 0 None 79 2 Human 9.3 pKi = 9.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 522 8 1 4 5.7 Cc1c(Cl)ccc(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158783 80859 0 None 79 2 Human 9.3 pKi = 9.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 522 8 1 4 5.7 Cc1c(Cl)ccc(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.103
12001832 80860 0 None 63 2 Human 9.3 pKi = 9.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 522 8 1 4 5.7 Cc1c(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158784 80860 0 None 63 2 Human 9.3 pKi = 9.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 522 8 1 4 5.7 Cc1c(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
16040671 80867 0 None 56 2 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 502 8 1 4 5.4 Cc1cc(Cl)ccc1OC1CCN(CC2CCN([C@@](C)(Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158791 80867 0 None 56 2 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 502 8 1 4 5.4 Cc1cc(Cl)ccc1OC1CCN(CC2CCN([C@@](C)(Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
17963201 81854 0 None 31 2 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 539 5 1 5 5.0 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(C)c4Cl)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171047 81854 0 None 31 2 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 539 5 1 5 5.0 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(C)c4Cl)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
66615702 80863 0 None 100 2 Human 9.1 pKi = 9.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 522 8 1 4 5.8 C[C@](Cc1ccc(F)cc1)(C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158787 80863 0 None 100 2 Human 9.1 pKi = 9.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 522 8 1 4 5.8 C[C@](Cc1ccc(F)cc1)(C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
59296033 83604 0 None 15 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 596 9 3 7 2.7 CN(C)S(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
CHEMBL2207286 83604 0 None 15 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 596 9 3 7 2.7 CN(C)S(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
59295968 83672 0 None 3 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 487 7 3 5 3.3 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3c(F)cccc23)CC1 10.1016/j.bmcl.2012.09.112
CHEMBL2207657 83672 0 None 3 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 487 7 3 5 3.3 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3c(F)cccc23)CC1 10.1016/j.bmcl.2012.09.112
59296099 83676 0 None 50 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 494 7 3 5 3.7 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]nc3C(F)(F)F)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
CHEMBL2207660 83676 0 None 50 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 494 7 3 5 3.7 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]nc3C(F)(F)F)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
46931923 128752 0 None - 1 Human 9.1 pKi = 9.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 6 1 5 4.2 Cc1cc(C(=O)N2CCCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670798 128752 0 None - 1 Human 9.1 pKi = 9.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 6 1 5 4.2 Cc1cc(C(=O)N2CCCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
59295928 83601 0 None 63 2 Human 9.0 pKi = 9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 581 8 3 7 3.2 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccc(S(C)(=O)=O)cc34)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
CHEMBL2207283 83601 0 None 63 2 Human 9.0 pKi = 9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 581 8 3 7 3.2 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccc(S(C)(=O)=O)cc34)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
66615606 80861 0 None 398 2 Human 8.9 pKi = 8.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 513 8 1 5 4.9 Cc1c(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc(C#N)c1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158785 80861 0 None 398 2 Human 8.9 pKi = 8.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 513 8 1 5 4.9 Cc1c(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc(C#N)c1Cl 10.1016/j.bmcl.2012.08.103
71462100 80868 0 None 39 2 Human 8.9 pKi = 8.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 502 8 1 4 5.4 Cc1cc(OC2CCN(CC3CCN([C@@](C)(Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158792 80868 0 None 39 2 Human 8.9 pKi = 8.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 502 8 1 4 5.4 Cc1cc(OC2CCN(CC3CCN([C@@](C)(Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc1Cl 10.1016/j.bmcl.2012.08.103
59295938 83680 0 None 7 2 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 521 7 3 5 3.6 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)cc3C(F)(F)F)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
CHEMBL2207664 83680 0 None 7 2 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 521 7 3 5 3.6 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)cc3C(F)(F)F)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
66615691 80865 0 None 125 2 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 518 8 1 4 5.9 Cc1c(OC2CCN(CC3CCN([C@@](C)(Cc4ccccc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158789 80865 0 None 125 2 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 518 8 1 4 5.9 Cc1c(OC2CCN(CC3CCN([C@@](C)(Cc4ccccc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
9870185 83682 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 489 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.113
CHEMBL2207666 83682 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 489 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.113
59295931 83797 0 None 5 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 462 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1n[nH]c2ccccc12 10.1016/j.bmcl.2012.09.113
CHEMBL2208429 83797 0 None 5 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 462 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1n[nH]c2ccccc12 10.1016/j.bmcl.2012.09.113
59296010 83799 0 None 3 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 490 7 3 6 2.9 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1n[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.113
CHEMBL2208431 83799 0 None 3 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 490 7 3 6 2.9 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1n[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.113
71459762 83677 0 None 7 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 452 8 3 5 3.2 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]nc1C1CC1 10.1016/j.bmcl.2012.09.112
CHEMBL2207661 83677 0 None 7 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 452 8 3 5 3.2 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]nc1C1CC1 10.1016/j.bmcl.2012.09.112
9870185 83682 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 489 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.112
CHEMBL2207666 83682 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 489 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.112
56967066 128777 0 None - 1 Human 8.8 pKi = 8.8 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 7 1 5 4.0 CCN(C)C(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670824 128777 0 None - 1 Human 8.8 pKi = 8.8 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 7 1 5 4.0 CCN(C)C(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
66615617 80864 0 None 31 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1c(OC2CCN(CC3CCN([C@@H](Cc4ccccc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158788 80864 0 None 31 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1c(OC2CCN(CC3CCN([C@@H](Cc4ccccc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
71456722 80869 0 None 39 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 486 8 1 4 4.9 Cc1cc(F)ccc1OC1CCN(CC2CCN([C@@](C)(Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158793 80869 0 None 39 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 486 8 1 4 4.9 Cc1cc(F)ccc1OC1CCN(CC2CCN([C@@](C)(Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
69262172 80881 1 None 3 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.5 O=C(O)c1ccccc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158822 80881 1 None 3 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.5 O=C(O)c1ccccc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
59295935 83596 0 None 3 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(F)ccc12 10.1016/j.bmcl.2012.09.112
CHEMBL2207278 83596 0 None 3 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(F)ccc12 10.1016/j.bmcl.2012.09.112
59295978 83671 0 None 1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2c(F)cccc12 10.1016/j.bmcl.2012.09.112
CHEMBL2207656 83671 0 None 1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2c(F)cccc12 10.1016/j.bmcl.2012.09.112
59296066 83679 0 None 5 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 487 7 3 5 3.0 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1 10.1016/j.bmcl.2012.09.112
CHEMBL2207663 83679 0 None 5 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 487 7 3 5 3.0 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1 10.1016/j.bmcl.2012.09.112
69347575 80880 0 None 10 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)[C@@H](c1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158821 80880 0 None 10 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)[C@@H](c1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71072040 80895 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 490 8 1 4 5.2 O=C(O)[C@H](Cc1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158835 80895 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 490 8 1 4 5.2 O=C(O)[C@H](Cc1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71072044 80897 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 524 8 1 4 5.9 O=C(O)[C@H](Cc1ccccc1Cl)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158837 80897 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 524 8 1 4 5.9 O=C(O)[C@H](Cc1ccccc1Cl)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71072050 80899 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1ccccc1F)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158839 80899 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1ccccc1F)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71072118 80901 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1ccc(F)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158841 80901 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1ccc(F)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
22397445 81827 0 None 2 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 499 4 1 4 5.0 O=C(c1c[nH]c(=O)c2ccccc12)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171020 81827 0 None 2 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 499 4 1 4 5.0 O=C(c1c[nH]c(=O)c2ccccc12)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
57718837 115512 0 None -1 3 Mouse 8.0 pKi = 8 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 414 7 1 2 6.4 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355932 115512 0 None -1 3 Mouse 8.0 pKi = 8 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 414 7 1 2 6.4 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
59295946 83599 0 None 5 2 Human 8.0 pKi = 8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 612 11 5 8 1.7 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(S(=O)(=O)NCCO)ccc12 10.1016/j.bmcl.2012.09.112
CHEMBL2207281 83599 0 None 5 2 Human 8.0 pKi = 8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 612 11 5 8 1.7 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(S(=O)(=O)NCCO)ccc12 10.1016/j.bmcl.2012.09.112
56965995 128750 0 None - 1 Human 8.0 pKi = 8.0 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 497 6 2 5 3.3 CNC(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670796 128750 0 None - 1 Human 8.0 pKi = 8.0 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 497 6 2 5 3.3 CNC(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
69260946 80882 1 None -19 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.5 O=C(O)c1cccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
CHEMBL2158823 80882 1 None -19 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.5 O=C(O)c1cccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
71462103 80890 1 None -2 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 492 8 1 5 5.2 O=C(O)COc1ccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
CHEMBL2158830 80890 1 None -2 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 492 8 1 5 5.2 O=C(O)COc1ccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
17963227 81819 0 None -39 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 539 5 0 5 5.1 Cc1ccc(S(=O)(=O)N(C)C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171013 81819 0 None -39 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 539 5 0 5 5.1 Cc1ccc(S(=O)(=O)N(C)C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
9910169 81824 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 422 7 1 4 4.3 COc1cccc(C(=O)NCCN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171018 81824 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 422 7 1 4 4.3 COc1cccc(C(=O)NCCN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.08.124
17963336 81851 0 None -5 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 536 5 1 6 4.3 N#Cc1cccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171044 81851 0 None -5 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 536 5 1 6 4.3 N#Cc1cccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
118721192 115521 0 None 4 2 Rat 7.0 pKi = 7 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 458 8 1 4 6.0 CCOC(=O)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355941 115521 0 None 4 2 Rat 7.0 pKi = 7 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 458 8 1 4 6.0 CCOC(=O)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
10300214 83784 0 None -6 2 Human 7.0 pKi = 7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 492 9 2 5 5.0 O=C(Nc1ccccc1OCC(O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)C1CCC1 10.1016/j.bmcl.2012.09.113
CHEMBL2208416 83784 0 None -6 2 Human 7.0 pKi = 7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 492 9 2 5 5.0 O=C(Nc1ccccc1OCC(O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)C1CCC1 10.1016/j.bmcl.2012.09.113
44389685 64402 0 None - 1 Human 7.0 pKi = 7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 459 4 1 2 6.3 Cc1ccccc1NC(=O)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL181894 64402 0 None - 1 Human 7.0 pKi = 7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 459 4 1 2 6.3 Cc1ccccc1NC(=O)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
17989653 81050 0 None - 1 Human 7.0 pKi = 7 Binding
Inhibition of CCR3 receptorInhibition of CCR3 receptor
ChEMBL 301 2 1 3 3.2 Fc1ccc2c(c1)nc(CC(F)(F)F)n2C1CCNCC1 10.1016/j.bmc.2012.09.013
CHEMBL2159765 81050 0 None - 1 Human 7.0 pKi = 7 Binding
Inhibition of CCR3 receptorInhibition of CCR3 receptor
ChEMBL 301 2 1 3 3.2 Fc1ccc2c(c1)nc(CC(F)(F)F)n2C1CCNCC1 10.1016/j.bmc.2012.09.013
44389678 122808 0 None - 1 Human 6.0 pKi = 6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 574 6 1 5 4.6 CS(=O)(=O)N[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL361620 122808 0 None - 1 Human 6.0 pKi = 6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 574 6 1 5 4.6 CS(=O)(=O)N[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44389669 62268 0 None - 1 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cccc(Cl)c3Cl)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178286 62268 0 None - 1 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cccc(Cl)c3Cl)CC2)CC1 10.1016/j.bmcl.2005.01.016
44401055 68340 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 454 7 2 4 4.6 COc1ccc(C(CNC(=O)Nc2ccc(F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL192162 68340 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 454 7 2 4 4.6 COc1ccc(C(CNC(=O)Nc2ccc(F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401192 70241 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 529 7 1 3 6.4 CC(C)(C)c1ccc(C(CNC(=O)Cc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL194943 70241 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 529 7 1 3 6.4 CC(C)(C)c1ccc(C(CNC(=O)Cc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401227 134718 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 421 9 1 4 4.5 COc1ccc(C(CNCCc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL372496 134718 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 421 9 1 4 4.5 COc1ccc(C(CNCCc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401173 69518 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 466 8 2 5 4.5 COc1ccc(NC(=O)NCC(c2ccccc2OC)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193871 69518 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 466 8 2 5 4.5 COc1ccc(NC(=O)NCC(c2ccccc2OC)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44400953 68939 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 488 6 2 3 5.8 Cc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL192751 68939 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 488 6 2 3 5.8 Cc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401108 69483 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 420 5 2 3 4.1 Cc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(C)CC2)cc1 10.1021/jm040827u
CHEMBL193732 69483 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 420 5 2 3 4.1 Cc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(C)CC2)cc1 10.1021/jm040827u
44401062 69707 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 502 9 1 4 5.6 CN(C)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193975 69707 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 502 9 1 4 5.6 CN(C)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721204 115544 0 None 5 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 532 9 3 2 6.7 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)[nH]c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355964 115544 0 None 5 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 532 9 3 2 6.7 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)[nH]c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
11477767 62698 0 None - 1 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL178818 62698 0 None - 1 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44391171 131274 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 294 1 0 2 4.7 Clc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL369351 131274 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 294 1 0 2 4.7 Clc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
25024650 115540 0 None -21 3 Mouse 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2014.11.063
CHEMBL3355960 115540 0 None -21 3 Mouse 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2014.11.063
118721203 115543 0 None -1 3 Mouse 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccnc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355963 115543 0 None -1 3 Mouse 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccnc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)c1 10.1016/j.bmcl.2014.11.063
118721194 115524 0 None -229 3 Rat 6.0 pKi = 6.0 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.4 COC(C)c1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355944 115524 0 None -229 3 Rat 6.0 pKi = 6.0 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.4 COC(C)c1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
25024651 115536 0 None -69 3 Rat 6.0 pKi = 6.0 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355956 115536 0 None -69 3 Rat 6.0 pKi = 6.0 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
44389719 62691 0 None - 1 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 408 5 0 2 4.6 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178771 62691 0 None - 1 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 408 5 0 2 4.6 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
44389750 165536 0 None - 1 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 469 4 1 2 6.0 O=C(c1cccc2[nH]ccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL425875 165536 0 None - 1 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 469 4 1 2 6.0 O=C(c1cccc2[nH]ccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
44401247 69082 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 492 6 2 3 5.7 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(F)cc1 10.1021/jm040827u
CHEMBL193332 69082 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 492 6 2 3 5.7 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(F)cc1 10.1021/jm040827u
44401111 68065 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 480 6 2 3 5.9 CC(C)(C)c1ccc(C(CNC(=O)Nc2ccc(F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL191719 68065 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 480 6 2 3 5.9 CC(C)(C)c1ccc(C(CNC(=O)Nc2ccc(F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44400945 70779 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 455 7 1 3 5.2 CC(C)(C)c1ccc(C(CNC(=O)Cc2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL195473 70779 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 455 7 1 3 5.2 CC(C)(C)c1ccc(C(CNC(=O)Cc2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
44401128 70770 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 462 6 2 3 5.8 CC(C)(C)c1ccc(C(CNC(=O)Nc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL195427 70770 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 462 6 2 3 5.8 CC(C)(C)c1ccc(C(CNC(=O)Nc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44400972 165440 0 None - 1 Human 4.9 pKi = 4.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 337 7 1 3 3.1 Cc1ccc(CCNCC(c2ccccc2)N2CCN(C)CC2)cc1 10.1021/jm040827u
CHEMBL425377 165440 0 None - 1 Human 4.9 pKi = 4.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 337 7 1 3 3.1 Cc1ccc(CCNCC(c2ccccc2)N2CCN(C)CC2)cc1 10.1021/jm040827u
44401053 70723 0 None - 1 Human 4.9 pKi = 4.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 371 8 1 4 3.0 COc1ccc(C(CNCCc2ccc(F)cc2)N2CCN(C)CC2)cc1 10.1021/jm040827u
CHEMBL195197 70723 0 None - 1 Human 4.9 pKi = 4.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 371 8 1 4 3.0 COc1ccc(C(CNCCc2ccc(F)cc2)N2CCN(C)CC2)cc1 10.1021/jm040827u
44401255 69514 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.5 COc1ccccc1CCNCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL193850 69514 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.5 COc1ccccc1CCNCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
44389674 62304 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 469 4 1 2 6.0 O=C(c1ccc2[nH]ccc2c1)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178367 62304 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 469 4 1 2 6.0 O=C(c1ccc2[nH]ccc2c1)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
71451391 80857 0 None 12 2 Human 7.9 pKi = 7.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 472 8 1 4 4.5 Cc1cc(F)ccc1OC1CCN(CC2CCN([C@@H](Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158781 80857 0 None 12 2 Human 7.9 pKi = 7.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 472 8 1 4 4.5 Cc1cc(F)ccc1OC1CCN(CC2CCN([C@@H](Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
10005242 80878 0 None 3 2 Human 7.9 pKi = 7.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)C(c1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158819 80878 0 None 3 2 Human 7.9 pKi = 7.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)C(c1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
23102749 81822 0 None 1 2 Human 7.9 pKi = 7.9 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 6 1 5 4.3 Cc1c(Cl)ccc(OC2CCN(C3CCN(S(=O)(=O)NC(=O)c4ccccc4)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.124
CHEMBL2171016 81822 0 None 1 2 Human 7.9 pKi = 7.9 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 6 1 5 4.3 Cc1c(Cl)ccc(OC2CCN(C3CCN(S(=O)(=O)NC(=O)c4ccccc4)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.124
59295926 83803 0 None -1 2 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 474 7 2 6 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1cnnc2ccccc12 10.1016/j.bmcl.2012.09.113
CHEMBL2208435 83803 0 None -1 2 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 474 7 2 6 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1cnnc2ccccc12 10.1016/j.bmcl.2012.09.113
59295914 83670 0 None 1 2 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 638 9 4 8 2.2 CC1(O)CN(S(=O)(=O)c2ccc3c(C(=O)NC[C@@H](O)CN4CCC(Oc5ccc(Cl)c(Cl)c5)CC4)c[nH]c(=O)c3c2)C1 10.1016/j.bmcl.2012.09.112
CHEMBL2207655 83670 0 None 1 2 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 638 9 4 8 2.2 CC1(O)CN(S(=O)(=O)c2ccc3c(C(=O)NC[C@@H](O)CN4CCC(Oc5ccc(Cl)c(Cl)c5)CC4)c[nH]c(=O)c3c2)C1 10.1016/j.bmcl.2012.09.112
11952525 115538 0 None 21 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 562 10 0 5 8.0 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355958 115538 0 None 21 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 562 10 0 5 8.0 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)cc1 10.1016/j.bmcl.2014.11.063
11952526 115533 0 None -24 3 Mouse 6.9 pKi = 6.9 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 534 9 1 4 7.5 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355953 115533 0 None -24 3 Mouse 6.9 pKi = 6.9 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 534 9 1 4 7.5 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
44391160 122772 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 413 1 1 4 5.6 CC(C)(C)c1csc2nc3n(c(=N)c12)CC/C3=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL361430 122772 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 413 1 1 4 5.6 CC(C)(C)c1csc2nc3n(c(=N)c12)CC/C3=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
44401004 70226 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 471 8 1 3 5.5 Fc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL194885 70226 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 471 8 1 3 5.5 Fc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
44389699 63587 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 445 4 1 3 5.1 Nc1cccc(C(=O)N2CCC(N3CCC(Cc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2005.01.016
CHEMBL180599 63587 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 445 4 1 3 5.1 Nc1cccc(C(=O)N2CCC(N3CCC(Cc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2005.01.016
71462102 80876 0 None -6 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 478 7 1 5 4.4 O=C(O)C(c1ccccc1)N1CCO[C@@H](CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.08.103
CHEMBL2158817 80876 0 None -6 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 478 7 1 5 4.4 O=C(O)C(c1ccccc1)N1CCO[C@@H](CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.08.103
71455217 81849 0 None -3 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1cccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171042 81849 0 None -3 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1cccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
17963141 81856 0 None -1 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 491 5 1 5 4.1 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)cc4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171049 81856 0 None -1 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 491 5 1 5 4.1 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)cc4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
71459825 83785 0 None 3 2 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 433 8 2 5 3.9 N#Cc1ccc(OC[C@@H](O)CNC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)cc1 10.1016/j.bmcl.2012.09.113
CHEMBL2208417 83785 0 None 3 2 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 433 8 2 5 3.9 N#Cc1ccc(OC[C@@H](O)CNC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)cc1 10.1016/j.bmcl.2012.09.113
71463288 83789 0 None -6 2 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 441 8 1 5 5.0 COc1cccc(SC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208421 83789 0 None -6 2 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 441 8 1 5 5.0 COc1cccc(SC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
44400992 69614 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 6 2 3 5.8 O=C(NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1)Nc1cc(Cl)cc(Cl)c1 10.1021/jm040827u
CHEMBL193931 69614 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 6 2 3 5.8 O=C(NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1)Nc1cc(Cl)cc(Cl)c1 10.1021/jm040827u
44389747 168637 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 424 5 0 2 5.1 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL440750 168637 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 424 5 0 2 5.1 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
44401135 69310 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 527 8 1 3 6.8 FC(F)(F)c1ccc(C(CNCCc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193507 69310 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 527 8 1 3 6.8 FC(F)(F)c1ccc(C(CNCCc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721187 115516 0 None -1 3 Mouse 6.9 pKi = 6.9 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(OC)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355936 115516 0 None -1 3 Mouse 6.9 pKi = 6.9 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(OC)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721188 115517 0 None -2 3 Mouse 5.9 pKi = 5.9 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355937 115517 0 None -2 3 Mouse 5.9 pKi = 5.9 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721200 115534 0 None -275 3 Rat 5.9 pKi = 5.9 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 558 9 1 6 7.0 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(-c2nnn[nH]2)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355954 115534 0 None -275 3 Rat 5.9 pKi = 5.9 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 558 9 1 6 7.0 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(-c2nnn[nH]2)cc1 10.1016/j.bmcl.2014.11.063
44401202 69786 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 542 6 2 3 6.5 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm040827u
CHEMBL194025 69786 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 542 6 2 3 6.5 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm040827u
44401183 69810 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 8 1 3 5.5 FC(F)(F)c1ccc(CCNCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL194040 69810 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 8 1 3 5.5 FC(F)(F)c1ccc(CCNCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44389709 63374 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 445 4 1 3 5.1 Nc1ccc(C(=O)N2CCC(N3CCC(Cc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2005.01.016
CHEMBL180122 63374 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 445 4 1 3 5.1 Nc1ccc(C(=O)N2CCC(N3CCC(Cc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2005.01.016
44389688 64214 0 None - 1 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 495 4 0 3 6.3 C[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181460 64214 0 None - 1 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 495 4 0 3 6.3 C[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44391330 63690 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 322 2 0 2 5.5 CCC1C/C(=C\c2ccccc2Cl)C2=Nc3ccccc3CN21 10.1016/j.bmcl.2004.11.039
CHEMBL180721 63690 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 322 2 0 2 5.5 CCC1C/C(=C\c2ccccc2Cl)C2=Nc3ccccc3CN21 10.1016/j.bmcl.2004.11.039
44389721 63952 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1nccc2ccccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL180988 63952 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1nccc2ccccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
44391276 122438 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 278 1 0 2 4.2 Fc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL360738 122438 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 278 1 0 2 4.2 Fc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
44391297 131967 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 288 2 0 2 4.6 CCc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL369778 131967 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 288 2 0 2 4.6 CCc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
44391307 167749 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 337 2 0 3 4.7 CN(C)c1ccc(/C=C2\CCN3Cc4ccccc4N=C23)c(Cl)c1 10.1016/j.bmcl.2004.11.039
CHEMBL434151 167749 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 337 2 0 3 4.7 CN(C)c1ccc(/C=C2\CCN3Cc4ccccc4N=C23)c(Cl)c1 10.1016/j.bmcl.2004.11.039
118721191 115520 0 None -331 3 Rat 5.9 pKi = 5.9 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 444 8 1 3 6.5 COC(C)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355940 115520 0 None -331 3 Rat 5.9 pKi = 5.9 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 444 8 1 3 6.5 COC(C)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
70790201 128756 0 None - 1 Human 5.9 pKi = 5.9 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 440 5 0 4 3.7 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)N(C)c3ccccn3)CC2)ccc1Cl nan
CHEMBL3670803 128756 0 None - 1 Human 5.9 pKi = 5.9 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 440 5 0 4 3.7 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)N(C)c3ccccn3)CC2)ccc1Cl nan
44389695 63599 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 424 5 0 2 5.1 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL180651 63599 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 424 5 0 2 5.1 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
44389712 62766 0 None - 1 Human 6.8 pKi = 6.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 442 5 0 2 5.3 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178916 62766 0 None - 1 Human 6.8 pKi = 6.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 442 5 0 2 5.3 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2005.01.016
44401086 70187 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 6 2 3 5.5 O=C(NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm040827u
CHEMBL194715 70187 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 6 2 3 5.5 O=C(NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm040827u
44401251 69083 0 None - 1 Human 4.8 pKi = 4.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 498 7 2 4 5.4 COc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL193334 69083 0 None - 1 Human 4.8 pKi = 4.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 498 7 2 4 5.4 COc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
11283679 64031 0 None - 1 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4cccnc4n3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181273 64031 0 None - 1 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4cccnc4n3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
17963315 81840 0 None 1 2 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 511 5 1 5 4.4 O=C(NS(=O)(=O)c1ccccc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171033 81840 0 None 1 2 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 511 5 1 5 4.4 O=C(NS(=O)(=O)c1ccccc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
59296109 83796 0 None 12 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 500 8 2 6 3.0 CS(=O)(=O)c1ccccc1C(=O)NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2012.09.113
CHEMBL2208428 83796 0 None 12 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 500 8 2 6 3.0 CS(=O)(=O)c1ccccc1C(=O)NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2012.09.113
59296077 83594 0 None 5 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 547 8 3 7 2.5 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3cc(S(C)(=O)=O)ccc23)CC1 10.1016/j.bmcl.2012.09.112
CHEMBL2207276 83594 0 None 5 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 547 8 3 7 2.5 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3cc(S(C)(=O)=O)ccc23)CC1 10.1016/j.bmcl.2012.09.112
44400973 127001 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.5 COc1ccc(C(CNC(=O)Nc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL366231 127001 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.5 COc1ccc(C(CNC(=O)Nc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
69260851 80883 1 None -2 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.5 O=C(O)c1ccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
CHEMBL2158824 80883 1 None -2 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.5 O=C(O)c1ccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
10143016 81861 0 None -3 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 6 1 5 4.5 O=C(NS(=O)(=O)Cc1ccccc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171215 81861 0 None -3 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 6 1 5 4.5 O=C(NS(=O)(=O)Cc1ccccc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
71454365 83786 0 None 1 2 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 465 8 2 6 4.6 O[C@@H](CNC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1)COc1ccc2ncsc2c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208418 83786 0 None 1 2 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 465 8 2 6 4.6 O[C@@H](CNC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1)COc1ccc2ncsc2c1 10.1016/j.bmcl.2012.09.113
59296073 83790 0 None -1 2 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 483 8 2 6 3.0 N#Cc1cccc(S(=O)(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208422 83790 0 None -1 2 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 483 8 2 6 3.0 N#Cc1cccc(S(=O)(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
44401172 123672 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 445 10 1 5 4.4 COc1ccccc1CCNCC(c1ccccc1OC)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
CHEMBL363409 123672 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 445 10 1 5 4.4 COc1ccccc1CCNCC(c1ccccc1OC)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
25024651 115536 0 None 39 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355956 115536 0 None 39 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
44391296 64972 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.0 FC(F)(F)c1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL182889 64972 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.0 FC(F)(F)c1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
44389722 63953 0 None - 1 Human 6.8 pKi = 6.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 538 5 1 4 5.2 CC(=O)N[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL180989 63953 0 None - 1 Human 6.8 pKi = 6.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 538 5 1 4 5.2 CC(=O)N[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44401052 69736 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 496 9 1 4 5.5 CN(C)c1ccc(C(CNCCc2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL193991 69736 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 496 9 1 4 5.5 CN(C)c1ccc(C(CNCCc2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
56967062 128769 0 None - 1 Human 7.8 pKi = 7.8 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 531 6 1 5 4.0 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)n1 nan
CHEMBL3670816 128769 0 None - 1 Human 7.8 pKi = 7.8 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 531 6 1 5 4.0 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)n1 nan
44391318 65371 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.3 Clc1ccc(/C=C2\CCN3Cc4ccccc4N=C23)c(Cl)c1 10.1016/j.bmcl.2004.11.039
CHEMBL183441 65371 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.3 Clc1ccc(/C=C2\CCN3Cc4ccccc4N=C23)c(Cl)c1 10.1016/j.bmcl.2004.11.039
118721199 115529 0 None 2 2 Rat 5.8 pKi = 5.8 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 440 8 2 3 5.9 CCc1[nH]c2cc(C(=O)O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355949 115529 0 None 2 2 Rat 5.8 pKi = 5.8 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 440 8 2 3 5.9 CCc1[nH]c2cc(C(=O)O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
25024650 115540 0 None -338 3 Rat 5.8 pKi = 5.8 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2014.11.063
CHEMBL3355960 115540 0 None -338 3 Rat 5.8 pKi = 5.8 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2014.11.063
44401235 69499 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.5 COc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193810 69499 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.5 COc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44400995 70755 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 505 7 2 4 5.9 CN(C)c1ccc(NC(=O)NCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL195353 70755 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 505 7 2 4 5.9 CN(C)c1ccc(NC(=O)NCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401188 69474 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 428 9 1 4 4.4 CN(C)c1ccc(CCNCC(c2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL193656 69474 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 428 9 1 4 4.4 CN(C)c1ccc(CCNCC(c2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
44401047 70786 0 None - 1 Human 6.8 pKi = 6.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 462 7 2 3 5.7 Cc1ccc(NC(=O)NCC(CC(C)C)N2CCN(c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm040827u
CHEMBL195495 70786 0 None - 1 Human 6.8 pKi = 6.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 462 7 2 3 5.7 Cc1ccc(NC(=O)NCC(CC(C)C)N2CCN(c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm040827u
118721190 115519 0 None 5 3 Mouse 7.8 pKi = 7.8 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 416 7 2 3 5.3 OCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355939 115519 0 None 5 3 Mouse 7.8 pKi = 7.8 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 416 7 2 3 5.3 OCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
11214422 123144 0 None - 1 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3cccc4cccnc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL362040 123144 0 None - 1 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3cccc4cccnc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44391258 121879 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.3 Clc1cccc(Cl)c1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL360075 121879 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.3 Clc1cccc(Cl)c1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
67114884 128755 0 None - 1 Human 7.7 pKi = 7.7 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 6 1 6 3.1 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N4CCOCC4)ccn3)CC2)ccc1Cl nan
CHEMBL3670802 128755 0 None - 1 Human 7.7 pKi = 7.7 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 6 1 6 3.1 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N4CCOCC4)ccn3)CC2)ccc1Cl nan
71072115 80846 0 None 1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 515 8 1 5 5.1 N#Cc1cccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
CHEMBL2158770 80846 0 None 1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 515 8 1 5 5.1 N#Cc1cccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
71072081 80849 0 None -1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1cccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
CHEMBL2158773 80849 0 None -1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1cccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
71072113 80850 0 None 3 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1ccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
CHEMBL2158774 80850 0 None 3 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1ccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
11444350 80853 0 None 7 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 558 8 1 4 6.3 O=C(O)[C@H](Cc1cccc(C(F)(F)F)c1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158777 80853 0 None 7 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 558 8 1 4 6.3 O=C(O)[C@H](Cc1cccc(C(F)(F)F)c1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71449584 80884 1 None -1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)Cc1ccccc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158825 80884 1 None -1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)Cc1ccccc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
69347719 80891 1 None 3 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)c1ccccc1CN1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158831 80891 1 None 3 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)c1ccccc1CN1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71460419 80898 0 None 1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 524 8 1 4 5.9 O=C(O)[C@H](Cc1ccc(Cl)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158838 80898 0 None 1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 524 8 1 4 5.9 O=C(O)[C@H](Cc1ccc(Cl)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
17963334 81845 0 None 2 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccccc1S(=O)(=O)NC(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171038 81845 0 None 2 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccccc1S(=O)(=O)NC(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
59296064 83791 0 None -1 2 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 447 7 2 5 3.5 N#Cc1cccc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208423 83791 0 None -1 2 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 447 7 2 5 3.5 N#Cc1cccc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
59295960 83683 0 None 12 2 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 532 8 4 6 2.6 NC(=O)c1c(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccccc34)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.09.112
CHEMBL2207667 83683 0 None 12 2 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 532 8 4 6 2.6 NC(=O)c1c(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccccc34)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.09.112
118721197 115527 0 None 19 2 Human 6.7 pKi = 6.7 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(OC)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355947 115527 0 None 19 2 Human 6.7 pKi = 6.7 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(OC)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44389730 64267 0 None - 1 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 442 5 0 2 5.3 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)c(F)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL181678 64267 0 None - 1 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 442 5 0 2 5.3 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)c(F)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
70790198 128749 0 None - 1 Human 6.7 pKi = 6.7 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 454 6 1 4 4.2 CCc1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670795 128749 0 None - 1 Human 6.7 pKi = 6.7 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 454 6 1 4 4.2 CCc1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
44401056 69505 0 None - 1 Human 5.7 pKi = 5.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 492 7 2 4 5.8 COc1ccc(NC(=O)NCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193827 69505 0 None - 1 Human 5.7 pKi = 5.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 492 7 2 4 5.8 COc1ccc(NC(=O)NCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
71462389 81831 0 None -1 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 5 1 4 4.8 O=C(O)c1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171024 81831 0 None -1 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 5 1 4 4.8 O=C(O)c1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
71462390 81833 0 None -6 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 500 5 1 6 4.3 O=C(c1ccc(-c2nn[nH]n2)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171026 81833 0 None -6 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 500 5 1 6 4.3 O=C(c1ccc(-c2nn[nH]n2)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
59296114 83793 0 None -12 2 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 480 7 2 6 3.4 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1cn2cc(F)ccc2n1 10.1016/j.bmcl.2012.09.113
CHEMBL2208425 83793 0 None -12 2 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 480 7 2 6 3.4 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1cn2cc(F)ccc2n1 10.1016/j.bmcl.2012.09.113
67114949 128763 0 None - 1 Human 8.6 pKi = 8.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 7 1 5 4.4 Cc1cc(C(=O)N(C)C(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670810 128763 0 None - 1 Human 8.6 pKi = 8.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 7 1 5 4.4 Cc1cc(C(=O)N(C)C(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
56967064 128773 0 None - 1 Human 8.6 pKi = 8.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 7 1 5 4.2 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)cc(C4CC4)n3)CC2)ccc1Cl nan
CHEMBL3670820 128773 0 None - 1 Human 8.6 pKi = 8.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 7 1 5 4.2 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)cc(C4CC4)n3)CC2)ccc1Cl nan
59295939 83798 0 None 12 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 461 7 3 4 4.1 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c2ccccc12 10.1016/j.bmcl.2012.09.113
CHEMBL2208430 83798 0 None 12 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 461 7 3 4 4.1 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c2ccccc12 10.1016/j.bmcl.2012.09.113
59296000 83800 0 None 7 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 478 6 3 6 3.1 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)n1c(=O)[nH]c2ccccc21 10.1016/j.bmcl.2012.09.113
CHEMBL2208432 83800 0 None 7 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 478 6 3 6 3.1 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)n1c(=O)[nH]c2ccccc21 10.1016/j.bmcl.2012.09.113
59296104 83801 0 None 1 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 503 7 2 5 3.8 CN(C[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)C(=O)c1c[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.113
CHEMBL2208433 83801 0 None 1 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 503 7 2 5 3.8 CN(C[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)C(=O)c1c[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.113
59295974 83688 0 None 19 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 581 8 3 7 3.2 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4cc(S(C)(=O)=O)ccc34)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
CHEMBL2207672 83688 0 None 19 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 581 8 3 7 3.2 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4cc(S(C)(=O)=O)ccc34)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
11179794 63962 0 None - 1 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3nccc4ccccc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181034 63962 0 None - 1 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3nccc4ccccc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44389770 123303 0 None - 1 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 552 6 1 4 5.5 CC(=O)NC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL362401 123303 0 None - 1 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 552 6 1 4 5.5 CC(=O)NC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44400954 126534 0 None - 1 Human 5.7 pKi = 5.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 518 6 2 3 7.1 CC(C)(C)c1ccc(NC(=O)NCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL365584 126534 0 None - 1 Human 5.7 pKi = 5.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 518 6 2 3 7.1 CC(C)(C)c1ccc(NC(=O)NCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721186 115515 0 None -2 3 Mouse 6.7 pKi = 6.7 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(O)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355935 115515 0 None -2 3 Mouse 6.7 pKi = 6.7 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(O)cc2)CC1 10.1016/j.bmcl.2014.11.063
44400982 70781 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 9 1 4 5.8 COc1ccccc1CCNCC(c1ccc(C(C)(C)C)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL195480 70781 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 9 1 4 5.8 COc1ccccc1CCNCC(c1ccc(C(C)(C)C)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
44401252 70472 0 None - 1 Human 4.7 pKi = 4.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 323 7 1 3 2.8 CN1CCN(C(CNCCc2ccccc2)c2ccccc2)CC1 10.1021/jm040827u
CHEMBL195093 70472 0 None - 1 Human 4.7 pKi = 4.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 323 7 1 3 2.8 CN1CCN(C(CNCCc2ccccc2)c2ccccc2)CC1 10.1021/jm040827u
44401225 69617 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 515 8 1 3 7.1 CC(C)(C)c1ccc(C(CNCCc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193938 69617 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 515 8 1 3 7.1 CC(C)(C)c1ccc(C(CNCCc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401067 167861 0 None - 1 Human 5.7 pKi = 5.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 450 7 2 4 4.8 COc1ccc(C(CNC(=O)Nc2ccc(C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL434918 167861 0 None - 1 Human 5.7 pKi = 5.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 450 7 2 4 4.8 COc1ccc(C(CNC(=O)Nc2ccc(C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44389690 64336 0 None - 1 Human 5.7 pKi = 5.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 426 5 0 2 4.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL181827 64336 0 None - 1 Human 5.7 pKi = 5.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 426 5 0 2 4.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
11386642 62760 0 None - 1 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 507 5 0 3 6.5 C=C[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL178887 62760 0 None - 1 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 507 5 0 3 6.5 C=C[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
56966925 128745 0 None - 1 Human 7.6 pKi = 7.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 483 6 2 5 3.0 CNC(=O)c1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670791 128745 0 None - 1 Human 7.6 pKi = 7.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 483 6 2 5 3.0 CNC(=O)c1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
24937092 115537 0 None -2 2 Mouse 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 500 10 0 5 6.4 CCOC(=O)Cn1c(CC)c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc21 10.1016/j.bmcl.2014.11.063
CHEMBL3355957 115537 0 None -2 2 Mouse 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 500 10 0 5 6.4 CCOC(=O)Cn1c(CC)c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc21 10.1016/j.bmcl.2014.11.063
118721186 115515 0 None -29 3 Rat 5.6 pKi = 5.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(O)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355935 115515 0 None -29 3 Rat 5.6 pKi = 5.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(O)cc2)CC1 10.1016/j.bmcl.2014.11.063
44401109 70737 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 515 8 1 3 6.8 CC(C)(C)c1ccc(C(CNCCc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL195293 70737 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 515 8 1 3 6.8 CC(C)(C)c1ccc(C(CNCCc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
56966998 128767 0 None - 1 Human 6.6 pKi = 6.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 527 7 1 6 3.3 COc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670814 128767 0 None - 1 Human 6.6 pKi = 6.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 527 7 1 6 3.3 COc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
118721194 115524 0 None -5 3 Mouse 7.6 pKi = 7.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.4 COC(C)c1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355944 115524 0 None -5 3 Mouse 7.6 pKi = 7.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.4 COC(C)c1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
71460416 80852 0 None 2 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 520 9 1 5 5.3 COc1ccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
CHEMBL2158776 80852 0 None 2 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 520 9 1 5 5.3 COc1ccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
71456725 80886 1 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)Cc1ccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
CHEMBL2158827 80886 1 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)Cc1ccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
71072057 80900 0 None 5 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1cccc(F)c1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158840 80900 0 None 5 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1cccc(F)c1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
17963332 81847 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 541 6 1 6 4.4 COc1ccccc1S(=O)(=O)NC(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171040 81847 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 541 6 1 6 4.4 COc1ccccc1S(=O)(=O)NC(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
17963153 81853 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)cc4Cl)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171046 81853 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)cc4Cl)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
59295982 83600 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 568 8 4 7 2.1 NS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
CHEMBL2207282 83600 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 568 8 4 7 2.1 NS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
44391331 64503 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 394 4 0 2 6.3 CCCCC1C/C(=C\c2ccccc2Br)C2=Nc3ccccc3CN21 10.1016/j.bmcl.2004.11.039
CHEMBL181984 64503 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 394 4 0 2 6.3 CCCCC1C/C(=C\c2ccccc2Br)C2=Nc3ccccc3CN21 10.1016/j.bmcl.2004.11.039
44389698 64039 0 None - 1 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(Cl)ccc3Cl)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL181290 64039 0 None - 1 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(Cl)ccc3Cl)CC2)CC1 10.1016/j.bmcl.2005.01.016
69347980 80892 1 None -5 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)c1cccc(CN2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
CHEMBL2158832 80892 1 None -5 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)c1cccc(CN2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
71458869 81829 0 None -2 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 506 7 1 5 4.6 O=C(O)COc1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171022 81829 0 None -2 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 506 7 1 5 4.6 O=C(O)COc1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
71449857 81830 0 None -10 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 5 1 4 4.8 O=C(O)c1ccccc1C(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171023 81830 0 None -10 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 5 1 4 4.8 O=C(O)c1ccccc1C(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
71463287 83787 0 None -79 2 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 420 7 1 5 4.1 N#Cc1cccc(OC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208419 83787 0 None -79 2 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 420 7 1 5 4.1 N#Cc1cccc(OC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
59296085 83794 0 None -2 2 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 506 8 2 7 3.1 CS(=O)(=O)c1ccc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)s1 10.1016/j.bmcl.2012.09.113
CHEMBL2208426 83794 0 None -2 2 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 506 8 2 7 3.1 CS(=O)(=O)c1ccc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)s1 10.1016/j.bmcl.2012.09.113
71458870 81838 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 5 1 4 5.2 Cc1ccc(C(=O)N2CCC(N3CC[C@@H](Oc4ccc(Cl)c(C)c4Cl)C[C@H]3C(=O)O)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171031 81838 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 5 1 4 5.2 Cc1ccc(C(=O)N2CCC(N3CC[C@@H](Oc4ccc(Cl)c(C)c4Cl)C[C@H]3C(=O)O)CC2)cc1 10.1016/j.bmcl.2012.08.124
44389832 63593 0 None - 1 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccnc4ccccc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL180621 63593 0 None - 1 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccnc4ccccc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44391176 122096 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 385 1 1 4 4.9 Cc1sc2nc3n(c(=N)c2c1C)CC/C3=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL360268 122096 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 385 1 1 4 4.9 Cc1sc2nc3n(c(=N)c2c1C)CC/C3=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
57718837 115512 0 None -45 3 Rat 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 414 7 1 2 6.4 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355932 115512 0 None -45 3 Rat 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 414 7 1 2 6.4 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721189 115518 0 None -7 3 Rat 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 400 6 1 2 6.1 Cc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355938 115518 0 None -7 3 Rat 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 400 6 1 2 6.1 Cc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
11952524 115531 0 None -3 3 Rat 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 490 8 0 3 7.8 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccccc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355951 115531 0 None -3 3 Rat 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 490 8 0 3 7.8 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccccc1 10.1016/j.bmcl.2014.11.063
11952525 115538 0 None -21 3 Mouse 5.6 pKi = 5.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 562 10 0 5 8.0 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355958 115538 0 None -21 3 Mouse 5.6 pKi = 5.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 562 10 0 5 8.0 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)cc1 10.1016/j.bmcl.2014.11.063
118721201 115535 0 None 2 2 Rat 5.6 pKi = 5.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 548 10 1 4 7.6 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1Cc1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355955 115535 0 None 2 2 Rat 5.6 pKi = 5.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 548 10 1 4 7.6 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1Cc1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
44389688 64214 0 None - 1 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 495 4 0 3 6.3 C[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181460 64214 0 None - 1 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 495 4 0 3 6.3 C[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44401117 69862 0 None - 1 Human 4.6 pKi = 4.6 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 413 7 1 3 4.2 Cc1ccc(CC(=O)NCC(c2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL194070 69862 0 None - 1 Human 4.6 pKi = 4.6 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 413 7 1 3 4.2 Cc1ccc(CC(=O)NCC(c2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
44391277 65455 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 369 1 1 4 4.4 Cc1oc2nc3n(c(=N)c2c1C)CC/C3=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL183478 65455 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 369 1 1 4 4.4 Cc1oc2nc3n(c(=N)c2c1C)CC/C3=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
118721205 115545 0 None -67 3 Mouse 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 653 11 3 5 7.2 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)O)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355965 115545 0 None -67 3 Mouse 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 653 11 3 5 7.2 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)O)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
44391236 122607 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 357 1 1 4 4.3 N=c1c2ccsc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL361149 122607 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 357 1 1 4 4.3 N=c1c2ccsc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
11360133 122804 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 351 1 1 3 4.2 N=c1c2ccccc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL361606 122804 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 351 1 1 3 4.2 N=c1c2ccccc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
44389704 62174 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 509 5 0 3 6.7 CC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL178136 62174 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 509 5 0 3 6.7 CC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44391252 65513 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 397 2 1 4 5.2 N=c1c2c(C3CC3)csc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL183520 65513 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 397 2 1 4 5.2 N=c1c2c(C3CC3)csc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
44391317 65171 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 336 2 0 2 5.7 C(=C1\CCN2Cc3ccccc3N=C12)\c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.11.039
CHEMBL183052 65171 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 336 2 0 2 5.7 C(=C1\CCN2Cc3ccccc3N=C12)\c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.11.039
44400990 165698 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 454 7 2 3 5.5 CC(C)CC(CNC(=O)Nc1cc(Cl)cc(Cl)c1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL426822 165698 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 454 7 2 3 5.5 CC(C)CC(CNC(=O)Nc1cc(Cl)cc(Cl)c1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
11466397 62550 0 None -407 4 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity against rat CC chemokine receptor 3In vitro binding affinity against rat CC chemokine receptor 3
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178447 62550 0 None -407 4 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity against rat CC chemokine receptor 3In vitro binding affinity against rat CC chemokine receptor 3
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
71451392 80862 0 None 31 2 Human 8.5 pKi = 8.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 C[C@](Cc1ccccc1)(C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158786 80862 0 None 31 2 Human 8.5 pKi = 8.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 C[C@](Cc1ccccc1)(C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71458868 81820 0 None 6 2 Human 8.5 pKi = 8.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 568 6 1 6 4.8 Cc1c(Cl)ccc(OC2CCN(C3CCN(C(=O)NS(=O)(=O)c4ccc(N(C)C)cc4)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.124
CHEMBL2171014 81820 0 None 6 2 Human 8.5 pKi = 8.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 568 6 1 6 4.8 Cc1c(Cl)ccc(OC2CCN(C3CCN(C(=O)NS(=O)(=O)c4ccc(N(C)C)cc4)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.124
59295958 83598 0 None 1 2 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2ccc(F)cc12 10.1016/j.bmcl.2012.09.112
CHEMBL2207280 83598 0 None 1 2 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2ccc(F)cc12 10.1016/j.bmcl.2012.09.112
59296100 83674 0 None 7 2 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 460 7 3 5 3.0 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]nc2C(F)(F)F)CC1 10.1016/j.bmcl.2012.09.112
CHEMBL2207659 83674 0 None 7 2 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 460 7 3 5 3.0 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]nc2C(F)(F)F)CC1 10.1016/j.bmcl.2012.09.112
59296090 83678 0 None 1 2 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.3 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)cc1C(F)(F)F 10.1016/j.bmcl.2012.09.112
CHEMBL2207662 83678 0 None 1 2 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.3 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)cc1C(F)(F)F 10.1016/j.bmcl.2012.09.112
10653 2256 6 None - 1 Human 8.5 pKi = 8.5 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C nan
59534386 2256 6 None - 1 Human 8.5 pKi = 8.5 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C nan
CHEMBL3670800 2256 6 None - 1 Human 8.5 pKi = 8.5 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C nan
DB15269 2256 6 None - 1 Human 8.5 pKi = 8.5 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C nan
11466397 62550 0 None -1 4 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178447 62550 0 None -1 4 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
11466397 62550 0 None -1 4 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178447 62550 0 None -1 4 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
56966926 128757 0 None - 1 Human 8.5 pKi = 8.5 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 8 2 5 4.1 Cc1cc(C(=O)NCC2CC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670804 128757 0 None - 1 Human 8.5 pKi = 8.5 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 8 2 5 4.1 Cc1cc(C(=O)NCC2CC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
71072104 80851 0 None 15 2 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 520 9 1 5 5.3 COc1ccccc1C[C@@H](C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158775 80851 0 None 15 2 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 520 9 1 5 5.3 COc1ccccc1C[C@@H](C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
66615678 80856 0 None 19 2 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 488 8 1 4 5.0 Cc1cc(Cl)ccc1OC1CCN(CC2CCN([C@@H](Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158780 80856 0 None 19 2 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 488 8 1 4 5.0 Cc1cc(Cl)ccc1OC1CCN(CC2CCN([C@@H](Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
59296039 83795 0 None 15 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 467 8 3 6 3.2 COc1cc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)ccc1N 10.1016/j.bmcl.2012.09.113
CHEMBL2208427 83795 0 None 15 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 467 8 3 6 3.2 COc1cc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)ccc1N 10.1016/j.bmcl.2012.09.113
59295984 83597 0 None 3 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 487 7 3 5 3.3 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3cc(F)ccc23)CC1 10.1016/j.bmcl.2012.09.112
CHEMBL2207279 83597 0 None 3 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 487 7 3 5 3.3 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3cc(F)ccc23)CC1 10.1016/j.bmcl.2012.09.112
59296048 83602 0 None 6 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 582 9 4 7 2.4 CNS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
CHEMBL2207284 83602 0 None 6 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 582 9 4 7 2.4 CNS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
59295969 83603 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 608 10 4 7 2.9 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(S(=O)(=O)NC3CC3)ccc12 10.1016/j.bmcl.2012.09.112
CHEMBL2207285 83603 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 608 10 4 7 2.9 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(S(=O)(=O)NC3CC3)ccc12 10.1016/j.bmcl.2012.09.112
71454296 83681 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 521 7 2 6 3.3 Cn1cc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c(C(F)(F)F)cc1=O 10.1016/j.bmcl.2012.09.112
CHEMBL2207665 83681 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 521 7 2 6 3.3 Cn1cc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c(C(F)(F)F)cc1=O 10.1016/j.bmcl.2012.09.112
59296094 83685 0 None 31 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 480 7 3 6 2.7 N#Cc1ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccccc34)CC2)cc1Cl 10.1016/j.bmcl.2012.09.112
CHEMBL2207669 83685 0 None 31 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 480 7 3 6 2.7 N#Cc1ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccccc34)CC2)cc1Cl 10.1016/j.bmcl.2012.09.112
44389737 123344 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1ccc2ncccc2c1)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL362649 123344 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1ccc2ncccc2c1)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
66906657 115522 0 None 12 2 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355942 115522 0 None 12 2 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
68849581 80877 0 None 3 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 478 7 1 5 4.4 O=C(O)C(c1ccccc1)N1CCO[C@H](CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.08.103
CHEMBL2158818 80877 0 None 3 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 478 7 1 5 4.4 O=C(O)C(c1ccccc1)N1CCO[C@H](CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.08.103
69348078 80879 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)[C@H](c1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158820 80879 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)[C@H](c1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
69272932 80887 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 492 8 1 5 5.2 O=C(O)COc1ccccc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158828 80887 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 492 8 1 5 5.2 O=C(O)COc1ccccc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71072034 80896 0 None 3 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 490 8 1 4 5.2 O=C(O)[C@@H](Cc1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158836 80896 0 None 3 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 490 8 1 4 5.2 O=C(O)[C@@H](Cc1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
17963208 81841 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 529 5 1 5 4.5 O=C(NS(=O)(=O)c1ccc(F)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171034 81841 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 529 5 1 5 4.5 O=C(NS(=O)(=O)c1ccc(F)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
71453505 81848 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 554 6 1 6 4.5 CN(C)c1ccccc1S(=O)(=O)NC(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171041 81848 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 554 6 1 6 4.5 CN(C)c1ccccc1S(=O)(=O)NC(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
17963347 81852 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 579 5 1 5 5.4 O=C(NS(=O)(=O)c1cccc(C(F)(F)F)c1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171045 81852 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 579 5 1 5 5.4 O=C(NS(=O)(=O)c1cccc(C(F)(F)F)c1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
71452601 83792 0 None -100 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 434 8 1 5 4.5 N#Cc1cccc(OC[C@@H](O)CCN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208424 83792 0 None -100 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 434 8 1 5 4.5 N#Cc1cccc(OC[C@@H](O)CCN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
59296098 83684 0 None 15 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 446 7 3 6 2.0 N#Cc1ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccccc34)CC2)cc1 10.1016/j.bmcl.2012.09.112
CHEMBL2207668 83684 0 None 15 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 446 7 3 6 2.0 N#Cc1ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccccc34)CC2)cc1 10.1016/j.bmcl.2012.09.112
44391213 122349 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 365 1 0 3 4.3 C/N=c1/c2ccccc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL360560 122349 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 365 1 0 3 4.3 C/N=c1/c2ccccc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
118721198 115528 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(C(N)=O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355948 115528 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(C(N)=O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44401177 68058 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 490 9 1 4 5.9 CN(C)c1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL191693 68058 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 490 9 1 4 5.9 CN(C)c1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401182 70725 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 476 7 2 3 6.0 Cc1cc(C)cc(NC(=O)NCC(CC(C)C)N2CCN(c3ccc(Cl)c(Cl)c3)CC2)c1 10.1021/jm040827u
CHEMBL195202 70725 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 476 7 2 3 6.0 Cc1cc(C)cc(NC(=O)NCC(CC(C)C)N2CCN(c3ccc(Cl)c(Cl)c3)CC2)c1 10.1021/jm040827u
25056325 70833 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 496 7 2 3 6.5 Cc1ccc(NC(=O)NCC(c2ccc(-c3ccccc3)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL195610 70833 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 496 7 2 3 6.5 Cc1ccc(NC(=O)NCC(c2ccc(-c3ccccc3)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
136229178 81832 0 None -19 2 Human 6.5 pKi = 6.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 516 5 1 6 4.5 O=C(c1ccc(-c2noc(=O)[nH]2)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171025 81832 0 None -19 2 Human 6.5 pKi = 6.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 516 5 1 6 4.5 O=C(c1ccc(-c2noc(=O)[nH]2)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
71452602 83804 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 433 8 2 5 3.9 N#Cc1cccc(OC[C@@H](O)CNC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208436 83804 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 433 8 2 5 3.9 N#Cc1cccc(OC[C@@H](O)CNC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
118721185 115514 0 None 1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355934 115514 0 None 1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721204 115544 0 None -28 3 Rat 6.5 pKi = 6.5 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 532 9 3 2 6.7 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)[nH]c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355964 115544 0 None -28 3 Rat 6.5 pKi = 6.5 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 532 9 3 2 6.7 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)[nH]c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
44391329 121826 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 344 2 0 3 4.9 FC(F)(F)Oc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL359918 121826 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 344 2 0 3 4.9 FC(F)(F)Oc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
11477767 62698 0 None - 1 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL178818 62698 0 None - 1 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44400948 70727 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 510 7 2 3 6.8 Cc1cc(C)cc(NC(=O)NCC(c2ccc(-c3ccccc3)cc2)N2CCN(C3CCCCC3)CC2)c1 10.1021/jm040827u
CHEMBL195214 70727 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 510 7 2 3 6.8 Cc1cc(C)cc(NC(=O)NCC(c2ccc(-c3ccccc3)cc2)N2CCN(C3CCCCC3)CC2)c1 10.1021/jm040827u
118721189 115518 0 None 1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 400 6 1 2 6.1 Cc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355938 115518 0 None 1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 400 6 1 2 6.1 Cc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44389738 64140 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 525 6 0 4 6.1 CCO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181379 64140 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 525 6 0 4 6.1 CCO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
118721206 115546 0 None -97 3 Rat 5.5 pKi = 5.5 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 667 11 2 6 7.3 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)OC)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355966 115546 0 None -97 3 Rat 5.5 pKi = 5.5 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 667 11 2 6 7.3 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)OC)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
44389868 64308 0 None - 1 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 588 7 1 5 4.9 CS(=O)(=O)NC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181789 64308 0 None - 1 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 588 7 1 5 4.9 CS(=O)(=O)NC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44401160 69122 0 None - 1 Human 5.5 pKi = 5.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 436 6 2 4 3.8 COc1ccccc1NC(=O)NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C)CC1 10.1021/jm040827u
CHEMBL193369 69122 0 None - 1 Human 5.5 pKi = 5.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 436 6 2 4 3.8 COc1ccccc1NC(=O)NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C)CC1 10.1021/jm040827u
118721206 115546 0 None 19 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 667 11 2 6 7.3 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)OC)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355966 115546 0 None 19 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 667 11 2 6 7.3 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)OC)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
44389784 63994 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3cnc4ccccc4n3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181137 63994 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3cnc4ccccc4n3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44401083 124019 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.8 COc1ccccc1C(CNCCc1cc(Cl)cc(Cl)c1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL364047 124019 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.8 COc1ccccc1C(CNCCc1cc(Cl)cc(Cl)c1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
44401154 69921 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 9 1 4 5.8 COc1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL194161 69921 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 9 1 4 5.8 COc1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401031 69692 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 503 8 1 3 7.1 CC(C)(C)c1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193973 69692 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 503 8 1 3 7.1 CC(C)(C)c1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401011 134717 0 None - 1 Human 4.5 pKi = 4.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 510 8 1 4 5.0 CN(C)c1ccc(C(CNC(=O)Cc2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL372493 134717 0 None - 1 Human 4.5 pKi = 4.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 510 8 1 4 5.0 CN(C)c1ccc(C(CNC(=O)Cc2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
44391247 122981 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 307 1 1 3 4.1 N=c1c2ccccc2nc2n1CC/C2=C\c1ccccc1Cl 10.1016/j.bmcl.2004.11.039
CHEMBL361761 122981 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 307 1 1 3 4.1 N=c1c2ccccc2nc2n1CC/C2=C\c1ccccc1Cl 10.1016/j.bmcl.2004.11.039
44389910 63026 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4cnccc4n3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL179490 63026 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4cnccc4n3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44391177 64138 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 411 1 1 4 5.2 N=c1c2c3c(sc2nc2n1CC/C2=C\c1ccccc1Br)CCCC3 10.1016/j.bmcl.2004.11.039
CHEMBL181367 64138 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 411 1 1 4 5.2 N=c1c2c3c(sc2nc2n1CC/C2=C\c1ccccc1Br)CCCC3 10.1016/j.bmcl.2004.11.039
44401206 126535 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 447 8 1 3 5.8 CC(C)(C)c1ccc(C(CNCCc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL365596 126535 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 447 8 1 3 5.8 CC(C)(C)c1ccc(C(CNCCc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721205 115545 0 None -870 3 Rat 5.5 pKi = 5.5 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 653 11 3 5 7.2 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)O)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355965 115545 0 None -870 3 Rat 5.5 pKi = 5.5 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 653 11 3 5 7.2 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)O)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
44401063 132578 0 None - 1 Human 5.5 pKi = 5.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 444 7 2 4 4.7 COc1ccccc1C(CNC(=O)Nc1ccc(C)cc1)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
CHEMBL370244 132578 0 None - 1 Human 5.5 pKi = 5.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 444 7 2 4 4.7 COc1ccccc1C(CNC(=O)Nc1ccc(C)cc1)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
44391192 63556 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 301 2 1 3 4.0 CCc1ccccc1/C=C1\CCn2c1nc1ccccc1c2=N 10.1016/j.bmcl.2004.11.039
CHEMBL180446 63556 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 301 2 1 3 4.0 CCc1ccccc1/C=C1\CCn2c1nc1ccccc1c2=N 10.1016/j.bmcl.2004.11.039
44401248 135464 0 None - 1 Human 5.4 pKi = 5.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.5 COc1ccccc1NC(=O)NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL373158 135464 0 None - 1 Human 5.4 pKi = 5.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.5 COc1ccccc1NC(=O)NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
118721189 115518 0 None -1 3 Mouse 7.4 pKi = 7.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 400 6 1 2 6.1 Cc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355938 115518 0 None -1 3 Mouse 7.4 pKi = 7.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 400 6 1 2 6.1 Cc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721196 115526 0 None -4 3 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355946 115526 0 None -4 3 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721197 115527 0 None -19 2 Rat 5.4 pKi = 5.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(OC)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355947 115527 0 None -19 2 Rat 5.4 pKi = 5.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(OC)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
57718829 115530 0 None 2 2 Human 7.4 pKi = 7.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 428 7 0 3 6.4 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1C 10.1016/j.bmcl.2014.11.063
CHEMBL3355950 115530 0 None 2 2 Human 7.4 pKi = 7.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 428 7 0 3 6.4 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1C 10.1016/j.bmcl.2014.11.063
44389752 63777 0 None - 1 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1ccnc2ccccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL180813 63777 0 None - 1 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1ccnc2ccccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
118721198 115528 0 None -1 2 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(C(N)=O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355948 115528 0 None -1 2 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(C(N)=O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44400950 68325 0 None - 1 Human 5.4 pKi = 5.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 449 6 2 4 4.2 CN1CCN(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)c2ccc(N(C)C)cc2)CC1 10.1021/jm040827u
CHEMBL192045 68325 0 None - 1 Human 5.4 pKi = 5.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 449 6 2 4 4.2 CN1CCN(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)c2ccc(N(C)C)cc2)CC1 10.1021/jm040827u
10151756 80874 0 None 1 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.1 O=C(O)C(c1ccccc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158815 80874 0 None 1 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.1 O=C(O)C(c1ccccc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
69274365 80885 1 None -7 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)Cc1cccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
CHEMBL2158826 80885 1 None -7 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)Cc1cccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
71449585 80888 0 None -7 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 492 8 1 5 5.2 O=C(O)COc1cccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
CHEMBL2158829 80888 0 None -7 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 492 8 1 5 5.2 O=C(O)COc1cccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
17963196 81843 0 None -1 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 541 6 1 6 4.4 COc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171036 81843 0 None -1 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 541 6 1 6 4.4 COc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
118721202 115542 0 None -77 3 Rat 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cc(C(=O)O)ccn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355962 115542 0 None -77 3 Rat 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cc(C(=O)O)ccn1 10.1016/j.bmcl.2014.11.063
44391212 65512 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 303 2 1 4 3.5 COc1ccc(/C=C2\CCn3c2nc2ccccc2c3=N)cc1 10.1016/j.bmcl.2004.11.039
CHEMBL183519 65512 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 303 2 1 4 3.5 COc1ccc(/C=C2\CCn3c2nc2ccccc2c3=N)cc1 10.1016/j.bmcl.2004.11.039
44401088 165797 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 483 9 1 4 5.4 COc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL427357 165797 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 483 9 1 4 5.4 COc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
44389675 62532 0 None - 1 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 525 6 0 4 6.0 COC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL178438 62532 0 None - 1 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 525 6 0 4 6.0 COC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
71449859 81836 0 None -10 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 600 10 1 8 5.1 O=C(O)CCCCn1nnc(-c2ccc(C(=O)N3CCC(N4CCC(Oc5ccc(Cl)c(Cl)c5)CC4)CC3)cc2)n1 10.1016/j.bmcl.2012.08.124
CHEMBL2171029 81836 0 None -10 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 600 10 1 8 5.1 O=C(O)CCCCn1nnc(-c2ccc(C(=O)N3CCC(N4CCC(Oc5ccc(Cl)c(Cl)c5)CC4)CC3)cc2)n1 10.1016/j.bmcl.2012.08.124
71462391 81839 0 None -1 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 554 6 1 6 3.9 CS(=O)(=O)c1cccc(C(=O)N2CC[C@@H](N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)[C@H](C(=O)O)C2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171032 81839 0 None -1 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 554 6 1 6 3.9 CS(=O)(=O)c1cccc(C(=O)N2CC[C@@H](N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)[C@H](C(=O)O)C2)c1 10.1016/j.bmcl.2012.08.124
118721205 115545 0 None 67 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 653 11 3 5 7.2 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)O)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355965 115545 0 None 67 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 653 11 3 5 7.2 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)O)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
67115149 128761 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 8 2 5 4.5 CCC(C)NC(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670808 128761 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 8 2 5 4.5 CCC(C)NC(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
68028908 128770 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 7 1 5 4.5 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)cc(C(C)C)n3)CC2)ccc1Cl nan
CHEMBL3670817 128770 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 7 1 5 4.5 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)cc(C(C)C)n3)CC2)ccc1Cl nan
68029259 128764 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 7 2 5 4.2 Cc1cc(C(=O)NC2CCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670811 128764 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 7 2 5 4.2 Cc1cc(C(=O)NC2CCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
118721191 115520 0 None 12 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 444 8 1 3 6.5 COC(C)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355940 115520 0 None 12 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 444 8 1 3 6.5 COC(C)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
67115103 128759 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 8 2 5 4.3 Cc1cc(C(=O)NCC(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670806 128759 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 8 2 5 4.3 Cc1cc(C(=O)NCC(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
56966996 128760 0 None - 1 Human 8.3 pKi = 8.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 547 8 2 5 3.9 Cc1cc(C(=O)NCC(F)F)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670807 128760 0 None - 1 Human 8.3 pKi = 8.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 547 8 2 5 3.9 Cc1cc(C(=O)NCC(F)F)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
118721200 115534 0 None 15 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 558 9 1 6 7.0 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(-c2nnn[nH]2)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355954 115534 0 None 15 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 558 9 1 6 7.0 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(-c2nnn[nH]2)cc1 10.1016/j.bmcl.2014.11.063
67115023 128754 0 None - 1 Human 8.3 pKi = 8.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 523 6 1 5 3.9 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N4CCCC4)ccn3)CC2)ccc1Cl nan
CHEMBL3670801 128754 0 None - 1 Human 8.3 pKi = 8.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 523 6 1 5 3.9 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N4CCCC4)ccn3)CC2)ccc1Cl nan
118721194 115524 0 None 5 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 426 8 1 3 6.4 COC(C)c1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355944 115524 0 None 5 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 426 8 1 3 6.4 COC(C)c1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
11952526 115533 0 None 24 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 534 9 1 4 7.5 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355953 115533 0 None 24 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 534 9 1 4 7.5 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
44389744 123355 0 None - 1 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL362700 123355 0 None - 1 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
66906657 115522 0 None -12 2 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355942 115522 0 None -12 2 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721199 115529 0 None -2 2 Human 5.4 pKi = 5.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 440 8 2 3 5.9 CCc1[nH]c2cc(C(=O)O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355949 115529 0 None -2 2 Human 5.4 pKi = 5.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 440 8 2 3 5.9 CCc1[nH]c2cc(C(=O)O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721188 115517 0 None -8 3 Rat 5.4 pKi = 5.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355937 115517 0 None -8 3 Rat 5.4 pKi = 5.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2014.11.063
44401189 69500 0 None - 1 Human 4.4 pKi = 4.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 429 8 1 4 3.9 COc1ccc(C(CNC(=O)Cc2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL193818 69500 0 None - 1 Human 4.4 pKi = 4.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 429 8 1 4 3.9 COc1ccc(C(CNC(=O)Cc2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
44391800 63942 0 None - 1 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 484 6 0 3 4.9 COc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL180939 63942 0 None - 1 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 484 6 0 3 4.9 COc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
44389675 62532 0 None - 1 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 525 6 0 4 6.0 COC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL178438 62532 0 None - 1 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 525 6 0 4 6.0 COC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
25024850 115541 0 None -6 3 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1cccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)n1 10.1016/j.bmcl.2014.11.063
CHEMBL3355961 115541 0 None -6 3 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1cccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)n1 10.1016/j.bmcl.2014.11.063
68028909 128768 0 None - 1 Human 6.4 pKi = 6.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 553 9 1 5 4.7 CCCCc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670815 128768 0 None - 1 Human 6.4 pKi = 6.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 553 9 1 5 4.7 CCCCc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
118721195 115525 0 None -9 3 Rat 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(C)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355945 115525 0 None -9 3 Rat 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(C)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44400977 69613 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 420 7 2 3 4.8 CC(C)CC(CNC(=O)Nc1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL193916 69613 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 420 7 2 3 4.8 CC(C)CC(CNC(=O)Nc1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
44400944 69973 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 442 9 1 4 4.8 Cc1ccc(CCNCC(c2ccc(N(C)C)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL194435 69973 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 442 9 1 4 4.8 Cc1ccc(CCNCC(c2ccc(N(C)C)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
118721188 115517 0 None 2 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355937 115517 0 None 2 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2014.11.063
44391312 65256 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 304 3 0 3 4.4 CCOc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL183229 65256 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 304 3 0 3 4.4 CCOc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
44389735 121810 0 None - 1 Human 6.3 pKi = 6.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1cnc2ccccc2c1)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL359850 121810 0 None - 1 Human 6.3 pKi = 6.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1cnc2ccccc2c1)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
118721195 115525 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(C)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355945 115525 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(C)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44389736 62507 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 513 5 0 3 6.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CF)C2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178422 62507 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 513 5 0 3 6.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CF)C2)CC1 10.1016/j.bmcl.2005.01.016
44389725 123138 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 482 4 0 4 5.5 O=C(c1cnnc2ccccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL362017 123138 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 482 4 0 4 5.5 O=C(c1cnnc2ccccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
56966927 128747 0 None - 1 Human 7.3 pKi = 7.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 456 6 1 5 3.6 COc1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670793 128747 0 None - 1 Human 7.3 pKi = 7.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 456 6 1 5 3.6 COc1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
118721193 115523 0 None -69 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 398 7 2 3 5.2 OCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355943 115523 0 None -69 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 398 7 2 3 5.2 OCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
11952525 115538 0 None -38 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 562 10 0 5 8.0 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355958 115538 0 None -38 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 562 10 0 5 8.0 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)cc1 10.1016/j.bmcl.2014.11.063
44401129 126256 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 391 7 1 3 3.8 CN1CCN(C(CNCCc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1021/jm040827u
CHEMBL365369 126256 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 391 7 1 3 3.8 CN1CCN(C(CNCCc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1021/jm040827u
44401175 126709 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.5 COc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL365806 126709 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.5 COc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401037 70736 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 6 2 3 5.5 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1ccccc1 10.1021/jm040827u
CHEMBL195291 70736 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 6 2 3 5.5 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1ccccc1 10.1021/jm040827u
118721195 115525 0 None -1 3 Mouse 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(C)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355945 115525 0 None -1 3 Mouse 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(C)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44389765 168770 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4nccnc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL441848 168770 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4nccnc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
118721192 115521 0 None -4 2 Human 6.3 pKi = 6.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 458 8 1 4 6.0 CCOC(=O)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355941 115521 0 None -4 2 Human 6.3 pKi = 6.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 458 8 1 4 6.0 CCOC(=O)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44401146 69918 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 8 1 3 5.5 FC(F)(F)c1ccc(C(CNCCc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL194135 69918 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 8 1 3 5.5 FC(F)(F)c1ccc(C(CNCCc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401256 70890 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 471 9 1 4 5.7 COc1ccccc1CCNCC(c1ccc(C(C)(C)C)cc1)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
CHEMBL195657 70890 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 471 9 1 4 5.7 COc1ccccc1CCNCC(c1ccc(C(C)(C)C)cc1)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
25024650 115540 0 None 21 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2014.11.063
CHEMBL3355960 115540 0 None 21 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2014.11.063
118721202 115542 0 None 15 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cc(C(=O)O)ccn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355962 115542 0 None 15 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cc(C(=O)O)ccn1 10.1016/j.bmcl.2014.11.063
9914506 80845 0 None 3 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 515 8 1 5 5.1 N#Cc1ccccc1C[C@@H](C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158769 80845 0 None 3 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 515 8 1 5 5.1 N#Cc1ccccc1C[C@@H](C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
68938028 80848 0 None 6 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1ccccc1C[C@@H](C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158772 80848 0 None 6 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1ccccc1C[C@@H](C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
66615705 80855 0 None 19 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1ccc(F)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158779 80855 0 None 19 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1ccc(F)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2012.08.103
69826668 81828 0 None 5 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 524 5 0 5 4.9 Cc1c(Cl)ccc(OC2CCN(C3CCN(C(=O)c4cccc(S(C)(=O)=O)c4)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.124
CHEMBL2171021 81828 0 None 5 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 524 5 0 5 4.9 Cc1c(Cl)ccc(OC2CCN(C3CCN(C(=O)c4cccc(S(C)(=O)=O)c4)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.124
71457010 81846 0 None 10 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 545 5 1 5 5.1 O=C(NS(=O)(=O)c1ccccc1Cl)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171039 81846 0 None 10 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 545 5 1 5 5.1 O=C(NS(=O)(=O)c1ccccc1Cl)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
70790202 128762 0 None - 1 Human 8.3 pKi = 8.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 553 8 1 5 4.8 CCC(C)N(C)C(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670809 128762 0 None - 1 Human 8.3 pKi = 8.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 553 8 1 5 4.8 CCC(C)N(C)C(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
57718837 115512 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 414 7 1 2 6.4 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355932 115512 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 414 7 1 2 6.4 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
56966997 128765 0 None - 1 Human 8.2 pKi = 8.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 555 6 1 5 3.8 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Br)c(C)c3)CC2)n1 nan
CHEMBL3670812 128765 0 None - 1 Human 8.2 pKi = 8.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 555 6 1 5 3.8 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Br)c(C)c3)CC2)n1 nan
11466397 62550 0 None -1 4 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178447 62550 0 None -1 4 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
10003872 69939 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 449 9 1 4 5.1 COc1ccc(C(CNCCc2cc(C)cc(C)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL194283 69939 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 449 9 1 4 5.1 COc1ccc(C(CNCCc2cc(C)cc(C)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
71451390 80854 0 None 7 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 474 8 1 4 4.7 O=C(O)[C@H](Cc1ccc(F)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158778 80854 0 None 7 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 474 8 1 4 4.7 O=C(O)[C@H](Cc1ccc(F)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2012.08.103
22397436 81825 0 None -6 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 510 5 0 5 4.5 CS(=O)(=O)c1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171019 81825 0 None -6 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 510 5 0 5 4.5 CS(=O)(=O)c1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
17963258 81844 0 None -2 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 554 6 1 6 4.5 CN(C)c1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171037 81844 0 None -2 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 554 6 1 6 4.5 CN(C)c1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
71451671 81835 0 None -31 2 Human 6.3 pKi = 6.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 519 8 2 5 5.0 O=C(O)CCNc1ccccc1C(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171028 81835 0 None -31 2 Human 6.3 pKi = 6.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 519 8 2 5 5.0 O=C(O)CCNc1ccccc1C(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
71451670 81823 0 None - 1 Human 5.3 pKi = 5.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 455 7 1 4 4.2 COc1ccc(C(=O)NCCN2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)cc1Cl 10.1016/j.bmcl.2012.08.124
CHEMBL2171017 81823 0 None - 1 Human 5.3 pKi = 5.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 455 7 1 4 4.2 COc1ccc(C(=O)NCCN2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)cc1Cl 10.1016/j.bmcl.2012.08.124
44389751 64313 0 None - 1 Human 6.3 pKi = 6.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 442 5 0 2 5.3 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(F)cc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL181794 64313 0 None - 1 Human 6.3 pKi = 6.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 442 5 0 2 5.3 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(F)cc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
44401136 70432 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 495 9 1 3 6.8 Cc1cc(C)cc(CCNCC(c2ccc(-c3ccccc3)cc2)N2CCN(C3CCCCC3)CC2)c1 10.1021/jm040827u
CHEMBL195081 70432 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 495 9 1 3 6.8 Cc1cc(C)cc(CCNCC(c2ccc(-c3ccccc3)cc2)N2CCN(C3CCCCC3)CC2)c1 10.1021/jm040827u
44401132 68294 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 5 2 3 5.1 CN1CCN(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1021/jm040827u
CHEMBL191824 68294 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 5 2 3 5.1 CN1CCN(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1021/jm040827u
118721191 115520 0 None -12 3 Mouse 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 444 8 1 3 6.5 COC(C)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355940 115520 0 None -12 3 Mouse 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 444 8 1 3 6.5 COC(C)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
25024849 115539 0 None -97 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)nc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355959 115539 0 None -97 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)nc1 10.1016/j.bmcl.2014.11.063
44401012 68328 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 454 7 2 4 4.6 COc1ccccc1C(CNC(=O)Nc1ccc(F)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL192066 68328 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 454 7 2 4 4.6 COc1ccccc1C(CNC(=O)Nc1ccc(F)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
44401145 69894 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 420 6 2 3 4.8 Cc1ccc(NC(=O)NCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL194086 69894 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 420 6 2 3 4.8 Cc1ccc(NC(=O)NCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
25024849 115539 0 None 13 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)nc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355959 115539 0 None 13 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)nc1 10.1016/j.bmcl.2014.11.063
44401048 69506 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 473 8 1 3 5.8 Cc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193828 69506 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 473 8 1 3 5.8 Cc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
11952526 115533 0 None -1122 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 534 9 1 4 7.5 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355953 115533 0 None -1122 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 534 9 1 4 7.5 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
44401209 69461 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 418 6 2 3 4.5 O=C(NCC(c1ccccc1)N1CCN(c2ccccc2)CC1)Nc1ccc(F)cc1 10.1021/jm040827u
CHEMBL193592 69461 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 418 6 2 3 4.5 O=C(NCC(c1ccccc1)N1CCN(c2ccccc2)CC1)Nc1ccc(F)cc1 10.1021/jm040827u
44389683 131128 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL369287 131128 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2005.01.016
118721196 115526 0 None -6 3 Rat 6.3 pKi = 6.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355946 115526 0 None -6 3 Rat 6.3 pKi = 6.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
24937215 115532 0 None -9 3 Rat 6.3 pKi = 6.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 472 9 1 4 5.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1CC(=O)O 10.1016/j.bmcl.2014.11.063
CHEMBL3355952 115532 0 None -9 3 Rat 6.3 pKi = 6.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 472 9 1 4 5.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1CC(=O)O 10.1016/j.bmcl.2014.11.063
44401226 70763 0 None - 1 Human 6.2 pKi = 6.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 429 9 1 4 4.7 COc1ccc(C(CNCCc2ccc(C)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL195406 70763 0 None - 1 Human 6.2 pKi = 6.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 429 9 1 4 4.7 COc1ccc(C(CNCCc2ccc(C)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
56966929 128753 0 None - 1 Human 8.2 pKi = 8.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 553 6 1 6 3.4 Cc1cc(C(=O)N2CCOCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670799 128753 0 None - 1 Human 8.2 pKi = 8.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 553 6 1 6 3.4 Cc1cc(C(=O)N2CCOCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
11753159 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.103
7679 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158814 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.103
11753159 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.124
7679 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.124
CHEMBL2158814 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.124
17963183 81850 0 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 545 5 1 5 5.1 O=C(NS(=O)(=O)c1cccc(Cl)c1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171043 81850 0 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 545 5 1 5 5.1 O=C(NS(=O)(=O)c1cccc(Cl)c1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
59296024 83595 0 None 9 2 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 547 8 3 7 2.5 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3ccc(S(C)(=O)=O)cc23)CC1 10.1016/j.bmcl.2012.09.112
CHEMBL2207277 83595 0 None 9 2 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 547 8 3 7 2.5 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3ccc(S(C)(=O)=O)cc23)CC1 10.1016/j.bmcl.2012.09.112
59296111 83673 0 None 2 2 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 480 7 3 5 3.4 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]nc1C(F)(F)F 10.1016/j.bmcl.2012.09.112
CHEMBL2207658 83673 0 None 2 2 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 480 7 3 5 3.4 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]nc1C(F)(F)F 10.1016/j.bmcl.2012.09.112
56966995 128758 0 None - 1 Human 8.2 pKi = 8.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 523 6 1 5 3.8 Cc1cc(C(=O)N2CCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670805 128758 0 None - 1 Human 8.2 pKi = 8.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 523 6 1 5 3.8 Cc1cc(C(=O)N2CCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
118721184 115513 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccccc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355933 115513 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccccc2)CC1 10.1016/j.bmcl.2014.11.063
25024850 115541 0 None 6 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1cccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)n1 10.1016/j.bmcl.2014.11.063
CHEMBL3355961 115541 0 None 6 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1cccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)n1 10.1016/j.bmcl.2014.11.063
44401005 70227 0 None - 1 Human 5.2 pKi = 5.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 9 1 5 3.9 COc1ccccc1CC(=O)NCC(c1ccccc1OC)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
CHEMBL194886 70227 0 None - 1 Human 5.2 pKi = 5.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 9 1 5 3.9 COc1ccccc1CC(=O)NCC(c1ccccc1OC)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
44401025 69334 0 None - 1 Human 6.2 pKi = 6.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 496 9 1 4 5.5 CN(C)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL193535 69334 0 None - 1 Human 6.2 pKi = 6.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 496 9 1 4 5.5 CN(C)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
11466397 62550 0 None -83 4 Mouse 6.2 pKi = 6.2 Binding
In vitro binding affinity against mouse CC chemokine receptor 3In vitro binding affinity against mouse CC chemokine receptor 3
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178447 62550 0 None -83 4 Mouse 6.2 pKi = 6.2 Binding
In vitro binding affinity against mouse CC chemokine receptor 3In vitro binding affinity against mouse CC chemokine receptor 3
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
24937215 115532 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 472 9 1 4 5.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1CC(=O)O 10.1016/j.bmcl.2014.11.063
CHEMBL3355952 115532 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 472 9 1 4 5.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1CC(=O)O 10.1016/j.bmcl.2014.11.063
70790203 128776 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 6 1 5 4.0 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3cc(C)c(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670823 128776 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 6 1 5 4.0 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3cc(C)c(Cl)c(C)c3)CC2)n1 nan
44391235 64914 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 376 1 0 4 4.1 N#C/N=c1/c2ccccc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL182719 64914 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 376 1 0 4 4.1 N#C/N=c1/c2ccccc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
118721185 115514 0 None -1 3 Mouse 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355934 115514 0 None -1 3 Mouse 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C)cc2)CC1 10.1016/j.bmcl.2014.11.063
25056323 70892 0 None - 1 Human 7.2 pKi = 7.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.8 COc1ccc(C(CNCCc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL195671 70892 0 None - 1 Human 7.2 pKi = 7.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.8 COc1ccc(C(CNCCc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401069 68768 0 None - 1 Human 4.2 pKi = 4.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 473 7 1 3 5.3 O=C(Cc1cc(Cl)cc(Cl)c1)NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL192384 68768 0 None - 1 Human 4.2 pKi = 4.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 473 7 1 3 5.3 O=C(Cc1cc(Cl)cc(Cl)c1)NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
44401110 68312 0 None - 1 Human 6.2 pKi = 6.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 9 1 4 5.8 COc1ccc(C(CNCCc2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL191959 68312 0 None - 1 Human 6.2 pKi = 6.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 9 1 4 5.8 COc1ccc(C(CNCCc2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
59296041 83686 0 None 3 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 558 8 3 8 2.1 CS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(C#N)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
CHEMBL2207670 83686 0 None 3 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 558 8 3 8 2.1 CS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(C#N)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
25024651 115536 0 None -39 3 Mouse 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355956 115536 0 None -39 3 Mouse 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
118721185 115514 0 None -19 3 Rat 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355934 115514 0 None -19 3 Rat 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C)cc2)CC1 10.1016/j.bmcl.2014.11.063
69347707 80893 1 None -5 2 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)c1ccc(CN2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
CHEMBL2158833 80893 1 None -5 2 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)c1ccc(CN2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
69260079 80894 2 None -63 2 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 463 6 1 5 4.8 O=C(O)c1cccnc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158834 80894 2 None -63 2 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 463 6 1 5 4.8 O=C(O)c1cccnc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71457009 81837 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 5 1 4 5.2 Cc1ccc(C(=O)N2CCC(N3CC[C@H](Oc4ccc(Cl)c(C)c4Cl)C[C@@H]3C(=O)O)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171030 81837 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 5 1 4 5.2 Cc1ccc(C(=O)N2CCC(N3CC[C@H](Oc4ccc(Cl)c(C)c4Cl)C[C@@H]3C(=O)O)CC2)cc1 10.1016/j.bmcl.2012.08.124
17963199 81858 0 None 1 2 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 493 5 1 5 3.7 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(F)c(F)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171050 81858 0 None 1 2 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 493 5 1 5 3.7 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(F)c(F)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
44401203 69787 0 None - 1 Human 5.2 pKi = 5.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 424 6 2 3 4.6 O=C(NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(F)cc1 10.1021/jm040827u
CHEMBL194026 69787 0 None - 1 Human 5.2 pKi = 5.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 424 6 2 3 4.6 O=C(NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(F)cc1 10.1021/jm040827u
118721204 115544 0 None -5 3 Mouse 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 532 9 3 2 6.7 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)[nH]c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355964 115544 0 None -5 3 Mouse 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 532 9 3 2 6.7 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)[nH]c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
25024850 115541 0 None -107 3 Rat 5.2 pKi = 5.2 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1cccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)n1 10.1016/j.bmcl.2014.11.063
CHEMBL3355961 115541 0 None -107 3 Rat 5.2 pKi = 5.2 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1cccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)n1 10.1016/j.bmcl.2014.11.063
118721184 115513 0 None -1 3 Mouse 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccccc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355933 115513 0 None -1 3 Mouse 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccccc2)CC1 10.1016/j.bmcl.2014.11.063
11952524 115531 0 None -9 3 Mouse 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 490 8 0 3 7.8 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccccc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355951 115531 0 None -9 3 Mouse 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 490 8 0 3 7.8 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccccc1 10.1016/j.bmcl.2014.11.063
118721193 115523 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 398 7 2 3 5.2 OCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355943 115523 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 398 7 2 3 5.2 OCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44389684 62653 0 None - 1 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 468 5 0 2 5.2 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178576 62653 0 None - 1 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 468 5 0 2 5.2 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
118721206 115546 0 None -19 3 Mouse 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 667 11 2 6 7.3 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)OC)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355966 115546 0 None -19 3 Mouse 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 667 11 2 6 7.3 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)OC)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
11952524 115531 0 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 490 8 0 3 7.8 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccccc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355951 115531 0 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 490 8 0 3 7.8 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccccc1 10.1016/j.bmcl.2014.11.063
56966928 128748 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 440 5 1 4 3.9 Cc1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670794 128748 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 440 5 1 4 3.9 Cc1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
44389677 62758 0 None - 1 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1cccc2cccnc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178875 62758 0 None - 1 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1cccc2cccnc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
56965997 128746 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 440 5 1 4 3.9 Cc1cccc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670792 128746 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 440 5 1 4 3.9 Cc1cccc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
118721201 115535 0 None -2 2 Human 5.2 pKi = 5.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 548 10 1 4 7.6 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1Cc1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355955 115535 0 None -2 2 Human 5.2 pKi = 5.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 548 10 1 4 7.6 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1Cc1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
11466397 62550 0 None 1 4 Rhesus macaque 8.1 pKi = 8.1 Binding
In vitro binding affinity against monkey CC chemokine receptor 3In vitro binding affinity against monkey CC chemokine receptor 3
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178447 62550 0 None 1 4 Rhesus macaque 8.1 pKi = 8.1 Binding
In vitro binding affinity against monkey CC chemokine receptor 3In vitro binding affinity against monkey CC chemokine receptor 3
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
11477767 62698 0 None - 1 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL178818 62698 0 None - 1 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
67115945 128774 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 7 1 5 3.9 CCc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)cc(C)n3)CC2)ccc1Cl nan
CHEMBL3670821 128774 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 7 1 5 3.9 CCc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)cc(C)n3)CC2)ccc1Cl nan
56967065 128775 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 521 6 1 5 3.3 C#Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670822 128775 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 521 6 1 5 3.3 C#Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
71072052 80847 0 None 1 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 515 8 1 5 5.1 N#Cc1ccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
CHEMBL2158771 80847 0 None 1 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 515 8 1 5 5.1 N#Cc1ccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
71453204 80858 0 None 12 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 488 8 1 4 5.0 Cc1cc(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158782 80858 0 None 12 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 488 8 1 4 5.0 Cc1cc(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc1Cl 10.1016/j.bmcl.2012.08.103
17963363 81842 0 None 2 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 545 5 1 5 5.1 O=C(NS(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171035 81842 0 None 2 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 545 5 1 5 5.1 O=C(NS(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
17963226 81855 0 None 3 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 505 5 1 5 4.4 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)cc4C)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171048 81855 0 None 3 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 505 5 1 5 4.4 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)cc4C)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
59295994 83802 0 None -1 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 489 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1cc(=O)[nH]c2ccccc12 10.1016/j.bmcl.2012.09.113
CHEMBL2208434 83802 0 None -1 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 489 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1cc(=O)[nH]c2ccccc12 10.1016/j.bmcl.2012.09.113
59295925 83687 0 None 2 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 567 8 3 7 2.9 CS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
CHEMBL2207671 83687 0 None 2 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 567 8 3 7 2.9 CS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
56966999 128771 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 495 6 1 5 3.1 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(F)c(C)c3)CC2)n1 nan
CHEMBL3670818 128771 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 495 6 1 5 3.1 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(F)c(C)c3)CC2)n1 nan
118721200 115534 0 None -15 3 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 558 9 1 6 7.0 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(-c2nnn[nH]2)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355954 115534 0 None -15 3 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 558 9 1 6 7.0 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(-c2nnn[nH]2)cc1 10.1016/j.bmcl.2014.11.063
67115364 123918 0 None - 1 Human 7.1 pKi = 7.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 483 6 2 5 3.0 CNC(=O)c1cccc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3639696 123918 0 None - 1 Human 7.1 pKi = 7.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 483 6 2 5 3.0 CNC(=O)c1cccc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
44391319 64007 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.3 Clc1ccc(/C=C2\CCN3Cc4ccccc4N=C23)cc1Cl 10.1016/j.bmcl.2004.11.039
CHEMBL181195 64007 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.3 Clc1ccc(/C=C2\CCN3Cc4ccccc4N=C23)cc1Cl 10.1016/j.bmcl.2004.11.039
118721190 115519 0 None -40 3 Rat 6.1 pKi = 6.1 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 416 7 2 3 5.3 OCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355939 115519 0 None -40 3 Rat 6.1 pKi = 6.1 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 416 7 2 3 5.3 OCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
24937215 115532 0 None -1 3 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 472 9 1 4 5.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1CC(=O)O 10.1016/j.bmcl.2014.11.063
CHEMBL3355952 115532 0 None -1 3 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 472 9 1 4 5.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1CC(=O)O 10.1016/j.bmcl.2014.11.063
25024849 115539 0 None -13 3 Mouse 6.1 pKi = 6.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)nc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355959 115539 0 None -13 3 Mouse 6.1 pKi = 6.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)nc1 10.1016/j.bmcl.2014.11.063
44391170 65388 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 399 1 1 3 4.1 N=c1c2ccccc2nc2n1CC/C2=C\c1ccccc1I 10.1016/j.bmcl.2004.11.039
CHEMBL183461 65388 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 399 1 1 3 4.1 N=c1c2ccccc2nc2n1CC/C2=C\c1ccccc1I 10.1016/j.bmcl.2004.11.039
44400991 69470 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 471 9 1 4 5.7 COc1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL193633 69470 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 471 9 1 4 5.7 COc1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
43957010 68295 7 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 399 6 2 4 3.0 CN1CCN(C(CNC(=O)Nc2ccc(F)cc2)c2ccc(N(C)C)cc2)CC1 10.1021/jm040827u
CHEMBL191828 68295 7 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 399 6 2 4 3.0 CN1CCN(C(CNC(=O)Nc2ccc(F)cc2)c2ccc(N(C)C)cc2)CC1 10.1021/jm040827u
118721186 115515 0 None 2 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(O)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355935 115515 0 None 2 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(O)cc2)CC1 10.1016/j.bmcl.2014.11.063
44401085 134979 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 527 8 1 3 6.5 FC(F)(F)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL372858 134979 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 527 8 1 3 6.5 FC(F)(F)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721202 115542 0 None -15 3 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cc(C(=O)O)ccn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355962 115542 0 None -15 3 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cc(C(=O)O)ccn1 10.1016/j.bmcl.2014.11.063
68846936 80875 0 None -1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)C(c1ccccc1)N1CCCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.08.103
CHEMBL2158816 80875 0 None -1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)C(c1ccccc1)N1CCCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.08.103
23102733 81821 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 511 6 1 5 4.0 O=C(NS(=O)(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1)c1ccccc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171015 81821 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 511 6 1 5 4.0 O=C(NS(=O)(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1)c1ccccc1 10.1016/j.bmcl.2012.08.124
71449858 81834 0 None -1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 582 9 1 6 4.8 O=C(O)CCCS(=O)(=O)c1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171027 81834 0 None -1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 582 9 1 6 4.8 O=C(O)CCCS(=O)(=O)c1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
71461541 83805 0 None 15 2 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 513 9 3 6 2.7 CS(=O)(=O)c1ccccc1C(=O)NCC(O)CNC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2012.09.113
CHEMBL2208437 83805 0 None 15 2 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 513 9 3 6 2.7 CS(=O)(=O)c1ccccc1C(=O)NCC(O)CNC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2012.09.113
44391240 123141 0 None - 1 Human 5.1 pKi = 5.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 432 2 0 2 6.7 Fc1ccc(C2C/C(=C\c3ccccc3Br)C3=Nc4ccccc4CN32)cc1 10.1016/j.bmcl.2004.11.039
CHEMBL362032 123141 0 None - 1 Human 5.1 pKi = 5.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 432 2 0 2 6.7 Fc1ccc(C2C/C(=C\c3ccccc3Br)C3=Nc4ccccc4CN32)cc1 10.1016/j.bmcl.2004.11.039
44389732 64017 0 None - 1 Human 6.1 pKi = 6.1 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 420 6 0 3 4.5 COc1ccc(CC2CCN(C3CCN(C(=O)Cc4ccccc4C)CC3)CC2)cc1 10.1016/j.bmcl.2005.01.016
CHEMBL181230 64017 0 None - 1 Human 6.1 pKi = 6.1 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 420 6 0 3 4.5 COc1ccc(CC2CCN(C3CCN(C(=O)Cc4ccccc4C)CC3)CC2)cc1 10.1016/j.bmcl.2005.01.016
71450777 83788 0 None -63 2 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 404 7 0 4 5.2 N#Cc1cccc(OCCCN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208420 83788 0 None -63 2 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 404 7 0 4 5.2 N#Cc1cccc(OCCCN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
56965994 128766 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 7 1 5 3.9 CCc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670813 128766 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 7 1 5 3.9 CCc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
56965996 128751 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 497 6 1 5 3.3 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)ccn3)CC2)ccc1Cl nan
CHEMBL3670797 128751 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 497 6 1 5 3.3 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)ccn3)CC2)ccc1Cl nan
25056324 126424 0 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 8 1 3 5.8 Clc1cc(Cl)cc(CCNCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)c1 10.1021/jm040827u
CHEMBL365551 126424 0 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 8 1 3 5.8 Clc1cc(Cl)cc(CCNCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)c1 10.1021/jm040827u
44401070 68769 0 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 414 6 2 3 4.7 Cc1ccc(NC(=O)NCC(c2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL192385 68769 0 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 414 6 2 3 4.7 Cc1ccc(NC(=O)NCC(c2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
24937092 115537 0 None 2 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 500 10 0 5 6.4 CCOC(=O)Cn1c(CC)c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc21 10.1016/j.bmcl.2014.11.063
CHEMBL3355957 115537 0 None 2 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 500 10 0 5 6.4 CCOC(=O)Cn1c(CC)c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc21 10.1016/j.bmcl.2014.11.063
44391282 122106 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 352 1 1 4 3.6 N=c1c2cccnc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL360308 122106 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 352 1 1 4 3.6 N=c1c2cccnc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
136216709 78556 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 341 1 2 4 2.9 N=c1c2nc[nH]c2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL2113024 78556 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 341 1 2 4 2.9 N=c1c2nc[nH]c2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
44387847 60172 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.8 COc1ccc(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL175547 60172 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.8 COc1ccc(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44387853 63115 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 515 8 1 3 6.8 CC(C)(C)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL179752 63115 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 515 8 1 3 6.8 CC(C)(C)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
57718829 115530 0 None -2 2 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 428 7 0 3 6.4 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1C 10.1016/j.bmcl.2014.11.063
CHEMBL3355950 115530 0 None -2 2 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 428 7 0 3 6.4 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1C 10.1016/j.bmcl.2014.11.063
118721196 115526 0 None 4 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355946 115526 0 None 4 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44389790 64441 0 None - 1 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3cnnc4ccccc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181929 64441 0 None - 1 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3cnnc4ccccc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
56967063 128772 0 None - 1 Human 7.1 pKi = 7.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 565 6 1 5 4.4 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C(F)(F)F)c3)CC2)n1 nan
CHEMBL3670819 128772 0 None - 1 Human 7.1 pKi = 7.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 565 6 1 5 4.4 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C(F)(F)F)c3)CC2)n1 nan
118721184 115513 0 None -14 3 Rat 6.1 pKi = 6.1 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccccc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355933 115513 0 None -14 3 Rat 6.1 pKi = 6.1 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccccc2)CC1 10.1016/j.bmcl.2014.11.063
44400974 134767 0 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 485 8 1 4 5.2 COc1ccccc1CC(=O)NCC(c1ccc(C(C)(C)C)cc1)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
CHEMBL372725 134767 0 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 485 8 1 4 5.2 COc1ccccc1CC(=O)NCC(c1ccc(C(C)(C)C)cc1)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
44400949 68814 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 8 1 3 5.7 Fc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL192412 68814 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 8 1 3 5.7 Fc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401155 69830 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.8 COc1ccccc1C(CNC(=O)Nc1cc(Cl)cc(Cl)c1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL194044 69830 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.8 COc1ccccc1C(CNC(=O)Nc1cc(Cl)cc(Cl)c1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
44401094 70785 0 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 391 7 1 3 3.8 CN1CCN(C(CNCCc2ccc(C(F)(F)F)cc2)c2ccccc2)CC1 10.1021/jm040827u
CHEMBL195488 70785 0 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 391 7 1 3 3.8 CN1CCN(C(CNCCc2ccc(C(F)(F)F)cc2)c2ccccc2)CC1 10.1021/jm040827u
11397231 81051 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of CCR3 receptorInhibition of CCR3 receptor
ChEMBL 469 7 0 4 6.2 Fc1ccc(SCCCN2CCC(n3c(CC(F)(F)F)nc4cc(F)ccc43)CC2)cc1 10.1016/j.bmc.2012.09.013
CHEMBL2159766 81051 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of CCR3 receptorInhibition of CCR3 receptor
ChEMBL 469 7 0 4 6.2 Fc1ccc(SCCCN2CCC(n3c(CC(F)(F)F)nc4cc(F)ccc43)CC2)cc1 10.1016/j.bmc.2012.09.013
9797962 65343 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 338 1 0 2 4.8 Brc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL183429 65343 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 338 1 0 2 4.8 Brc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
44401032 69785 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 492 7 2 4 5.8 COc1ccc(C(CNC(=O)Nc2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL194022 69785 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 492 7 2 4 5.8 COc1ccc(C(CNC(=O)Nc2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401234 69498 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 435 9 1 4 4.8 COc1ccc(C(CNCCc2ccc(C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193809 69498 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 435 9 1 4 4.8 COc1ccc(C(CNCCc2ccc(C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721193 115523 0 None -1 3 Mouse 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 398 7 2 3 5.2 OCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355943 115523 0 None -1 3 Mouse 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 398 7 2 3 5.2 OCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44401089 123541 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.5 COc1ccc(C(CNCCc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL363181 123541 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.5 COc1ccc(C(CNCCc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44391268 63568 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 312 1 0 2 4.8 Fc1ccc(/C=C2\CCN3Cc4ccccc4N=C23)c(Cl)c1 10.1016/j.bmcl.2004.11.039
CHEMBL180493 63568 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 312 1 0 2 4.8 Fc1ccc(/C=C2\CCN3Cc4ccccc4N=C23)c(Cl)c1 10.1016/j.bmcl.2004.11.039
44387857 60709 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 542 6 2 3 6.8 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1cc(Cl)cc(Cl)c1 10.1021/jm040827u
CHEMBL176281 60709 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 542 6 2 3 6.8 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1cc(Cl)cc(Cl)c1 10.1021/jm040827u
44389729 64018 0 None - 1 Human 6.0 pKi = 6.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(Cl)cc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL181232 64018 0 None - 1 Human 6.0 pKi = 6.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(Cl)cc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
118721187 115516 0 None -10 3 Rat 6.0 pKi = 6.0 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(OC)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355936 115516 0 None -10 3 Rat 6.0 pKi = 6.0 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(OC)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721187 115516 0 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(OC)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355936 115516 0 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(OC)cc2)CC1 10.1016/j.bmcl.2014.11.063
44400978 135353 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 530 6 2 3 6.8 CC(C)(C)c1ccc(C(CNC(=O)Nc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL373092 135353 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 530 6 2 3 6.8 CC(C)(C)c1ccc(C(CNC(=O)Nc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721203 115543 0 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccnc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355963 115543 0 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccnc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)c1 10.1016/j.bmcl.2014.11.063
44400983 70794 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 436 7 2 4 4.5 COc1ccc(NC(=O)NCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL195533 70794 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 436 7 2 4 4.5 COc1ccc(NC(=O)NCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401176 68059 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 517 7 2 4 5.9 CN(C)c1ccc(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL191696 68059 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 517 7 2 4 5.9 CN(C)c1ccc(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721190 115519 0 None -5 3 Human 7.0 pKi = 7 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 416 7 2 3 5.3 OCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355939 115519 0 None -5 3 Human 7.0 pKi = 7 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 416 7 2 3 5.3 OCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721203 115543 0 None -10 3 Rat 6.0 pKi = 6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccnc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355963 115543 0 None -10 3 Rat 6.0 pKi = 6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccnc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)c1 10.1016/j.bmcl.2014.11.063
795 568 3 None - 1 Human 8.3 pKd None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
796 568 3 None - 1 Human 8.3 pKd None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
9913085 568 3 None - 1 Human 8.3 pKd None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
CHEMBL20921 568 3 None - 1 Human 8.3 pKd None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
11753159 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Assay using sodium salt of the compoundAssay using sodium salt of the compound
Guide to Pharmacology 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 23031591
7679 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Assay using sodium salt of the compoundAssay using sodium salt of the compound
Guide to Pharmacology 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 23031591
CHEMBL2158814 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Assay using sodium salt of the compoundAssay using sodium salt of the compound
Guide to Pharmacology 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 23031591
10653 2256 6 None - 1 Human 8.5 pKi = 8.5 Binding
Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.
Guide to Pharmacology 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C None
59534386 2256 6 None - 1 Human 8.5 pKi = 8.5 Binding
Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.
Guide to Pharmacology 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C None
CHEMBL3670800 2256 6 None - 1 Human 8.5 pKi = 8.5 Binding
Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.
Guide to Pharmacology 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C None
DB15269 2256 6 None - 1 Human 8.5 pKi = 8.5 Binding
Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.
Guide to Pharmacology 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C None
3492 685 0 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 12067561
9868459 685 0 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 12067561
CHEMBL50593 685 0 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 12067561
3530 3462 0 None - 1 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 378 6 1 5 3.3 COC(=O)[C@@H](NC(=O)c1ccc2c(c1)cccc2)Cc1ccc(cc1)N(=O)=O None
5311092 3462 0 None - 1 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 378 6 1 5 3.3 COC(=O)[C@@H](NC(=O)c1ccc2c(c1)cccc2)Cc1ccc(cc1)N(=O)=O None
795 568 3 None - 1 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
796 568 3 None - 1 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
9913085 568 3 None - 1 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
CHEMBL20921 568 3 None - 1 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
758 851 0 None -3 4 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8642344
759 854 0 None 6 4 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8642344
787 812 0 None - 1 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8642344
769 813 0 None 446 2 Human 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8642344
771 825 0 None 1 2 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8642344